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ABSTRACT 
 
A wealth of information on proteins involved in many aspects of disease is encased 
within formalin-fixed paraffin-embedded (FFPE) tissue repositories stored in hospitals 
worldwide. However, FFPE full-length protein extracts, as described to date, often 
exhibit a low pattern complexity, together with a poor suitability for downstream gel-
based proteomic techniques. Thus, an optimised method for extraction of full-length 
proteins from FFPE tissues was developed. The results obtained analysing FFPE muscle, 
liver, and thyroid extracts by GeLC-MS/MS, western immunoblotting, protein arrays, 
ELISA, are presented and discussed. An evaluation of the extent of modifications 
introduced on proteins by formalin fixation and crosslink reversal, and their impact on 
quality of MS results, is also reported.  
Moreover, 2D-PAGE, and 2D-DIGE, protein maps of formalin-fixed samples, which 
show satisfactory proteomic information and comparability to fresh tissues, have 
never been illustrated so far. In the present study, 2D-PAGE and 2D-DIGE separation 
and mass spectrometry identification of full-length proteins extracted from fixed 
skeletal muscle and liver tissues are reported. Furthermore, interesting features are 
detailed, such as the composition of formalin-induced protein artificial complexes, the 
constant acidic shift of FFPE proteins pI, as well as the inverse correlation between 
percentage of lysine residues of a protein and preservation of signal intensity of its 2D-
spot.  
Finally, the application of 2D-DIGE-MS and GeLC-MS/MS for differential proteomic 
investigation of FFPE diseased samples was pursued. First, a comparison between the 
proteomes of sheep liver samples, affected by heavy metal intoxication at two 
different levels, is presented. Several differential stress biomarkers were detected, and 
data achieved by the two gel-based proteomic methods exhibit a high consistency. 
Subsequently, a biomarker discovery study was conducted, analysing two human lung 
neuroendocrine tumour forms (typical carcinoid, TC, and small cell lung carcinoma, 
SCLC). Duplicate GeLC-MS/MS analysis of 3 TC and 3 SCLC cases led to the 
identification of over 400 unique proteins per tumour class, which were classified 
according to molecular function, biological process, and cellular localisation. A panel of 
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over 30 differentially expressed putative biomarkers was identified. In addition, a 2D-
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1. AIM OF THE STUDY 
 
 
I. Preliminary remarks 
 
The research field denominated biomarker discovery can be considered as a hub of 
biomedical translational research. A plethora of degenerative and infectious diseases 
can be subject of a biomarker discovery study. Indeed, the crucial challenge is to make 
molecular information achieved for a specific illness state useful for clinical 
applications.  
Biomarkers can be classified according to different points of view. Under a clinical 
approach, diagnostic, prognostic, and predictive biomarkers can be distinguished. 
Diagnostic biomarkers facilitate to discriminate a pathological from a healthy state; 
prognostic ones allow identifying severity degree of a disease and predicting its future 
course; last, but not least, a predictive marker enables to select the more appropriate 
drug for a particular subtype of a disease, in relation to resistance forms or peculiar 
physiopathological features. 
Moreover, several biological molecules can be targeted as disease markers, namely 
genomic sequences, transcripts (mRNA, miRNA), proteins, and metabolites. Protein 
biomarkers reflect more truly the functional properties of a tissue and can be 
measured by cheap and widespread methods, such as immunoassays. Recent 
technological development makes available a wide range of molecular techniques, 
which represent an optimal tool for mining the proteome in search for robust and 
suitable markers. Differential proteomics projects, carried out by electrophoresis- 
and/or mass spectrometry-based approaches, are the best way for identifying 
molecule panels which can be associated with a typical pathological state. 
However, when the aim is to characterise the proteome of a diseased tissue, poor 
availability of clinical samples often makes difficult to perform thorough and 
statistically supported researches. Therefore, it is very important to find new methods 
to elucidate molecular signature of important diseases with a low, or lowest, 
population prevalence. 
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II. Primary and secondary objectives 
The objective of this study was to develop and apply proteomics methodologies useful 
for biomarker research in rare disease samples. Proteomic techniques allow the 
identification of differential protein profiles between pathological and healthy tissues, 
or between different degrees or subtypes of a particular disease.  
Yet, the only feasible way to investigate rare disease samples relies on the valuable 
repositories of fixed and embedded bioptic tissues, stored in hospitals worldwide. 
Unfortunately, the fixation procedure, most frequently performed with formalin, 
causes an “entrapment” of macromolecules within the tissue matrix, due to intra- and 
intermolecular crosslinking, which dramatically impairs protein extraction efficiency 
and antigen immunoreactivity. The methods developed so far to extract proteins from 
fixed tissues samples exhibit a poor suitability for downstream proteomics techniques. 
Thus, the primary objective of this work was to develop an efficient and versatile 
procedure for protein extraction from formalin-fixed, paraffin-embedded tissues 
(FFPE), that would allow differential proteomic analysis by widespread laboratory 
methods.  
In keeping with this effort, the present choice for a diagnostic model fell on lung 
neuroendocrine tumours (lung NETs), because of their heterogeneity, clinic impact and 
diagnostic complexity. Indeed, since some of them (especially typical carcinoid, TC) 
show a very low frequency, it is not realistic to envisage that a whole biomarker 
discovery study could be carried out analysing only fresh biopsies. Hence, to perform 
an in-depth proteomic characterisation of model FFPE tissues, a secondary objective of 
this study was to apply the above mentioned method to the investigation of diagnostic 
and prognostic markers of lung NETs. 
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2. EXPERIMENTAL METHODOLOGY 
 
 
I. State of the art in biomarker discovery methodologies 
 
1. Biomarkers: essential concepts  
The term biomarker (biological marker) was introduced in 1989 as “measurable and 
quantifiable biological parameter which serves as index for health- and physiology-
related assessments”. In 2001, an NIH working group standardised its definition as “a 
characteristic that is objectively measured and evaluated as an indicator of normal 
biological processes, pathogenic processes, or pharmacologic responses to a 
therapeutic intervention”.  Though historically associated with a physical trait or a 
physiological measure, the term is now typically synonymous to molecular biological 
marker [1,2]. 
Biomarkers can be indicators of disease trait (risk factor), disease state (preclinical or 
clinical), or disease rate (progression). Accordingly, biomarkers can be classified as 
antecedent biomarkers (identifying the risk of developing an illness), screening 
biomarkers (screening for subclinical disease), diagnostic biomarkers (recognizing 
overt disease), staging biomarkers (categorizing disease severity), prognostic 
biomarkers (predicting future disease course), predictive biomarkers (forestalling 
response to therapy), or monitoring biomarkers (monitoring efficacy of therapy). In the 
biopharmaceutical industry, biomarkers define molecular taxonomies of patients’ 
diseases and serve as surrogate endpoints in early-phase drug trials [1-4].  
Biomarker discovery is a systematic process in which a series of experimental aims 
need to be considered. Currently, the most commonly applied pipeline for biomarker 
development involves a global discovery phase on small numbers of samples followed 
by validation of the potential biomarker with large numbers of patient samples, before 
it is eventually adopted as a clinical tool. A plan including five distinct phases for the 
development and testing of disease biomarkers, established by the US National Cancer 
Institute, is shown in Table 2.1 [5-6]. 
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Table 2.1. The five phases involved in the development and testing of disease biomarkers (Issaq, 2007) 
Phase Description 
1 Discovery phase: Exploratory studies to identify potentially useful biomarkers. 
2 Validation phase: Biomarkers are studied to determine their capacity to distinguish 
between diseased and healthy people. 
3 Studies to assess the capacity of a biomarker to detect preclinical disease by testing the 
marker against tissues collected longitudinally from research cohorts. 
4 Prospective screening studies. 
5 Definitive large-scale population studies to determine the overall impact of screening on 
health outcomes in the target populations. 
 
An ideal biomarker should be found in a sample whose acquisition is as noninvasive as 
possible (blood, urine, saliva, etc.), and sample preparation is minimal. The required 
technology for biomarker identification should be simply to operate, easily accessible, 
and low-cost. The results should be rapidly attainable and easily interpreted, and 
should give a high degree of accuracy with no false-positives or false-negatives (i.e., 
100% specificity and sensitivity) [6]. 
 
2. “Omics” revolution and biomarker discovery  
The sequencing of the human genome, together with the introduction of new 
technologies allowing rapid, wide range, quantitative analysis of gene and protein 
expression in cells and tissues,  were perceived as a major revolution in biomedical 
research.  Besides genomics, several holistic approaches aimed at studying entities in 
groups or aggregates (“omics”) have been introduced and developed more or less 
successfully, including epigenomics, transcriptomics, microRNomics, proteomics, 
metabolomics, gylcomics, lipidomics, interactomics, and so on.  
The concept beyond omics approaches is that a given biological or molecular system 
can be best determined and understood by considering it in its globality, rather than 
studying its components individually. This concept is also the founding principle of 
systems biology, in which a given system is monitored in its entirety (“holistically”) in 
response to changes, so that it can be better modeled and thoroughly understood 
compared to a single gene, or single pathway, approach. Omics studies generate high-
dimensional data sets, which often require the implication of mathematical, statistical 
and computational efforts (i.e. bioinformatics) and the development of novel analytical 
tools [7-10]. 
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All omics sciences, in view of aforenamed features, can represent a useful tool for the 
identification of new biomarkers. Comparing molecular profiles of healthy and 
pathological samples, or those of different subtypes of a disease, according to a 
genomic, transcriptomic, proteomic, and/or metabolomic approach, can highlight 
differential patterns, which may have a significative clinical application.  
 
3. Genomics, transcriptomics, and metabolomics approaches   
Recent advances in microarrays and deep sequencing technologies allow to thoroughly 
investigate DNA and RNA peculiarities of a tissue. Genomics, epigenomics, 
transcriptomics, and miRNomics, can exploit these two high-throughput approaches in 
order to characterise and quantify cellular nucleic acids and their modifications. 
Genomics focuses on determination of DNA sequence variations among a population, 
which can be strongly correlated to disease risk. Genome-wide association studies 
investigate millions of common DNA sequence variants in the human genome, whose 
most common type are single nucleotide polymorphisms (SNPs), which can informative 
antecedent biomarkers. Also sequencing of tumour cell genomic DNA has been applied 
to identify “driver mutations”, which might clearly have an important impact on cancer 
molecular diagnosis and prognosis assessment [12-14].  
Epigenomics studies essentially DNA methylation and post-translational modifications 
of histones, which can both be related to various illness states. Recent technology 
development has enabled the analysis of DNA methylation in a genome-wide scale, by 
array-based or non-array-based approaches, allowing the detection of epigenetic 
cancer biomarkers [12, 15-16]. 
Transcriptomics has been used to describe the global mRNA expression of a particular 
tissue, yielding information about the transcriptional differences between two or more 
healthy or disease states. Genome-wide expression studies empowered by microarray 
analysis enable the systematic analysis of complex biological systems. Differentially 
expressed genes demonstrated the potential to serve as prognostic biomarkers and 
therapeutic targets [12, 17]. 
Also microRNAs (miRNA) have been implicated in many human diseases, including 
tumor initiation and progression. Differential expression of miRNAs has revealed 
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diagnostic, prognostic and therapeutic implications. There are several approaches for 
genome scale miRNA expression profiling, such as miRNA oligo arrays,  multiplexed q-
RT–PCR assays and bead-based methods [18-24]. 
Metabolomics is a discipline that aims to identify and quantify the global composition 
of ‘metabolites’ of a biological fluid, tissue, or organism. A ‘metabolite’ may be defined 
as a native small molecule that participates in general metabolic reactions and is 
required for the maintenance, growth, and normal function of cells. The primary aim 
of global profiling of the endogenous and exogenous metabolites in biological samples 
is to discover single or associated biomarkers that aid in early diagnosis [25-26].  
The experimental approach for global metabolic analysis has evolved over time. 
Nuclear magnetic resonance spectroscopy (NMR) has been used long since for the 
study of the chemical composition of biological fluids; recently, other techniques has 
been introduced, like gas chromatography (GC) (for nonpolar compounds) and liquid 
chromatography (LC) (for polar compounds), followed by MS detection, as well as 
Fourier transform infra-red spectroscopy, Raman spectroscopy, and direct infusion ESI-
MS. There is no current method capable to detect and quantitate the entire 
metabolome of a tissue; indeed, subdivisions of metabolomics are now emerging, such 
as peptidomics, glycomics, and lipidomics [27-30]. 
 
4. Proteomics techniques for biomarker discovery: gel-based vs gel-free 
The term proteome was first coined to describe the set of proteins encoded by a 
genome in a specific cell type or condition. The study of the proteome, called 
proteomics, now evokes not only all the proteins in any given cell, but also the set of 
all protein isoforms and modifications, the interactions between them, the structural 
description of proteins and their higher-order complexes. Since proteins represent the 
preponderance of the biologically active molecules responsible for most cellular 
functions, it is believed that the direct measurement of protein expression can 
more accurately indicate cellular dysfunction underlying the development of disease; 
thus, proteomics holds special promise for biomarker discovery. Proteomics 
techniques useful for biomarker research can be divided into two principal  groups: 
gel-based proteomics methods and gel-free proteomics methods [4, 31].  
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A gel-based proteomic experiment comprises a first separation of a protein mixture 
through gel electrophoresis, followed by MS identification. The two most common 
forms of gel electrophoresis are 2D-PAGE and 2D-DIGE. In both methods, proteins are 
resolved in two sequential steps, according to their charge in the first dimension and 
to their mass in the second dimension. Good resolution of proteins is obtainable; 
however, the technique is not amenable to automation or direct coupling to the mass 
spectrometer. In 2D-PAGE, each sample is analysed in a distinct gel. After separation, 
staining is carried out to reveal protein expression; protein signals are compared, spots 
of interest are excised, proteins within the spot are enzymatically digested, and 
resultant peptides are extracted and analysed using MS [32-25] .  
Ünlü et al. introduced 2D-DIGE to improve the reproducibility and reliability issues 
encountered with 2D-PAGE. In a simple DIGE experiment, proteins from two samples 
are labelled, each with a different cyanine fluorescent dye that has a different 
excitation and emission wavelengths. The two samples are mixed and loaded in the 
same gel. The same protein labelled with any of the dyes will migrate to the same 
position on the gel, because the dyes do not affect the size or the isoelectric point of 
the protein. Proteins are visualized by subjecting the gel to the excitation wavelengths 
of each of the dyes. Spots of interest are excised and treated as mentioned earlier. 
(Issaq, 2009) Several benefits of 2D-DIGE for proteomic analysis of biological samples 
in search of a biomarker can be highlighted. First, the use of the internal standard, 
which allows reliable comparison between different gels; second, separation of the 
two protein extracts of interest employing the same gel improves reproducibility 
because 50% fewer gels are required; third, differences in protein expression between 
two samples of proteins are easier to compare and can be more accurately imaged; 
fourth, DIGE requires less time to detect the protein spots because the labelling 
reaction in DIGE is faster than visualization using other staining methods. Hence, 2D-
DIGE can be considered as the method of choice when absolute protein variation 
between two biological samples is the primary target, as in biomarker discovery 
projects. (32, 33, 36-39) 
An alternative simple and easily performed approach is one-dimensional (1D)-SDS-
PAGE protein separation, combined with nano-LC-MS/MS of in-gel-generated peptides 
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for protein identification. This method, named GeLC-MS/MS, constitutes an interesting 
compromise between the advantages and shortcomings of the aforementioned 
techniques; actually, it gains access to categories of proteins typically not accessible via 
2D-PAGE (notably, large proteins and those with extreme pIs), and exploits excellent 
sensitivity of LC-MS/MS identification with samples of low complexity, as 
prefractionated by an electrophoretic separation [40-43].  
Among gel-free methods, “shotgun proteomics”, also named multidimensional protein 
identification technology (MudPIT), has achieved a great success and a widespread 
application in the last few years. This technique consists of an early enzymatic 
digestion of the entire protein mixture, and a subsequent multidimensional separation 
of peptides, followed by on-line mass spectrometric peptide detection and sequencing. 
Many approaches, using two or more orthogonal HPLC procedures (for example, 
IEX/RP, Affinity/IEX/RP), or capillary electrophoresis  separation (namely, CZE, CEC, 
CIEF), have been tried to separate complex peptide mixtures such as cell lysate digest 
[44-48]. Relative quantitation of proteins in a bottom-up LC/MS-based proteomics 
experiment is carried out by a variety of stable isotope labelling techniques. Typically, 
control and compared samples are differentially stable isotope tagged using in vivo or 
in vitro labelling.  An alternative approach has been developed, that does not require 
differential stable isotope labelling, and is thus referred to as label-free method. This 
approach is attractive because of its simplicity, cheapness and easiness to be carried 
out. However, it requires high reproducibility of HPLC separation and high sensitivity to 
detect low abundance peptides [33, 49-52] 
Furthermore, proteomic analyses have been recently extended to whole tissue 
sections by using MALDI imaging. This approach allows detection of proteins in situ in 
the tissue sections, and analysis of their spatial distribution. Each MALDI imaging data 
set containing large number of mass spectra may be evaluated using hierarchical 
clustering, that is helpful in classification and interpretation of complex tissue 
proteomic patterns [53-54]. 
Another MS-based technology, useful for proteomic patterns comparison for 
diagnostic purposes, is SELDI TOF-MS. In this technique, sample is captured by the 
chromatographic surface of a protein chip arrays and then analysed by MS. The result 
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is a mass spectrum of all the bound proteins/peptides, which serves as a “fingerprint” 
of tissue proteome [55-56]. 
Trying to summarise principal benefits and drawbacks of gel-based and gel-free 
methods, it can be noted that gel-based strategies offer the advantage of visualisation 
of proteins and, to some extent, their modifications, and therefore preserves the 
protein context. On the other hand, gel electrophoresis has the intrinsic limitation of 
reducing sample complexity to more limited MW and pI ranges, if compared to 
shotgun approach. By contrast, early digestion strategies generate peptides upstream 
in the analysis workflow; peptides are more easily amenable to separation and analysis 
and behave more uniformly than proteins. Another difference between the two 
methods is that the relative abundances of proteins in the samples are compared 
before MS analysis (2D-PAGE), while in LC/MS the comparison is carried out after the 
MS data have been acquired [57-58]. 
 
 
II. Methods for extracting and analysing proteins from FFPE tissues 
 
1. Formalin fixation, antigen retrieval and protein extraction methods 
Formaldehyde fixation and paraffin embedding of tissue biopsies are routinely 
performed in hospitals worldwide. Formaldehyde fixation allows long-term stability 
and maintenance of tissue architecture, and paraffin embedding facilitates handling 
and microtome slicing of samples [59]. The combined FFPE treatment is aimed to 
histological examination of tissues, and results in highly stable tissue blocks which can 
be easily stored for years at room temperature in form of “biopsy banks”. In the last 
decades, large repositories of healthy and pathological FFPE tissues have been 
generated worldwide, with associated information concerning diagnosis, treatment, 
and outcome of the patient. These FFPE tissue archives might therefore represent an 
important resource for retrieving information on proteomic repertoires associated to 
many disease processes. 
Unfortunately, however, the FFPE procedure leads to what is regarded as an 
irreversible “entrapment” of macromolecules within the tissue matrix, consequent to 
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the establishment of extensive intra-and intermolecular crosslinks. Formaldehyde 
fixation acts on basic and amidic side chains through a serial process involving 
generation of methylol (hydroxymethylol) adducts, formation of Schiff bases, and 
finally introduction of apparently irreversible, stable methylene bridges. These bonds 
impair protein extraction efficiency, reduce immunoreactivity, and may result in 
alterations leading to misidentification of proteins with MS techniques [60-63]. 
For several years, immunohistochemistry (IHC) has been the only technique able to 
gather information from FFPE samples. In 1991, Shi and coworkers demonstrated that 
a brief incubation at high temperatures in suitable buffers allowed a considerable 
improvement in the IHC signal [64]. This simple and efficient empiric method, named 
antigen retrieval, is still regarded as the only procedure able to induce a strong 
increase of the immunohistochemical signal. The mechanism underlying the antigen 
retrieval process seems to rely on restoration of antigenic properties through a series 
of protein conformational changes, probably facilitated by the hydrolysis of formalin-
induced crosslinks [65-70]. 
Almost all FFPE full-length protein extraction methods developed so far (also patented 
ones) are based on antigen retrieval concept; they necessarily provide a heating step, 
in order to release an adequate amount of proteins from the crosslinked matrix [71-
79]. 
 
2. FFPE proteomics: shotgun vs full-length analysis 
Many efforts are now underway by several research groups, aimed to release the 
proteomic information entrapped within this tissue matrix. To date, two main 
strategies have been applied, with varying degrees of success. One is based on direct 
proteolytic digestion followed by MS characterization of the complex peptide mixture 
by means of sophisticated mass spectrometry instrumentation, according to a shotgun 
proteomics experimental workflow. The second approach is aimed to recover full-
length proteins by reversing the formaldehyde-induced crosslinks, through various 
modifications of the seminal antigen retrieval technique above mentioned. Reaching 
this goal would open the way to observe differential protein expression by combining 
2D-PAGE/MS analysis, immunostaining of 2D-PAGE separated proteins, staining for 
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phosphorylated or post-translationally-modified proteins, and, last but not least, 
differential in gel electrophoresis (DIGE), on proteins extracted from FFPE tissues. 
In a pioneering work published in 1998, Ikeda and coworkers [71] used the heat-
induced antigen retrieval process to obtain protein extracts from FFPE tissues, but 
failed to obtain results comparable to fresh tissues. However, their method allowed 
the identification of eight diagnostically useful proteins at the expected molecular 
weight by western immunoblotting. Since then, several studies have been undertaken 
with various modifications to obtain proteins from FFPE tissues. Quality and viability of 
FFPE protein extracts have been evaluated by classical protein analysis methods such 
as SDS-PAGE, western immunoblotting, and protein arrays, with variable results [73, 
79]. Recently, Becker and coworkers [80-83] developed a patented heat-extraction 
method and demonstrated its applicability to expression studies based on reverse 
phase protein microarrays. In these studies, despite the intensive efforts to settle the 
issue, quality of FFPE extracts is overall far from enabling differential proteomic 
analysis and application of mass spectrometry procedures on SDS-PAGE separated 
proteins.  
Furthermore, only few studies to date reported the tentative application of 2D-PAGE 
to protein extracts from FFPE tissues [84-85]. Noteworthy, the aim of one of these two 
reports was to demonstrate the purported unsuitability of FFPE tissues to 2D 
proteomic studies. Therefore, application of 2D-PAGE separation followed by in-situ 
protein digestion and MS or MS/MS analysis, the fundamentals of gel-based 
proteomics, still appears to be challenging on FFPE tissues.  
To overcome the limitations due to protein quality, several authors recently provided a 
rational development of methods to extract peptides from FFPE tissues followed by 
direct mass spectrometry identification. Taken together, these studies provide several 
methods enabling peptide MS analysis on FFPE extracts, which have been fruitfully 
applied for biomarker discovery investigations on a vast set of tissues and diseases [74-
75, 77-78, 86-97]. However, information about the entire protein is lost, protein 
extract is not suitable also for subsequent immunological assays, and, most of all, 
advanced instrumentation is required for direct MS analysis of the extracted peptides, 
such as Orbitrap mass spectrometers or 2D chromatography-MS/MS facilities. At the 
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time of this writing, the application of these methods by use of more widespread 
analytical platforms, such as LC-ESI-QTOF instrumentations, has restricted 
identification to a very limited number of proteins [76]. Recently, also MALDI imaging 




III. Gel-based proteomics on FFPE tissues: what, how and why 
 
In view of the above mentioned state of the art in FFPE proteomics field, gel-based 
proteomics techniques were chosen to be applied for the characterisation and 
biomarker discovery-oriented investigation of formalin-fixed tissues. As described in 
the previous section, this is an almost  unexplored field in FFPE research, and the 
potential of the wide gamut of methods, ranging from GeLC-MS/MS to 2D-DIGE, have 
still to be thoroughly and effectively exploited. Moreover, working with full-length 
proteins bears several advantage, such as the opportunity to use the same protein 
extract for electrophoretic, MS, and immunological analysis, to search for post-
translational modifications, and to evaluate the overall “entire proteins” profile of a 
tissue. The pre-fractionation step carried out by 1D- or 2D-electrophoresis leads also to 
the possibility to achieve protein identification without the need of highly 
sophisticated MS instrumentation. 
According to this reasons, the development of an optimised full-length protein 
extraction method from FFPE tissues was pursued. Such an extract is suitable for direct 
PAGE analysis, and allows the application of a vast and complete assortment  of 
downstream proteomic techniques and immunoassays. Hence, several animal and 
human tissues (healthy skeletal muscle, liver, and thyroid, as well as pathological liver, 
lung carcinoid, and small cell lung carcinoma) were subjected to a proteomic 
investigation by means of various gel-based approaches, as GeLC-MS/MS, 2D-PAGE-
MS, and 2D-DIGE-MS, with the final purpose of identifying useful putative disease 
biomarkers.  
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3. EXPERIMENTAL ACTIVITIES 
 
 
I. Experimental design 
 
 





1. Sheep samples  
Sheep tissues used for optimisation of extraction and analysis procedures were 
obtained as follows. Immediately after slaughtering, tissue cubes smaller than 1 cm3 
were cut from femoral muscle and liver, and multiple replicate samples were 
immediately frozen at -80°C, or fixed in 10% buffered formalin for 48 h, dehydrated 
with a graded series of alcohol, and embedded in paraffin, respectively. 
 
2. Human samples 
Samples of human hyperplastic thyroid gland were obtained from routine hospital 
surgical procedures and immediately frozen at -80°C. Bioptic human hyperplastic 
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thyroid gland, small cell lung carcinoma, and typical carcinoid sections were cut from 1 






Figure 3.2. Methodologies flowchart 
 
1. Protein extraction and quantitation 
Replicates of 10 FFPE tissue microtome sections, 10 µm thick, 80 mm2 wide, were 
placed in Eppendorf safe-lock tubes (Eppendorf, Hamburg, Germany) and 
deparaffinised by incubation at RT in xylene for 10 min. After each incubation, the 
tissue was pelleted at 12,000 x g for 3 min, and incubation/centrifugation steps were 
repeated two more times. The deparaffinised tissue pellets were then rehydrated with 
a graded series of ethanol. Replicates of fresh-frozen tissues were minced with a sterile 
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scalpel and placed in Eppendorf safe-lock tubes. All samples were then weighed, and 
matched amounts of tissues were each immersed at a 20% w/v ratio in a 20 mM Tris 
HCl pH 8.8, 2% SDS, 200 mM DTT, extraction buffer (EB). All samples were subjected to 
high-temperature extraction at 100°C for 20 min, and then at 80°C for 2 h with 
shaking.  
For extraction efficacy and protein recovery evaluation, replicates of ten 80 mm2 wide, 
10 μm thick, FFPE skeletal muscle and liver tissue sections, and replicates of ~35 mg of 
fresh-frozen matched tissues were treated as follows. FFPE tissue replicates were 
deparaffinised, rehydrated, and weighed as above. Three replicates of deparaffinised, 
rehydrated FFPE muscle and liver tissue pellets, and three aliquots of fresh-frozen 
muscle and liver tissue were centrifuged to dryness using a Centrivac system (Heraeus, 
Hanau, Germany) and reweighed in order to assess average dry weight compared to 
wet weight. Three replicates of each deparaffinised, rehydrated tissue and three 
replicates of each fresh-frozen tissue were then subjected to comparative extraction as 
above or with the method described by Shi et al. [75]. Tissue pellets were alternatively 
immersed in of EB or retrieval solution (RS, 20 mM Tris HCl pH 7, 2% SDS), with a ratio 
of 5 μl for 1mg of wet weight. Extraction was then carried out at 100°C for 20 min, and 
then at 80°C with agitation (EB samples), or at 60°C without agitation (RS samples), for 
2 h.  
For preparation of protein extracts of fresh-frozen tissues with mechanical lysis, 
replicates of fresh-frozen tissues were fragmented into small pieces with a sterile 
scalpel, placed in 2 mL Eppendorf safe-lock tubes (Eppendorf, Hamburg, Germany), 
immersed at 5% w/v in EB, and subjected to three cycles of 3 min at 30 cycles/s in a 
TissueLyser mechanical homogenizer (Qiagen, Hilden, Germany).  
All extracts were clarified for 15 min at 12,000 x g at 4°C, quantified by the Bradford 
method [104] and with the EZQ protein quantitation kit (Molecular Probes, Eugene, 
OR), and stored at -80°C until needed. 
 
2. Electrophoretic techniques: SDS-PAGE, 2D-PAGE, 2D-DIGE 
Protein extracts obtained from fresh-frozen and FFPE tissues were subjected to SDS-
PAGE according to Laemmli [105]. Proteins were stained with Brilliant blue G 250 
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according to Westermeier [106] and gel images were digitalised with an ImageScanner 
(GE Healthcare, Little Chalfont, UK). 
For two-dimensional electrophoresis, protein extracts obtained from fresh-frozen and 
fixed tissues were precipitated with TCA-Acetone [20]. To 200 µl of FFPE protein 
extract in EB, 40 µl of 60% TCA were added and the mixture was incubated overnight 
in ice. The mixture was centrifuged at 10,000 x g at 4°C for 30 min, the supernatant 
was removed, and 100 µl of ice-cold acetone were added to the pellet. The sample was 
incubated on ice for 15 min and centrifuged as above. The acetone-containing 
supernatant was removed and the pellet was air-dried. Protein pellets were 
resuspended at the desired protein concentration in 9 M urea, 4% CHAPS, 1% 3-10 NL 
IPG buffer, and 50 mM DTT.  
Resuspended proteins were then absorbed overnight into 7 cm or 18 cm 3-10 NL IPG 
strips. Focusing was carried out for a total of 25,000 and 55,000 Vh for 7 cm and 18 cm 
strips, respectively. After focusing, strips were equilibrated in 50 mM Tris HCl, pH 6.8, 
2% SDS, 7 M urea, 10% glycerol, supplemented with 2% DTT for 10 min, and then with 
2.5% iodoacetamide for 10 min. Proteins were subjected to SDS-PAGE on 12% 
polyacrylamide gels with the mini and midi formats (10 cm and 20 cm, respectively) on 
the Mini Protean Tetra Cell and on the Protean Xi Cell (Bio-Rad Laboratories, Hercules, 
CA), respectively, following the manufacturer instructions.  
Proteins were stained with colloidal Coomassie staining [106], mass-compatible silver 
staining [107], or with Sypro Ruby protein gel stain (Molecular Probes, Eugene, OR). 
Images were digitalized with an Image Scanner (GE Healthcare, Little Chalfont, UK). 
Image analysis was carried out with ImageMaster Platinum 6.0 (GE Healthcare), and 
with PDQuest Advanced 8.0.1 (Bio-Rad). For ImageMaster Platinum, values of smooth, 
min. area, and saliency were of 7, 10, and 250, respectively, while for PDQuest 
Advanced, values of sensitivity, size scale, and min. peak were of 4, 11, and 1500, 
respectively. 
For 2D-DIGE analysis, protein extracts obtained from fresh-frozen and fixed tissues 
were precipitated with TCA-Acetone as described above, and resuspended at a 
concentration of 1-5 mg/ml in a buffer composed by urea (7M), Thiourea (2M), and 
CHAPS (4%).  
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Then, samples were labelled with CyDye DIGE Fluors (GE Healthcare), according to the 
minimal labelling protocol provided by the manufacturer. Briefly, after CyDye 
reconstitution with dimethylformamide (DMF) and preparation of a working solution 
(200 pmol/μl), 1 μl of diluted CyDye was added to a volume of protein sample 
equivalent to 50 μg. Samples were left on ice for 30 minutes in the dark, and then 1 μl 
of 10 mM lysine was added to stop the reaction. After 10 minutes on ice in the dark, 
labelled samples were directly mixed and analysed by DIGE or stored at -80°C until 
needed.  
After mixing the labelled protein extracts to be loaded on the same gel, IPG buffer 
(corresponding to the desired pH range, at a 1% final concentration) and DeStreak 
Rehydration Solution (GE Healthcare) were added to a final volume of 450 μl. 24 cm 
IPG strips (GE Healthcare) were passively rehydrated for at least 6 hours. IEF was 
carried out on a Ettan IPGphor II (Amersham) for a total of 90-100.000 Vh. After 
focusing, strips were equilibrated as stated above. Proteins were then subjected to 
SDS-PAGE in 10-18% gradient polyacrylamide gels on the Ettan DALTsix system (GE 
Healthcare), following the manufacturer instructions. Gel image acquisition was 
performed on a Typhoon 9400 laser scanner, and image analysis was carried out using 
DeCyder 2D software  (version 7.0, GE Healthcare). 
 
3. In-gel trypsin digestion 
For 1D-PAGE bands, visible protein bands were excised, or all lane was fractionated 
into gel slices, independently from band position and intensity. Bands were destained 
by repetitive washings with 50 mM NH4HCO3, pH 8.0, and acetonitrile. Samples were 
reduced and carbamidomethylated in 50 mM NH4HCO3 buffer, pH 8.0, first with 10 
mM DTT at 56°C, and then with 55 mM iodoacetamide at RT in the dark. Tryptic 
digestion of the alkylated samples was performed at 37°C overnight using 60 to 100 ng 
of trypsin per band or gel slice, according or not to band intensity, respectively. 
For 2D-PAGE spots, protein spots were excised from the gel and destained by 
repetitive washings with 50 mM NH4HCO3, pH 8.0, and acetonitrile. Tryptic digestion 
was performed at 37°C overnight using 50 to 100 ng of trypsin, according to spot 
intensity. 
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4. Mass spectrometry techniques: LC-MS/MS and MALDI-MS 
LC-MS/MS analyses of tryptic digests were performed on a Q-TOF hybrid mass 
spectrometer equipped with a nano lock Z-spray source,  and coupled on-line with a 
capillary chromatography system CapLC (Waters, Manchester, UK). After loading, the 
peptide mixture (6 µL) was first concentrated and washed at 20 µL/min onto a reverse-
phase pre-column (Symmetry 300, C18, 5 µm, NanoEase, Waters) using 0.2% formic 
acid as eluent. The sample was then fractionated onto a C18 reverse-phase capillary 
column (Symmetry, 75 µm x 15 mm, Waters) at a flow rate of 250 nL/min, using a 
linear gradient of eluent B (0.2% formic acid in 95% acetonitrile) in A (0.2% formic acid 
in 5% acetonitrile) from 7 to 50% in 40 min. Mass spectrometer was set up in a data-
dependent MS/MS mode where a full scan spectrum (m/z acquisition range from 400 
to 1600 Da/e) was followed by a tandem mass spectrum (m/z acquisition range from 
100 to 2000 Da/e). Peptide ions were selected as the three most intense peaks of the 
previous scan. A suitable collision energy was applied depending on the mass and 
charge of the precursor ion. Argon was used as the collision gas.  
ProteinLynx software, provided by the manufacturers, was used to analyze raw MS and 
MS/MS spectra and to generate a peak list which was introduced in the in-house 
Mascot MS/MS ion search software (Version 2.2, Matrix Science, Boston, MA) for 
protein identification. Search parameters were as follows: peptide tolerance 50 ppm, 
MS/MS tolerance 0,4 Da, charge state +2 and +3, enzyme trypsin, allowing up to 1 or 2 
missed cleavages.  
In regard to MALDI-MS analyses, mass spectra were recorded on a MALDI micro 
(Waters, Manchester, UK) equipped with a reflectron analyser and used in delayed 
extraction mode. Peptide samples were mixed with an equal volume of α-cyano-4-
hydroxycynnamic acid as matrix (10 mg/mL in acetonitrile/0.2% TFA) (70:30, v/v), 
applied to the metallic sample plate, and air dried. Mass calibration was performed by 
using the standard mixture provided by manufacturer. Raw data, reported as 
monoisotopic masses, were then introduced into in house MASCOT Peptide Mass 
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5. Data analysis 
Total peptide hits were used as a parameter for estimating and comparing protein 
abundance. Total peptide hits value for each protein was calculated by summing 
“queries  matched” number (as indicated by Mascot) of all gel bands corresponding to 
a single sample. Unique peptides and sequence coverage values reported in all tables 
have to be intended as the best value obtained in a single LC-MS/MS run (always 
among all bands analysed for a sample). Only proteins which reported at least one 
peptide ranked by Mascot with a value equal to 1 were included. Queries matched 
with more than a protein hit (among protein hits obtained from a single LC-MS/MS 
run) were counted for each of the proteins. Skin keratins were excluded from the final 
protein list. 
Gene Ontology (GO) assignments were carried out using GoMiner [108] and DAVID 
[109] softwares, and graphical representations (histograms, pie charts, plots) were 
generated with Microsoft Excel.  
Assessment of aminoacidic residues percentage were carried out by means of 
ProtParam tool, ExPASy [110]. 
Statistical analysis of data illustrated in Chapter 6 was performed by exploiting a 
Wilcoxon's Rank-Sum test [111]. Statistical analysis of data illustrated in Chapter 8 was 
carried out using a Kruskal-Wallis H test, which is a nonparametric version of one-way 
analysis of variance [111]. Considering k samples of sizes N1, N2, .., Nk, with N = 
sumNi, ranking all the data, regardless to the k samples, and indicating with R1, R2, ..., 
Rk the sums of the ranks for the k samples, the following statistic is defined:  
H = {12/N(N+1)}*sum {j=1 to k} (Rj^2/Nj) - 3(N+1). 
 
6. Immunological techniques: Western blot, Protein arrays, ELISA 
For western blot, electrophoresed proteins were transferred to nitrocellulose using the 
Bio-Rad MiniTransBlot apparatus according to standard procedures. After transfer, 
membranes were blocked in Phosphate Buffered Saline, 0,05% Tween 20 (PBS-T), and 
5% skim milk or 3% BSA for 1 hour to overnight, and then processed for immunological 
detection. Antibody reactivity was detected using HRP-conjugated secondary goat anti-
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rabbit IgG, and visualized with a chemiluminescent peroxidase substrate (Sigma-
Aldrich). Blot images were processed with QuantityOne (Bio-Rad, Hercules, CA). 
In order to perform protein arrays experiments, fresh-frozen and FFPE tissue extracts 
were spotted on nitrocellulose sheets at 1 µg of total protein extract per spot, and 
then in 2 serial dilutions (1:2, 1:4) in extraction buffer, followed by extraction buffer 
without protein as a negative control. Nitrocellulose sheets were allowed to dry, and 
then blocked and processed for immunological detection as explained for Western 
blot.  
ELISAs were carried out as follows. Total proteins from fresh-frozen and FFPE tissue 
extracts were precipitated with trichloroacetic acid/acetone following standard 
procedures, quantified, and resuspended in PBS at a concentration of 100 µg/mL. One 
hundred µL were dispensed in each well of a Maxisorp ELISA plate (NUNC, Thermo 
Fisher Scientific, Rochester, NY), and incubated at room temperature until dry. Wells 
were then washed and blocked with PBS-T plus 5% BSA for 1 hour and then processed 
for immunological detection. Controls for reactivity after incubation with water only, 
PBS only, and secondary antibody only, were always run in parallel with each 
experiment. A chromogenic substrate was then added to all wells (Sigma Peroxidase 
ELISA Substrate) and absorbance was read in wells at 650 nm every 15 min for 1 h. 
Assays were repeated in triplicate, and mean and SD were calculated and plotted with 
Microsoft Excel (Microsoft, Redmond, WA).  
Antibodies and dilutions used were as follows: rabbit polyclonal antibodies (Sigma) 
against actin (1:50,000), GAPDH (1:50,000), tropomyosin (1:5,000), vinculin (1:5,000), 
and mouse monoclonal antibodies against E-cadherin (Zymed, 1:1000), and myosin 
(Millipore, 1:50,000).  
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I. Introduction  
 
Formalin-fixed, paraffin-embedded (FFPE) tissue banks generated for histopathological 
analysis and stored in hospitals worldwide can be considered as a “hidden treasure” 
which could open the way to retrospective studies for biomarker discovery and 
validation. Unfortunately, the fixation procedure causes an “entrapment” of 
macromolecules within the tissue matrix, due to intra- and intermolecular crosslinking, 
which dramatically impairs protein extraction efficiency and antigen immunoreactivity 
[60]. Antigen retrieval (AR) is still considered as the only procedure able to induce a 
considerable improvement in antigenic reactivity of FFPE tissues, through a high-
temperature treatment which probably induces cleavage of protein-protein bonds [64-
66]. Current methodologies that aim to extract full-length proteins from FFPE tissues, 
useful for gel-based proteomics or immunological studies, are based on the antigen 
retrieval concept [71-79]. However, protein extracts produced by the methods 
described to date exhibit a low pattern complexity, together with a poor suitability for 
downstream gel-based proteomic techniques. Thus, the aim of this research was to 
develop an extraction method with a high degree of efficiency and versatility, which 
allows the application of a wide gamut of analytical approaches, such as GeLC-MS/MS, 





1. High-quality proteins can be extracted with high yield from FFPE tissues  
After slaughtering, muscle and liver sheep tissues were cut into blocks, and 
immediately fixed to avoid autolysis of proteins. Parallel samples were also frozen in 
order to obtain valid tissue and subject-matched controls for viable, unfixed proteins. 
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Starting from one month after fixation and embedding, microtome sections were cut 
from the FFPE blocks and used for optimisation of the extraction protocol. The best 
extraction performance was obtained upon deparaffinisation with xylene, rehydration 
with a graded series of alcohols, and serial incubation at 100°C and 80°C with a 
buffered detergent solution in a reducing environment. Extraction efficacy was 
assessed comparatively and in triplicate for FFPE and fresh-frozen muscle and liver 
tissues, by relating the amount of extracted proteins to the wet and dry weights of 
starting tissues. Results are reported in Table 4.1.  
 
Table 4.1. Comparative yield of protein extraction from fresh-frozen and FFPE sheep tissues relative to 






Extracted protein/                    
tissue wet weight 
(μg/mg) 
Extracted protein/                      
tissue dry weight 
(μg/mg) 
Skeletal muscle Fresh-frozen 10.2 48.6 145.7 
 
FFPE 2.1 8.2 40.9 
Liver Fresh-frozen 10.8 50.9 152.6 
  FFPE 7.0 28.8 143.8 
 
 
This extraction procedure yielded an efficient and reproducible extraction of proteins, 
especially from liver; the extraction efficacy from FFPE samples reached levels 
comparable to the fresh-frozen samples, especially when dry weights were compared. 
Extraction efficacy was also reproducible but slightly lower for muscle. For comparison, 
protein extraction was also performed in triplicate and in parallel by using the method 
described by Shi et al [75]. Our method produced average protein yields of 16.3 µg and 
86,8 µg per 80 mm2 FFPE muscle and liver tissue slice, respectively, whilst extraction 
with the method described in literature produced average protein yields of 4,6 µg and 
2,4 µg per 80 mm2 FFPE muscle and liver tissue slice, respectively. However, with this 
method, recovery was difficult since the tissue pellet generated was less compact, and 
did not separate from the supernatant as well as the tissue pellet generated with our 
method. For comparison, the yields stated for the main commercial method suited for 
the extraction of full-length proteins from FFPE tissues, the Qproteome FFPE Tissue Kit 
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(Qiagen, Hilden, Germany), are of 15 µg per 10 µm thick,  80 mm2 wide, liver tissue 
slice (comparison in Figure 4.1).  
 
 
Figure 4.1. Quantitative comparison between values of extraction efficiency (expressed in terms of 
micrograms of proteins extracted per tissue slice) achieved using the method developed by our 
laboratory and those stated by a commercial method. 
 
In order to assess integrity, preservation of relative abundance, and quality of 
electrophoretic separation, proteins extracted from FFPE tissues were subjected to 
SDS-PAGE. Figure 4.2 shows the SDS-PAGE profiles obtained upon separation of 
proteins extracted from fresh-frozen and FFPE sheep skeletal muscle and liver tissues. 
Although with few differences, and presence of a light background, the protein 
patterns corresponding to FFPE tissue extracts appear comparable to those 
corresponding to fresh-frozen tissue extracts, both in terms of position and relative 
abundance of protein bands.  
In order to assess consistency and reproducibility of the extraction method when 
applied to FFPE human tissue bank samples, FFPE tissue sections from fresh-frozen and 
FFPE human hyperplastic thyroid gland were subjected to the same extraction 
protocol, producing consistent protein extract concentrations and acceptable SDS-
PAGE banding patterns, although with a lower resolution compared to fresh tissues.  
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Figure 4.2. Representative SDS-PAGE patterns of fresh-frozen and FFPE tissue extracts. Sheep skeletal 
muscle, sheep liver, and human thyroid tissue extracts, obtained from fresh-frozen and FFPE tissues, are 
shown. 
 
2. Proteins extracted from FFPE tissues can be reliably identified by 1D-GeLC-MS/MS 
As stated above, the SDS-PAGE protein separation patterns of fresh-frozen and FFPE 
tissue extracts were of acceptable quality, and resolved protein bands were present. 
Therefore, the SDS-PAGE separation was used as a “pre-fractionation” step for an in 
situ hydrolysis approach, allowing MS/MS analysis of FFPE tissues with a nanoHPLC-
nanoESI-QTOF tandem mass spectrometer. A comparative analysis of fresh-frozen and 
FFPE tissue extracts was then performed by staining the electrophoresed proteins with 
Coomassie, cutting corresponding areas from both lanes (particuarly, 21 matched 
bands), performing in situ digestion, and then subjecting tryptic peptides to MS/MS 
analysis. 
Overall, 85 and 66 proteins were identified from fresh-frozen and FFPE tissue, 
respectively. Fifty-four (64%) of proteins identified in the fresh-frozen tissue were also 
identified in the FFPE tissue; on the other hand, 18% of proteins identified in the FFPE 
tissue were not identified in the fresh-frozen tissue (Figure 4.3, left). The identification 
of some proteins only in FFPE tissues was observed mostly for proteins with one or 
 25 
Alessandro Tanca, Novel methods for proteomics analysis of formalin-fixed, paraffin-embedded tissues (FFPE), and their 
applications for biomarker discovery, Tesi di dottorato in Scienze biomolecolari e biotecnologiche, Università degli studi di Sassari 
two peptide hits. In fact, when considering the top 50 proteins based on the number of 
queries matched, 80% were identified from both tissue extracts (Figure 4.3, right). 
Total peptide hits from FFPE and fresh-frozen tissue sections were 1706 and 1824, 
respectively. It is important to note that these proteins and peptides represent only a 
part of the whole muscle proteome, since only visible gel bands were cut and 
analyzed; nevertheless, when compared with the recent data concerning MS analysis 
of FFPE extracts, which were carried out with more sophisticated instrumentation 
(such as the Orbitrap mass spectrometer), the number of peptide hits obtained from 
the FFPE extract is a satisfactory result. 
 
 
Figure 4.3. Venn diagrams illustrating distribution of proteins identified from fresh-frozen and FFPE 
tissues. Left: 64% of proteins identified from fresh-frozen tissues were also identified from FFPE tissues, 
and 85% of proteins identified from FFPE tissue are also identified from fresh-frozen tissues. Right: 
Among the top 50 proteins, 80% were identified from both fresh-frozen and FFPE tissues. 
 
Initially, we expected the extraction of basic proteins to be a difficult challenge, since 
formalin fixation acts mainly on basic aminoacid residues and therefore basic proteins 
should bear more crosslinks compared to acidic proteins. Yet, even proteins with high 
isoelectric points could be easily identified from FFPE tissue extracts with high levels of 
confidence (for a complete list of GeLC-MS/MS data see Apeendices 1 and 2). 
The mass spectrometry data from 10 selected gel-separated proteins, covering 
molecular weights from 100 to 15 kDa, and isoelectric points from 4 to 9, were also 
used to evaluate the extent of crosslinking reversal and the degree of chemical 
alteration introduced by  fixation. Accordingly, the K-to-R ratio, the extent of 
methionine oxidation, and the number of missed cleavages, were evaluated. Results  
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Name MW pI FrFr FFPE FrFr FFPE FrFr FFPE FrFr FFPE FrFr FFPE 
Alpha actinin-2 104 5.31 27 12 44.4 100 10:17 6:6 3.7 0 3.7 0 
Heat shock 70 kDa protein 70 5.54 10 7 40 71.4 4:6 3:4 0 0 10 14.2 
ATP synthase subunit alpha, mitochondrial  60 9.16 8 9 75 66.6 3:5 3:6 0 0 12.5 0 
Beta-enolase 47 7.60 11 13 81.8 69.2 9:2 10:3 0 15.3 27.3 7.7 
Actin, alpha skeletal muscle 42 5.23 15 14 93.3 100 7:8 6:8 26.6 28.6 26.6 21.4 
Fructose-bisphosphate aldolase A 40 8.31 14 10 71.4 100 7:7 5:5 0 0 35.7 20 
Triosephosphate isomerase  27 6.45 9 8 88.9 100 8:1 7:1 11.1 0 11.1 12.5 
Myosin light chain 1, skeletal muscle isoform 21 4.97 6 6 83.3 83.3 2:4 3:3 0 0 16.7 16.7 
Alpha-crystallin B chain 20 6.76 6 8 100 75 5:1 7:1 0 0 16.7 42.8 
Troponin C, skeletal muscle 18 4.06 8 3 37.5 100 5:3 2:1 25 66.7 0 0 
             
                          




7 11 16 13 
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are summarised in Table 4.2. Overall, only minor differences were observed for these 
parameters among fresh-frozen and FFPE tissue proteins. 
Overall, quality of MS identifications was comparable for both extracts types. Figure 
4.4 presents a comparison of protein distribution according to sequence coverage, 
showing that identification data of FFPE tissue proteins have a confidence level 




Figure 4.4. Histogram representing distribution of proteins identified from fresh-frozen tissues and FFPE 
tissues according to their sequence coverage (expressed in percentage). 
 
Peptides produced after trypsin digestion of proteins extracted from FFPE tissues 
generated nanoLC-nanoESI-Q-TOF fragmentation spectra comparable to those 
generated from fresh-frozen tissue extracts (Figure 4.5). Formalin fixation seemed to 
have no detrimental effects on the quality of the MS/MS spectra obtained from FFPE 
and fresh-frozen tissues. These results suggest that formalin fixation either does not 
involve all proteins, and therefore the ones which are not damaged produce a number 
of peptides sufficient for identification, or that crosslink reversal does not impair the 
identification of peptides after extraction with the conditions described in this paper.  
For comparison of extraction quality and reproducibility, all protein identifications 
obtained from fresh-frozen and FFPE tissue extracts were analysed for molecular 
function and cellular localisation. Figure 4.6 reports the GO classification obtained for 
both extracts. Although few differences can be observed, the distribution of classes 
and their relative abundances are mostly preserved; therefore FFPE fixation performed 
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before extraction of proteins from tissues does not seem to introduce a significant bias 
over particular protein functions or localisations. 
 
 
Figure 4.5. Comparison of representative MS/MS spectra of a peptide identified in extracts obtained 




Figure 4.6. Comparison of gene ontology (GO) ratios for proteins identified from fresh-frozen (left) and 
FFPE (right) protein extracts. The upper diagrams indicate functional classification as follows: B, binding; 
C, catalytic; M, motor; S, structural; T, transport, R: transcription/regulation, O: other. The lower 
diagrams indicate subcellular localisation as follows: E, extracellular; Y, cytoplasmic; Mt, mitochondrial; 
N, nuclear; Mn, membrane; U, other/undefined. 
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3. Standard immunoassays can be applied to proteins extracted from FFPE tissues 
The protein extraction method evaluated in this study stems from the antigen retrieval 
procedure used in IHC. Other authors applied western blotting protocols to FFPE 
protein extracts obtained with the antigen retrieval strategy, although cross-reactivity 
problems and a limited molecular range for protein identification were often reported. 
In view of these results, and to assess the reactivity of extraction products, we initially 
probed all tissue extracts with anti-actin and anti-GAPDH antibodies. As shown in 
Figure 4.7, clear, defined, and marked bands corresponding to actin and GAPDH were 
observed at the expected positions in all protein extracts, confirming that proteins 
retained their molecular weight and that immunoreactivity was preserved.  
 
 
Figure 4.7. Reactivity of actin, GAPDH, and E-cadherin with the tissue extracts reported in the 
corresponding positions of Figure . 
 
Reproducibility and consistency of western immunoblotting results was assessed in 
triplicate ad evaluated by densitometric quantitation. Results are reported in Table 4.3, 
in terms of band volume for actin and GAPDH in all tissues. Mean, SD, and CV are also 
reported. A high reproducibility was observed for the animal model tissues, whilst the 
human tissue showed a higher degree of variability among replicates. However, this 
could be explained by the higher tissue heterogeneity of thyroid compared to liver or 
muscle. 
Many of the heat-induced antigen-retrieval techniques for intact proteins have the 
disadvantage of reduced or incomplete membrane protein extraction. In order to 
evaluate the extraction performance for this difficult subset of proteins, the human 
thyroid tissue extracts were also probed with antibodies to E-cadherin. As shown in 
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Figure 4.7, E-cadherin could be detected by western immunoblotting in an FFPE extract 
generated from an archival human biopsy, although with a significantly lower intensity 
compared to fresh-frozen human thyroid tissue extract. 
 
Table 4.3. Evaluation of western blotting reproducibility measured by densitometric quantitative 
comparison with QuantityOne (BioRad). Values correspond to band volume, defined as sum of the 
intensities of the pixels inside the volume boundary x area of a single pixel (in mm2). Average (AV), 
standard deviation (SD), and coefficient of variation (CV), are reported for each tissue. 
Antigen Tissue Exp. 1 Exp. 2 Exp. 3 AV SD CV 
Actin Skeletal muscle 54.6 42.4 41.9 46.3 7.2 0.2 
 
Liver 8.2 8.1 10.3 8.9 1.2 0.1 
 
Thyroid 10.4 7.0 3.8 7.0 3.3 0.5 
GAPDH Skeletal muscle 11.1 13.7 19.1 14.7 4.1 0.3 
 
Liver 23.2 23.2 26.8 24.4 2.1 0.1 
  Thyroid 2.7 5.4 8.0 5.3 2.7 0.5 
 
In view of these results, FFPE skeletal muscle tissue extracts were then used for 
comparative evaluation of reactivity by western immunoblotting, ELISA, and protein 
arrays with antibodies against GAPDH, tropomyosin, vinculin, and myosin.  
As regards to western blotting results (as shown in Fig. 4.8), GAPDH reactivity was clear 
and consistent with the protein molecular weight (about 36 kDa). Tropomyosin 
reactivity was also consistently observed at the expected position (about 33 kDa), 
although with a lesser defined reactivity compared to fresh tissues, and with the 
presence of a cross-reactive smear at higher molecular weight (as described in [79]). 
Vinculin, a 120 kDa protein, showed an unexpected and interesting behaviour. The 
western immunoblot reactivity of the anti-vinculin antibodies in sheep skeletal muscle 
extracts was always comparable for FFPE and fresh tissues; however, instead of a 120 
kDa band, two bands of about 45 and 55 kDa, often accompanied by a lighter band of 
about 28 kDa, were consistently observed in all experiment replicates performed 
during this study. This could be explained by presence of splice variants or truncated 
forms in this individual, by inability of this particular antibody to react with the full-
length sheep protein, or by other reasons. In any case, however, this only adds to the 
demonstration that FFPE tissue extracts generate results comparable to fresh tissue 
extracts, even when unexpected results or unusual behaviours are observed. Myosin, a 
high molecular weight protein, could not be detected in FFPE tissue extracts with the 
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antibody used in this study. Poor immunological detection of high molecular weight 
proteins can either be related to an alteration of antigenicity in FFPE tissue extracts, 
blotting efficiency at high molecular weights, or simply to the limited SDS-PAGE 
resolution of highly crosslinked protein structures. 
 
Figure 4.8. Summary of western blot reactivities obtained with proteins from fresh-frozen and FFPE 
tissues. Molecular weights of the reactive protein bands are shown. 
 
Recently, reverse phase protein arrays have proven to be a very efficient and versatile 
technology for studying protein abundance and function, and have been applied to 
screening and quantitative profiling of disease-associated proteins. Applicability of 
FFPE protein extracts to protein arrays was introduced by Chu [73] and it was recently 
confirmed by Becker and co-workers [80]. Therefore, we evaluated reactivity of the 
FFPE extracts obtained in this study with the array technique (Figure 4.9). 
  
 
Figure 4.9. Summary of protein array reactivities obtained with serial dilutions of proteins from fresh-
frozen and FFPE tissues. 
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All antibodies tested produced a strong, reproducible, and quantitative signal in FFPE 
extracts. Even myosin, although problematic by western blotting, was clearly detected 
by the protein array method.  
ELISA is a widespread immunoassay technique presenting several important 
advantages, such as amenability to automation, diffusion of compatible 
instrumentation and assay platforms, and availability of antibodies optimised for this 
methodology. Therefore, we evaluated its applicability to FFPE protein extracts. In this 
case, proteins were precipitated and resuspended in an adequate buffer, since the 
detergent content of the extract would have interfered with the coating process. 
Encouraging results were obtained with almost all antibodies tested, as shown in 




Figure 4.10. Summary of ELISA reactivities for proteins from fresh-frozen and FFPE tissues. The mean 
and SD values of OD650 for three independent experimental replicates are reported. 
 
 
III. Discussion and concluding remarks 
 
The primary purpose of this work was the development and optimisation of an 
efficient, reproducible, and versatile procedure for extracting proteins from FFPE 
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tissues. Therefore, in order to eliminate experimental variability due to storage 
duration of FFPE tissue blocks, differences in fixing times, autolysis due to delayed 
fixing, individual differences in samples, anatomical or regional heterogeneity, and 
other possible sources of variability, an animal model was established. Sheep was 
chosen as a tissue source, since the large animal size allowed the collection of 
significant amounts of tissue with a high uniformity of organ cuts, and it was possible 
to access tissues from a healthy animal monitored by a veterinarian during 
slaughtering for meat production. Skeletal muscle and liver of the same individual 
were used for all the studies concerning evaluation of extraction ability, 
reproducibility, and flexibility, because of their different densities, cell compositions, 
and protein abundance distributions. Subsequently, skeletal muscle tissue extracts 
were used for application of GeLC-MS/MS, protein arrays, and ELISA, due to the lower 
proteome complexity and variability in physiological conditions, as compared to other 
tissues. 
After evaluation of several parameters, such as reagents for deparaffinisation, 
composition and pH of extraction buffer, temperature values of heat incubation and 
their sequence and duration, an optimised procedure was developed. The combination 
of an antigen retrieval-based high-temperature treatment and a Laemmli-based 
extraction buffer allowed the achievement of a noteworthy extraction efficiency, 
particularly from liver, significantly higher than that attained by commercial methods. 
The full-length protein extracts generated by this novel protocol exhibit a high pattern 
reproducibility, demonstrated by SDS-PAGE analysis, besides a remarkable versatility, 
since the same extract can be subjected to a wide gamut of proteomic and 
immunological analytical approaches. 
Previous investigators showed SDS-PAGE images of proteins extracted from FFPE 
material; however, protein patterns were globally of low quality and definition, and 
mostly related to medium to low molecular weight proteins. [75, 80]  As showed in 
Figure 4.2, 1-D profiles present a good definition, and a substantial preservation of 
band intensities relative ratio, although combined with an evident background, which 
seems to decrease proportionally to molecular weight. Even if this fact has modest 
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analytical consequences, it indirectly represents an index of protein extract overall 
quality.  
1D-GeLC-MS/MS approach represents an interesting hybrid between gel-based and 
shotgun proteomics. It allows performing robust and in-depth proteomic profiling, 
thanks to a combination of two common proteomic techniques, such as SDS-PAGE and 
LC-MS/MS, and without the need of sophisticated instrumentation, for instance 
Orbitrap mass spectrometer. In the case of this study, only visible gel bands were cut 
and analysed, therefore only a quite partial “snapshot” of the skeletal muscle 
proteome was done. Nonetheless, data are undoubtedly promising, above all for the 
effective comparability between fresh and FFPE results. Proteins covering a wide range 
of pIs, molecular weights, functions, relative abundances were identified and 
characterised also in FFPE extracts. Total number of peptide hits, sequence coverage, 
MS/MS spectra quality, percentage of chemically modified residues, and K/R ratio of 
fresh-frozen and FFPE proteins were compared, and no significant differences were 
found. In our experience, protein identification is achievable also analysing gel regions 
which did not show a visible Coomassie stain (data not shown); thus, subjecting to a 
GeLC-MS/MS investigation all the gel lane should considerably improve numerousness 
and completeness of proteomic data. Although it may appear lengthy and labour-
intensive, the ability to GeLC-MS/MS might open new and interesting perspectives for 
biomarker discovery and proteomic profiling in a wealth of diseases. Particularly, still 
notable differences between fresh-frozen and FFPE tissue profiles may be overcome 
performing a comparative analysis between two or more FFPE extract, which share the 
same drawbacks and bias. 
In the FFPE extract, some of the most abundant muscle proteins (such as actin, 
tropomyosin, myoglobin, GAPDH, creatine kinase, and so on) were detected along the 
whole gel area, beyond their expected molecular weight. In fact, peptides with a 
sequence corresponding to these proteins were found in tryptic mixtures together 
with peptides corresponding to proteins at the “correct” MW. It appears that small 
peptides belonging to the most represented proteins might form a “background” of 
fragments which remain linked to other proteins, probably as a result of an incomplete 
reversal of crosslinks, and are released only after trypsin hydrolysis [88]. However, 
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these represent a sort of “background noise” which can be processed and subtracted, 
and does not interfere with correct identification of co-migrating proteins. This 
background can be seen in the western blotting patterns, in the “trail” of reactivity at 
higher molecular weights (Figure 4.8). 
In order to assess the actual restoration of immunoreactivity of fixed proteins, fresh-
frozen and FFPE extracts were subjected to the best-known immunoassays, i.e. 
western blotting, protein arrays and ELISA. These kinds of techniques represent the 
preferential choice, together with immunohistochemistry, for assessing and validating 
differential expression of proteins. Mostly protein arrays and ELISA, because of their 
elevated reproducibility, high-throughput feature and suitability to automation, can be 
considered as the optimum approaches for validation of protein putative biomarkers. 
Antigens to be probed, namely myosin, vinculin, GAPDH, and tropomyosin, were 
selected with the intention to enclose proteins with different molecular weights, 
isoelectric points and levels of expression. Apart from vinculin, which falls in a gel area 
that was not cut, the other proteins were all previously identified by GeLC-MS/MS. 
Both MS and blotting data underline that is difficult to obtain satisfactory results with 
very high-molecular proteins, such as myosin heavy chain, whilst GAPDH and 
tropomyosin show similar blot signal and total peptide hits number between fresh and 
FFPE. This phenomenon can be explained by the fact that western blotting and GeLC-
MS/MS share the first electrophoretic step, and bulky proteins, maybe extensively 
crosslinked, can difficultly enter the gel matrix.  
Among all immunological techniques evaluated, protein arrays bear several 
advantages. Compared to ELISA, protein extracts obtained with this method can be 
used directly without further processing. The extraction buffer described here does 
not interfere with protein binding, so making precipitation unnecessary. Extracted 
proteins can be spotted directly on membranes, and therefore there is no selective 
loss, thus allowing maintenance of relative ratios. This is especially remarkable when 
performing quantitative studies. However, crossreactivity issues need to be taken into 
account and carefully evaluated, since they might interfere with quantitation. In this 
respect, more reliable results can be obtained by western blotting, but high molecular 
weight proteins can be problematic due to transfer and migration issues, as already 
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discussed. Moreover, western blotting it is a low-throughput technique requiring a 
consistent amount of work and user experience compared to protein arrays. 
The peculiarities seen in antibody reactivity of FFPE protein extracts have been 
addressed by Sompuram and co-workers [112]. These authors demonstrated that 
antibodies reacting with proteins subjected to antigen-retrieval techniques recognize 
linear epitopes; therefore, only these antibodies should be expected to display 
reactivity with FFPE tissue extracts. The different protein folding occurring in ELISA, 
caused by removal of SDS and resuspension in buffers such as PBS, might “hide” or 
refold the linear epitopes recognised by these antibodies. The current Human Protein 
Atlas initiative, in this respect, may represent an invaluable resource for identification 
of the most suitable antibodies to be used for investigation of FFPE protein extracts 
with different immunoassays [113]. 
As reported by a few researchers, various factors influence extraction efficacy and 
protein extract properties, such as duration of formalin fixation and bioptic sample 
“aging” (67,96). This study has been conducted deliberately reducing as more as 
possible all source of variability, as asserted above. Actually, when collecting samples 
for a proteomic study, i.e. for biomarker discovery aims, it is not ever possible to keep 
a significant degree of homogeneity as far as these features are concerned. A thyroid 
sample was subjected to the same procedure carried out on sheep tissues, in order to 
demonstrate the applicability of the method also to a “true” human bioptic specimen. 
Satisfactory SDS-PAGE and western blotting results were obtained, even though with a 
significantly lower reproducibility and 1D-PAGE sharpness. Anyhow, it is realistic to 
foresee that the quality of the protein extracts and the efficacy of the extraction 
procedure might vary in a considerable measure in relation to the peculiarities of 
selected samples. Further studies, conducted getting out proteomic information from 
routinely processed biopsies (also from “aged” ones), may support and definitively 
ascertain the actual effectiveness and widespread applicability of this method. 
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I. Introduction  
FFPE tissue banks represent a potentially invaluable resource for retrospective studies 
aimed to biomarker discovery and validation, both in cancer and in other important 
diseases. Application of standard proteomic profiling techniques to FFPE protein 
extracts would unveil a wealth of statistically supported information concerning 
functions involved in many aspects of disease, enabling identification of meaningful 
biomarkers related to specific disease diagnosis, prognosis, monitoring, and treatment. 
A method enabling extraction of full-length proteins from FFPE tissues based on the 
antigen retrieval strategy was optimized in our laboratory, as described in Chapter 4. 
The protein extracts generated with this method produced a well-resolved protein 
pattern by SDS-PAGE and were successfully subjected to MS/MS characterization 
following in gel trypsin digestion.  
To date, only few studies reported the tentative application of 2D-PAGE to protein 
extracts from FFPE tissues [84-85]. Noteworthy, the aim of one of these two reports 
was to demonstrate the purported unsuitability of FFPE tissues to 2D proteomic 
studies. Therefore, application of 2D-PAGE separation followed by in-situ protein 
digestion and MS or MS/MS analysis, the fundamentals of gel-based proteomics, still 
appears to be challenging on FFPE tissues.  
In view of these facts, 2D-PAGE separation of FFPE tissue proteins extracted with the 
previously described method was pursued. Specifically, 2D-PAGE separation, 2D-
western immunoblotting, MALDI-MS, and nano-HPLC-nano-ESI-Q-TOF mass 
spectrometry of in-situ digested spots were successfully applied to FFPE skeletal 
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II. Results 
 
1. Proteins can be extracted from FFPE tissues, and separated by 2D-PAGE 
Formalin-fixed, paraffin embedded tissue samples are largely available as “tissue 
banks” in hospitals worldwide. If accessible to proteomic investigations, these samples 
would represent an invaluable source of information on disease biomarkers. In order 
to investigate the possibility of performing 2D-PAGE and MALDI/MS analysis on FFPE 
extracts, fresh-frozen and FFPE sheep skeletal muscle tissue samples were used. For 
optimisation of the various protocol steps, an animal model was established. Sheep 
was chosen as a tissue source, since the large animal size allowed to collect a 
significant amount of tissue with a high uniformity of organ cuts, and facilitated 
optimisation of the extraction and separation steps starting from plenty of 
reproducible samples. Skeletal muscle was chosen for its availability in large amounts, 
its low proteome variability in physiological conditions, and its relatively lower 
proteome complexity compared to other organs. 
Replicates of FFPE muscle tissue samples were treated for full-length protein 
extraction in presence of detergents and reducing agents (see Chapter 4). In order to 
eliminate interferences by these compounds during the focusing steps, protein 
extracts were subjected to precipitation with TCA/acetone, and resuspended in a 
suitable buffer. Figure 5.1 shows the 18 cm 2D-PAGE map of proteins extracted from 
fresh-frozen (top) skeletal muscle tissue using mechanical lysis, and FFPE (bottom) 
skeletal muscle tissue using the high-temperature extraction protocol. Up to 250 
different spots could clearly be detected after 2D-PAGE separation and mass-
compatible silver staining of 300 µg of proteins extracted from FFPE skeletal muscle 
tissue, corresponding approximately to 18 FFPE microtome slices, 10 µm thick, 80 mm2 
wide (according to statements reported in Chapter 4). Most importantly, the molecular 
mass and the isoelectric point of proteins extracted from fresh-frozen tissue sections 
(Fig. 5.1, left), appeared comparable to those subjected to the fixation and extraction 
procedure (Fig. 5.1, right). For comparison, up to 397 spots were detected in matched 
fresh-frozen tissue 2D-PAGE maps. Although fewer spots were present in the FFPE 
tissue map compared to the fresh-frozen tissue map, the FFPE muscle tissue protein 
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pattern could be matched to the fresh-frozen protein pattern. To our knowledge, this 
is the first report showing comparable 2D-PAGE protein profiles for formalin-fixed and 
fresh-frozen replicate sample tissues. 
 
 
Figure 5.1. 2-DE analysis of proteins from fresh-frozen (left) and FFPE (right) sheep skeletal muscle tissue 
on 18 cm gels. Proteins were separated in 3-10NL pH ranges, and then in 12% polyacrylamide gels. Gels 
were stained with mass-compatible silver staining. Up to 250 spots were detected in the FFPE 2D-PAGE 
gels. 
 
2. Proteins can be revealed by western immunoblotting at comparable molecular 
weights and isoelectric points 
Proteins extracted from FFPE fixed tissues have been shown to recover their 
antigenicity, and can be detected with immunoassay techniques [71, 80]. Hence, fresh-
frozen and FFPE skeletal muscle tissue proteins were subjected to 2D western 
immunoblotting, in order to assess whether specific proteins could be detected from 
both extracts, at comparable molecular weights and isoelectric points. Polyclonal 
antibodies were used to probe actin (pI 5.3) and GAPDH (pI 8.5) in fresh-frozen and 
FFPE muscle tissue extracts. As shown in Figure 5.2, anti-actin antibodies detected a 
protein spot at the expected MW and pI ranges, demonstrating that actin extracted 
from FFPE tissue retains its focusing characteristics. When the blot was probed with 
anti-GAPDH antibodies, a clear and defined positivity was detected at the expected 
MW and pI values. GAPDH produced a pattern formed by a “spot train” of presumptive 
isoforms, although a slight crossreactivity was present at higher MW (Figure 5.2, 
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bottom, right), probably due to residual crosslinked peptides bound to higher 
molecular weight proteins (as stated in Chapter 4). A comparable pattern of reactivity 
was observed for the fresh-frozen tissue extracts (Figure 5.2, bottom, left). Taken 
together, these data suggest that proteins extracted from FFPE tissues preserve 




Figure 2. Western immunoblots of proteins from fresh-frozen (left) and FFPE (right) skeletal muscle 
tissue, separated in 7 cm 2D-gels, transferred to nitrocellulose, and developed with antibodies for actin 
(top) and GAPDH (bottom). 
 
3. 2D-PAGE separated protein spots can be reliably identified by MALDI-MS and by 
MS/MS analysis  
In order to evaluate whether FFPE protein extracts resolved by 2D-PAGE were suitable 
to mass spectrometry identification, matched protein spots generated from fresh-
frozen and FFPE sheep skeletal muscle were subjected to comparative MS analysis. 
Replicate 7 cm 2D-PAGE gels were run with corresponding fresh-frozen and FFPE 
protein loads, namely, about 80 µg of proteins, obtained from 5 FFPE tissue slices, and 
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then stained with the colloidal Coomassie staining procedure (Figure 5.3). After 
staining, gels were processed with the ImageMaster Platinum 6.0 image analysis 
software for spot detection and matching.  
 
 
Figure 5.3. 2-DE analysis of proteins from fresh-frozen (A) and FFPE (B) sheep skeletal muscle tissue 
performed on 7 cm gels. Proteins were separated in 3-10NL pH ranges, and then in 12% polyacrylamide 
gels. Gels were stained with colloidal Coomassie. Numbers indicate picked and identified spots. 
Rectangles illustrate an enlargement of the selected zone obtained in replicate gels with higher protein 
loads. Spots 40-43 (corresponding to spot 37 in the larger map) were identified as alpha-crystallin 
isoforms; spots 44-45 (corresponding to spot 38 in the larger map) were identified as heat-shock protein 
beta-6 isoforms. 
 
Among matched spots detected in fresh-frozen and FFPE gels, 39 were excised and 
subjected to MALDI/MS identification (Figure 5.3). Identities of fainter spots or 
uncertain identifications were confirmed by nanoLC-nanoESI-Q-TOF mass 
spectrometry.  
As shown in Appendix 3, proteins were identified with high levels of confidence from 
2D-PAGE spots corresponding to FFPE extracts, and estimated MW and pI on gel were 
always comparable to those corresponding to proteins from fresh-frozen tissue 
extracts. Moreover, many spot “trains”, probably corresponding to protein isoforms, 
showed a very good match between fresh-frozen and FFPE gels. This is 
representatively illustrated in Figure 5.3 (detailed frames) where FFPE-extracted 
isoforms of the same proteins, identified in this case as alpha-cristallin (spot N.38, 
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isoforms are spots 40-43) and heat-shock protein 6 (spot N. 39, isoforms are spots 44-
45), form distinct spot “trains” equivalent to those observed in gels from fresh-frozen 
tissues. 
Quality of mass spectra generated from FFPE and fresh-frozen tissue extracts was 
comparable. Figure 5.4 reports four representative MALDI-MS spectra. Spectra at the 
top correspond to creatine kinase M-type, a highly abundant protein, and spectra at 
the bottom correspond to carbonic anhydrase 3, a protein with low-medium 
abundance in skeletal muscle. Proteins were identified in two matched spots from 
fresh-frozen and FFPE extracts. In both cases, quality of the protein spectra was 
extremely high and similar to that of fresh-frozen extracts. 
Following in-situ hydrolysis and MS/MS analysis, peptides belonging to other proteins 
of lower molecular weight were detected together with proteins of the expected 
molecular weight (Table 5.1, shaded). The number of these artificially complexed 
peptides was significantly more represented in the acidic-high molecular weight 
region, whilst it was less pronounced in other areas of the 2D map. This phenomenon 
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Figure 5.4. Representative MALDI-MS spectra of proteins from fresh-frozen and FFPE muscle tissue 
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MW on gel 
Estimated 












1 83781 5.42 Actin, alpha skeletal muscle 62 35 2132 42366 5.23 
   
Myosin light chain 1, skeletal muscle isoform 11 27 389 209930 4.97 
   
Creatine kinase M-type 6 14 279 43190 6.63 
   
Myoglobin 2 19 111 17044 6.87 
   
Tropomyosin-1 alpha chain 2 14 89 32746 4.69 
   
Serum albumin precursor 2 2 72 71139 5.80 
   
Triosephosphate isomerase 1 4 50 26901 6.45 
   
Hornerin 2 1 95 283140 10.05 
   
Fructose-bisphosphate aldolase A 1 2 48 39851 8.30 
   
Creatine kinase, sarcomeric mitochondrial precursor 1 2 42 47714 8.45 
3 63677 6.54 Actin, alpha skeletal muscle 15 19 440 42366 5.23 
   
Phosphoglucomutase-1 11 10 417 61805 6.58 
   
Creatine kinase M-type 6 14 243 43190 6.63 
   
Fructose-bisphosphate aldolase A 7 14 219 39851 8.30 
   
Triosephosphate isomerase 4 19 196 26901 6.45 
   
Carbonic anhydrase 3 5 17 194 29637 7.71 
   
Pyruvate kinase isozyme M1 5 8 175 58522 7.24 
   
Myosin light chain 1, skeletal muscle isoform 5 16 149 20993 4.97 
   
Myoglobin 3 26 119 17044 6.87 
   
Heat-shock protein beta-1 2 4 86 22436 5.98 
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Fructose-bisphosphate aldolase C 1 6 75 39830 6.41 
   
L-lactate dehydrogenase A chain 1 3 75 36916 8.12 
   
Beta-enolase 6 10 64 47409 7.60 
   
ATP synthase subunit alpha, mitochondrial precursor 2 3 58 59828 9.16 
   
Myosin light polypeptide 4 1 11 53 21665 4.97 
   
Glyceraldehyde-3-phosphate dehydrogenase 1 4 51 36073 8.50 
5 58522 7.24 Pyruvate kinase isozyme M1 31 22 886 58522 7.24 
   
Creatine kinase M-type 7 17 346 43190 6.63 
   
Glyceraldehyde-3-phosphate dehydrogenase 5 13 294 36073 8.50 
   
Fructose-bisphosphate aldolase A 7 27 238 39851 8.30 
   
Carbonic anhydrase 3 4 14 203 29637 7.71 
   
Fructose-bisphosphate aldolase C 2 6 185 39830 6.41 
   
Triosephosphate isomerase 2 10 108 26901 6.45 
   
Myoglobin 2 9 94 17044 6.87 
   
Hemoglobin subunit alpha-1/2 3 16 86 15212 8.72 
   
Actin, alpha skeletal muscle 2 5 62 42366 5.23 
   
Creatine kinase, sarcomeric mitochondrial precursor 1 2 55 47714 8.45 
   
Beta-enolase 3 7 53 47409 7.60 
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III. Discussion and concluding remarks 
 
Full-length proteins were extracted from fresh-frozen and FFPE muscle tissue, 
separated by 2D-PAGE, and comparatively identified by means of MALDI and 
nanoHPLC-nanoESI-Q-TOF mass spectrometry, producing matched 2D-PAGE maps and 
matched protein identifications. This goal was reached through adaptation of a 
recently developed method for generation of well-defined bands after SDS-PAGE 
separation of FFPE tissue protein extracts (described in Chapter 4). The application of a 
precipitation step allowed to remove interfering substances, namely SDS and salts, and 
to achieve the successful focusing of proteins in an immobilised pH gradient, allowing 
2D-PAGE separation. To our knowledge, this is the first report presenting the 
differential comparison of 2D-PAGE protein extracts obtained from a fresh-frozen and 
a replicate FFPE tissue. As shown in Fig. 5.1, Fig. 5.3, and Appendix 3, it is possible to 
separate by 2D-PAGE, and to identify by MS, full-length proteins from FFPE tissues, 
obtaining datasets that are comprehensive and comparable to those produced with 
fresh-frozen tissues. Nevertheless, evident differences in spot intensity or focusing 
quality can still be seen between fresh-frozen and FFPE tissue 2D maps. During this 
study, however, we observed that the 2D maps generated from FFPE tissues were 
highly reproducible. Therefore, although a perfect match may not be obtained 
between fresh and FFPE 2D maps, differential proteomics studies could be performed 
among FFPE 2D maps, allowing comparison of healthy and pathological tissues stored 
in bioptic tissue banks. 
The successful 2D-PAGE separation of FFPE extracts suggests that a sufficient amount 
of proteins can be recovered with unaltered or restored physical properties, even from 
limited amounts of tissue, allowing electrophoretic migration under both conditions, 
IEF and SDS-PAGE. The migration of proteins at the expected MW and pI ranges was 
also suggested by the western immunoblotting studies. In fact, as shown in Figure 5.2, 
the pattern of reactivity observed with anti-actin and anti-GAPDH antibodies when 
probing FFPE skeletal muscle extracts is comparable with the pattern of reactivity 
obtained when probing fresh-frozen tissues, notably, also in terms of the isoelectric 
series of spots. The result obtained with GAPDH (pI 8.5) is of particular relevance, since 
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basic proteins are able to engage a high number of formaldehyde-induced crosslinks. 
GAPDH, therefore, is expected to be extracted and separated less efficiently compared 
to actin or other acidic proteins. The results reported here demonstrate that the FFPE 
protein extraction method used efficiently reverts formaldehyde-induced crosslinks, 
and that such reversal does not impact significantly neither focusing properties nor 
immunoreactivity of the extracted proteins. This opens the way to many applications, 
such as immunostaining for post-translational modifications, for example. However, 
potential crossreactivity problems caused by residual crosslinked peptides need to be 
taken into account in this type of assays. 
Following 2D-PAGE separation, focused protein spots can be successfully excised from 
the gel and identified by MALDI-MS analysis after in-situ hydrolysis. The MS spectra 
generated are of high quality, and are comparable to those obtained with proteins 
from fresh-frozen tissue extracts. Alterations of the peptide mass fingerprint, if 
present, are minimal, and do not impair identification of the protein. Mass 
spectrometry results were always comparable in matched protein spots scattered 
throughout acidic, basic, high MW, and low MW areas of the map. 
Notably, MS/MS analysis of many spots from FFPE maps led to detect a significant 
number of peptides belonging to the most abundant skeletal muscle proteins (such as 
actin, myoglobin, creatine kinase, and others) besides those coming from the expected 
proteins. This phenomenon was especially present in the high molecular weight and 
acidic region (Table 5.1). This might suggest the presence of short, residual fragments 
that remain linked to medium-high MW proteins, as a consequence of an incomplete 
reversal of crosslinks and protein breakdown. These peptides could be released owing 
to trypsin digestion and codetected by MS/MS, without impairing MALDI-MS 
identification of the “correct” protein species present within the spot. 
To date, only two reports described the application of 2D-PAGE to proteins extracted 
from FFPE tissues [84-85]. The 2D-PAGE map published by Ahram and his colleagues 
was virtually devoid of focused spots, and was indeed specifically aimed to 
demonstrate the purported unsuitability of FFPE protein extracts to 2D-PAGE-MS 
studies [84]. This study, in fact, suggested the use of ethanol for tissue fixation if the 
biopsies were to be subjected to proteomic studies. On the other hand, a recently 
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published study described application of 2D-PAGE for the discovery of biomarkers in 
cervical carcinoma [85]. Although this is a valuable work, and interesting results were 
obtained by these investigators, the 2D-PAGE maps generated were of poor quality in 
terms of number and resolution of protein spots. Moreover, these authors used 
cyanine dyes for staining, while the 2D maps reported here allowed to detect a higher 
number of spots by means of far less sensitive staining chemistries. Nevertheless, the 
results obtained by Ono et al. are of great interest, since the possibility of staining 2D-
PAGE FFPE maps with cyanine dyes strongly encourages the application of the recently 
developed DIGE protocols. 
2D-PAGE maps and MS identifications presented here demonstrate that it is possible 
to carry out gel-based differential proteomics experiments on FFPE samples. 
Standardisation and optimisation of this protocol may open the way to biomarker 
discovery studies, as well as systematic proteomic profiling of difficultly available 
tissues, such as rare tumour samples. Enlarging and improving the range of techniques 
useful for the molecular characterisation of FFPE tissues can be considered a crucial 
point of biomedical translational research for the next few years. 
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I. Introduction  
 
FFPE tissues represent an invaluable source of information in the field of disease 
molecular characterisation, both for diagnostic and therapeutic purposes. A critical 
target of proteomics in the few past and next years might be to improve the ability to 
carry out biomarker discovery projects on this complicated kind of biological samples. 
2D-DIGE is nowadays considered as the most refined technique for performing gel-
based differential proteomics studies [36, 38]. As described in Chapter 5, recent data 
demonstrated the skill of separating and identifying proteins from FFPE tissues, by 
means of 2D-PAGE-MS. Thus, the following step became the implementation and 
validation of this result by the application of DIGE technique to FFPE samples. As well, 
when a limited amount of sample is available, as for fixed tissues, 2D-DIGE allows to 
obtain significant results because of its property of minimizing experimental variability. 
Thus, here we present a 2D-DIGE characterisation of healthy sheep skeletal muscle and 
liver tissues, and a comparison of two pathological FFPE liver samples, still by a DIGE 
approach, in order to investigate usefulness and reliability of this technique for 





1. FFPE extracts can be successfully separated and analysed by 2D-DIGE 
In order to evaluate the suitability of 2D-DIGE for FFPE protein extracts, an animal 
model was used. Indeed, performing optimisation experiments on human bioptic 
samples would have been unreasonable, owing to their scarceness and preciousness. 
Thus, skeletal muscle and liver tissues samples were collected from a single sheep 
individual, with the aim of reducing biological variability. Every tissue block was divided 
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into two parts: the first was subjected to formalin fixation and subsequent paraffin 
embedding, following standard laboratory procedures; the second was immediately 
frozen at -80°C. FFPE blocks were microtomised into 10 μm sections and kept at room 
temperature. For protein extraction, FFPE sections were subjected to a high-
temperature protein extraction procedure, as described in previous chapters. Fresh-
frozen tissue samples were minced with a sterile scalpel, immersed in the same buffer 
used for FFPE samples, and then subjected to an extraction procedure based on 
mechanical lysis. Protein extracts were treated with 2-D Clean-Up Kit (GE Healthcare), 
in order to eliminate SDS and other substances which could interfere with IEF 
separation; final protein pellets were resuspended in a buffer suited for DIGE analysis, 
and quantified by EZQ fluorescent method (Molecular Probes). For evaluating FFPE 
extraction technical variability and its impact on 2D-DIGE, three replicates, each 
consisting of ten adjacent FFPE skeletal muscle or liver sections, were subjected to 
distinct extraction procedures. As internal standard, a pool comprising 25 μg of each 
FFPE replicate and 75 μg of fresh-frozen extract was prepared. Then, sample pool, FFPE 
replicates and fresh-frozen extract of each tissue were labelled with CyDyes, and 
mixed for performing three DIGE experiments per tissue, as summarised in Table 6.1. 
Proteins were isoelectrofocused along two different pH ranges: 3-10 for skeletal 
muscle, and 4-7 for liver. SDS-PAGEs were carried out on gradient (8-18%) 
polyacrilamide 24 cm gels.   
 
Table 6.1. Summary of DIGE experiments. 
exp. tissue pH range Cy2 Cy3 Cy5 
M1 Skeletal muscle 3-10 Pool standard FFPE repl. 1  Fresh-frozen 
M2 Skeletal muscle 3-10 Pool standard Fresh-frozen FFPE repl. 2  
M3 Skeletal muscle 3-10 Pool standard FFPE repl. 3  Fresh-frozen 
F1 Liver 4-7 Pool standard FFPE repl. 1  Fresh-frozen 
F2 Liver 4-7 Pool standard Fresh-frozen FFPE repl. 2  
F3 Liver 4-7 Pool standard FFPE repl. 3  Fresh-frozen 
 
Representative 2-D maps are shown in Figure 6.1. Skeletal muscle patterns are similar 
or even slightly better to those obtained by silver-staining, and previously published by 
our group. It was not an obvious result, because only 50 μg of FFPE proteins were 
loaded; moreover, cyanine minimal labelling involves lysine residues, that were 
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demonstrated to be one of the favourite targets of formalin in the context of fixation 
reactions [60-62]. Liver extract behaviour was really surprising. Unlike skeletal muscle, 
which is characterised by the presence of a few acidic highly abundant proteins, well 
conserved in FFPE pattern, liver proteome shows a narrower dynamic range, and a  
plenty of medium-low abundant proteins. In view of these features, IPG strips with a 
more limited pH range were chosen for liver DIGE experiments, in order to reduce 
pattern density. In spite of these expectations, liver FFPE 2D-profile exhibits a good 
complexity, a notable resolution, as well as an outstanding comparability with fresh-
frozen pattern. Indeed, it is noteworthy the preservation of isoform “trains”, also for 
medium-high molecular weight proteins. Up to 250 and 350 spots could be detected in 
skeletal muscle and liver FFPE maps, respectively, compared to a mean of about 450 
spots for fresh-frozen samples.  
 
 
Figure 6.1. 2D-DIGE analysis of proteins from sheep skeletal muscle and liver tissues. FFPE and fresh-
frozen extracts of each tissue were run in the same gel. Proteins were separated first along 3-10 NL 
(muscle) and 4-7 (liver) pH ranges, and then on 24 cm polyacrilamide gradient gels (8-18%).  
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In order to discover the identity of the main proteins expressed by liver and skeletal 
muscle, fresh-frozen and FFPE extracts of both tissues were separated by 24 (or 7) cm 
gel electrophoresis; globally, 41 spots were excised, subjected to in situ hydrolysis with 
trypsin, and tryptic digests were analysed by MALDI-MS or LC-MS/MS.  
 
2. FFPE extract replicates show a high reproducible 2D-DIGE pattern 
High experimental reproducibility is an essential condition for performing differential 
proteomics studies. Thus, one of the aims of this work was to assess the level of 
reproducibility between 2D-DIGE maps of FFPE technical replicates. For technical 
replicates, identical samples subjected to distinct protein extraction procedures are 
intended. Therefore, a triplicate DIGE analysis were conducted, as already displayed in 
Table 6.1. 2D-DIGE images of FFPE replicates are comparatively shown in Figure 6.2.  
 
Figure 6.2. 2D-DIGE profiles of FFPE extracts technical replicates from skeletal muscle (upper line) and 
liver (lower line) tissues.  
 
Reproducibility rate was measured by two different methods: comparing, between 
fresh-frozen and FFPE maps, standard deviation and coefficient of variation of overall 
spot number (see Table 6.2), or coefficient of variation of spot volume for ten selected 
and matched spots for each tissue (see Figure 6.3 and Appendix). 
Comparing gel images, and data presented in Table 6.2, overall 2D-profile of FFPE 
muscle and liver replicates appears highly reproducible, in terms of quantity and 
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quality. Coefficient of variation value is evidently low and very similar with fresh-
frozen.  
 
Table 6.2. Overall spot number of triplicate 2D-DIGE maps for skeletal muscle (left) and liver (right) 
fresh-frozen and FFPE extracts. Mean value (MV), standard deviation (SD) and coefficient of variation 
(CV) of spot number are also reported for each tissue.  
muscle FrFr  FFPE 
 
liver FrFr  FFPE 
exp. 1 456 224 
 
exp. 1 440 345 
exp. 2 423 251 
 
exp. 2 512 315 
exp. 3 444 216 
 
exp. 3 471 323 
   
 
   
MV 441 230 
 
MV 474 328 
SD 16,7 18,3 
 
SD 36,1 15,5 
CV 0,04 0,08 
 
CV 0,08 0,05 
 
Furthermore, ten widespread distributed spots per tissue were selected; their volumes 
among the three replicates were measured, and respective means, standard deviations 
and coefficients of variation were calculated. Considering the average of coefficients of 
variation, variability assumes a more significant value than that computed with the 
previous method. However, FFPE and fresh-frozen data are widely comparable (see 
Fig. 6.3 and Appendix 4).  
 
 
Figure 6.3. Histogram comparing average coefficient of variation (CV, in ordinate) of spot volumes 
(calculated for ten selected spots per tissue), as a measure of technical variability. 
 
It is not trivial to observe that, whereas fresh-frozen replicates shared the same 
extract, each FFPE replicate derived from a different tissue portion and was extracted 
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in a distinct time. Therefore, the greater part of the variability amongst FFPE maps was 
due to electrophoresis, while the contribution of extraction procedure or sample 
heterogeneity was almost negligible. 
 
3. FFPE proteins are acidic-shifted compared to corresponding fresh-frozen ones 
The purpose of 2D-DIGE experiments was to compare FFPE and fresh-frozen protein 
extracts, not only for investigating the degree of comparability between them, but also 
for determining peculiar pattern differences, which would be taken into account for 
further studies. 2D-DIGE overlay patterns of skeletal muscle and liver tissues 
(presented in Fig. 6.4) show an evident, unambiguous acidic-shift that affects almost all 
FFPE spots and spot “trains”. Considering for the moment only the conserved trains 
(specific preservation or depletion of FFPE spots will be treated in the next paragraph), 
a typical fashion can be noticed: in the basic side of the train the “fresh” protein seems 
to prevail, in the middle a substantial balance can be highlighted, whilst the acidic 
isoforms appear to be highly more abundant in FFPE extract. 
In order to elucidate more in depth this interesting phenomenon, six selected spot 
trains, widely distributed for molecular weight and isoelectric point within skeletal 
muscle and liver maps, were analysed, as shown in Figure 6.5. The colour gradient is 
extremely evident, and pI values point out how ample is the shift. Considering as a 
measure of the shift the difference between the mean isoelectric point of fresh-frozen 
trains and that one of FFPE trains, the top value, among the six selected proteins, 
coincides with 0.28 pI units of shift, determined for liver superoxide dismutase [Cu-Zn] 
train (Fig. 6.5, panel E). 
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Figure 6.4. 2D-DIGE analysis of skeletal muscle (A) and liver (B) protein extracts. In A, fresh-frozen, FFPE 
and overlay patterns are marked in green, dark blue, and light blue, respectively. In B, fresh-frozen, FFPE 
and overlay patterns are marked in red, dark blue and pink, respectively. 
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Figure 6.5. Selected spot “trains” from skeletal muscle (left) and liver (right) 2D-DIGE maps, 
corresponding to actin (A), myosin light chain 1 (B), myoglobin (C), regucalcin (D), Cu-Zn superoxide 
dismutase (E), and cytochrome b5 (F). Fresh-frozen, FFPE and overlapped patterns are depicted in 
green, dark blue, and light blue, respectively. Estimated molecular weights and isoelectric points are 
also indicated.  
 
4. Formalin fixation detrimental impact on preservation of electrophoretic protein 
pattern seem to be correlated with lysine residues percentage 
Another point to be investigated was the preservation (or the depletion) of specific 
proteins in FFPE patterns, and whether any protein physico-chemical feature might be 
correlated with this event. Therefore, image analysis of 2D-DIGE gels was carried out 
with DeCyder software, with the aim of identifying FFPE (or fresh) protein spots whose 
intensity was significantly changed, compared to fresh-frozen (or FFPE). The first ten 
“overexpressed” spots for each gel are highlighted with red (more abundant in fresh) 
or blue (more abundant in FFPE) circles in Figure 6.6. Hatched circles indicate spots 
pointed out in the corresponding sample (always fresh vs FFPE), for comparison 
purposes. Spots distribution according to molecular weight and pI shows interesting 
features. First, proteins more abundant in fresh-frozen extract (and, consequently, 
depleted in FFPE) are mostly confined in the medium-high molecular weight gel region, 
and only a few high MW proteins are properly conserved in FFPE gels; it may be due to 
the fact that bulky proteins are more difficult to be extracted, to enter the gel or to be 
correctly separated and visualised in electrophoresis. Second, in regard to skeletal 
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muscle map, acidic proteins appear more easily preserved than basic. The same 




Figure 6.6. Skeletal muscle (top) and liver (bottom), fresh-frozen (left) and FFPE (right) 2D-DIGE maps. 
Circles and numbers indicate differentially “represented” proteins (ordered by decreasing spot volume 
ratio) in comparison with matched fresh-frozen or FFPE tissue. Spots which show higher volume in fresh-
frozen maps are marked in red, while those more represented in FFPE extracts are marked in light blue. 
Hatched circles refer to spots that are overexpressed in the corresponding FFPE, or fresh-frozen, map. 
 
In order to understand what structural factors influence preservation of fixed proteins, 
some physico-chemical features were considered for the forty differentially expressed 
proteins mentioned above. Particularly, lysine and arginine percentages, as well as 
their ratio, were calculated, with the aid of ProtParam tool [110], and the trend of 
these values for fresh and FFPE proteins were statistically analysed. Wilcoxon’s Rank-
Sum test results demonstrate a significant variation between the two groups for lysine 
percentage (p = 0.005) and lysine to arginine ratio (p = 0.01) of liver proteins, while 
only lysine percentage (p = 0.035) shows a significantly difference in skeletal muscle 
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proteins (Figure 6.7, and Appendices 5-6). Therefore, depletion of lysine-rich proteins 
observed in FFPE 2D-maps might be caused by a probable more extensive reactivity 
with formalin [60-62], which should affect protein extraction and/or separation.  
 
 
Figure 6.7. Comparison of mean lysine percentage and K to R ratio between a group of ten spots more 
represented in fresh-frozen map and a group of ten spots more represented in FFPE map. 
 
5. 2D-DIGE and GeLC-MS/MS allow the identification of several heavy metal damage 
biomarkers in sheep liver FFPE tissues 
The first purpose of this work was to demonstrate that proteomic differential studies 
could be performed through gel-based DIGE technology. Once proved adequate  
reproducibility and efficacy of the method, in comparison with fresh-frozen tissue, the 
following step was to apply extraction procedure and 2D-DIGE workflow to 
differentially analyse FFPE samples. In view of the satisfactory results achieved with 
sheep liver,  two sheep samples affected by heavy metal liver intoxication at different 
stages, and routinely fixed and embedded, were chosen. Hence, the goal of this part of 
the survey was to recognise a few disease biomarkers overexpressed by the more 
damaged liver (hereafter called A), in comparison to the case with a less advanced 
stage of degeneration (hereafter called B).  
In order to reach this outcome, proteins were extracted from A and B FFPE samples, 
and separated by SDS-PAGE; subsequently, the same extracts were labelled with Cy2 
and Cy5, respectively, with the aim of performing a preliminary 1D-DIGE analysis. 
Comparing the two patterns, placed side by side in Figure 6.8, four differential bands 
were detected, excised and processed by a GeLC-MS/MS approach.  
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Figure 6.8. SDS-PAGE (left, grey-scale) and 1D-DIGE (right, in colour) of sheep pathological liver extracts. 
SDS-PAGE gel was stained with colloidal Coomassie blue. Lane M represents Precision Plus Protein 
Standard (Bio-Rad). For DIGE analysis, sample A was labelled with Cy2 (in blue), and sample B with Cy5 
(in red); overlapped bands are in pink. Arrows indicate picked bands.   
 
Table 6.3. List of differentially expressed proteins identified by GeLC-MS/MS, ordered decreasingly 
according to molecular weight. Total number of peptide hits for each sample (in columns A and B, 
respectively) and band(s) corresponding to protein identification are also reported.  
Overexpressed proteins MW A B Band 
78 kDa glucose-regulated protein 72 11 0 1 
Protein disulfide-isomerase A2 59 11 0 1,2 
Protein disulfide-isomerase 58 23 0 1,2 
D-3-phosphoglycerate dehydrogenase 57 8 0 2 
Protein disulfide-isomerase A3 57 6 0 2 
Peroxiredoxin-4 31 10 0 4 
14-3-3 protein epsilon 29 3 0 2,3 
Chymotrypsin-like elastase family member 1 29 8 0 4 
Proproteinase E 28 5 0 4 
Chymotrypsinogen A 26 6 0 4 
Endoplasmic reticulum resident protein ERp27 23 5 0 2,3,4 
Peroxiredoxin-1 22 6 0 4 
     
     Underexpressed proteins MW A B Band 
Glutamate dehydrogenase 1, mitochondrial  62 0 27 1,2,3,4 
Catalase 60 0 54 1,2,3,4 
Retinal dehydrogenase 1  55 0 5 2 
Regucalcin 34 0 5 1,3 
Enoyl-CoA hydratase, mitochondrial  32 0 8 2,4 
3-hydroxyacyl-CoA dehydrogenase type-2 27 8 62 1,2,3,4 
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As previously described in Chapter 4, GeLC-MS/MS analysis of FFPE extracts proved to 
be a useful and robust method for the characterisation of proteomic profile. Here, a 
mean of 30 protein identifications per band was attained, and over 90 and 60 unique 
proteins were detected in total for A and B samples, respectively. Complete MS 
identifications are listed in Appendix 7. Table 6.3 reports main proteins that exhibited 
a differential abundance, estimated by total peptide hits number, between A and B. 
Interestingly, several of the proteins overexpressed in the most damaged tissue are 
clearly related to liver stress and intoxication states, as will be more widely discussed 
below.  
Then, liver pathological samples were subjected to 2D-DIGE analysis. Protein extracts 
were firstly isoelectrofocused in 3-11 IPG strips, and secondly separated according to 
their molecular weight in (8-16%) gradient polyacrilamide gels. 2D-maps in Figure 6.9 
reveal a quite acceptable complexity and resolution, at least for the zone 
corresponding to a molecular weight lower than 40 kDa. Image analysis was carried 
out by means of DeCyder software, and principal differential expressed spots are 
marked with blue circles (those overexpressed in A) or red rectangles (those 
underexpressed in A).  
 
 
Figure 6.9. 2D-DIGE analysis of FFPE sheep liver samples affected by heavy metal intoxication at two 
different stages. Differentially expressed proteins are numbered and marked in light blue (spots 
overexpressed in A) and red (spots underexpressed in A). 
 
Differential spots were cut from DIGE gels, digested with trypsin, and analysed by 
MALDI-MS and LC-MS/MS. Protein identities confirmed identifications achieved by 
GeLC-MS/MS, as illustrated in Table 6.4. All discovered putative biomarkers, such as 78 
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kDa glucose-regulated protein (also known as GRP78), protein disulfide-isomerases, 
14-3-3 proteins, and ERp27, share functional properties and molecular pathways [114-
116], and have been previously indicated as heavy metal intoxication markers [117-
119], or liver stress signallers [120-122]. 
 
Table 6.4.  Proteins identified by MALDI-MS and LC-MS/MS from 2D-DIGE differentially expressed spots.  
Spot AN Overexpressed proteins MW pI UP SC 
1 Q0VCX2 78 kDa glucose-regulated protein 72 5,07 8 15 
2 P05307 Protein disulfide-isomerase 58 4,80 11 26 
  Q13087 Protein disulfide-isomerase A2 59 4,89 6 8 
3 P62261 14-3-3 protein epsilon 29 4,63 2 7 
  Q32L47 ERp27 23 4,81 1 5 
4 P00432 Catalase 60 6,78 6 14 
5 Q9TTJ5 Regucalcin 34 5,54 4 16 
6 Q58DM8 Enoyl-CoA hydratase, mitochondrial  32 8,82 2 7 
7 O02691 3-hydroxyacyl-CoA dehydrogenase type-2 27 8,45 7 46 
UP, unique peptides; SC, sequence coverage (in percentage). 
 
 
III. Discussion and concluding remarks 
 
In the past few years, 2D-DIGE has emerged as one the more suited and sophisticated 
techniques for gel-based differential proteomics studies. Utmost sensitivity of cyanine 
staining, noteworthy minimisation of experimental variability, opportunity to run up to 
three different samples in a single gel, make this system as a perfect way for the 
analysis of FFPE tissues. In fact, limited size of greater part of stored FFPE biopsies does 
not allow the access to an elevate amount of proteins; hence, the ability to perform a 
proteomic investigation without the need of a large number of experiments, or of a 
huge availability of protein extract, may represent an invaluable resource for rare 
disease research. In view of these reasons, the successful 2D-DIGE analysis of FFPE 
extracts described here can be considered as a significant advance in clinical 
proteomics. 
FFPE 2D-maps, as described above, show a notable degree of comparability with fresh-
frozen, a high reproducibility between replicates, and an unexpected pattern 
complexity, particularly for liver. Compared to the only attempt of applying DIGE to 
FFPE samples published so far [85], overall map quality has been considerably 
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improved. Furthermore, when applied to routinely collected biopsies, the combination 
of the FFPE protein extraction method developed in our laboratory and 2D-DIGE led to 
significant results. The experiment consisted in a comparison between proteomes 
expressed by two FFPE sheep liver samples, affected by different levels of heavy metal 
intoxication, in order to identify damage biomarkers. All main differentially expressed 
spots correspond to proteins which have been involved in liver stress pathways. GRP78 
and protein disulfide-isomerase (PDI) are long since well-known liver damage 
biomarkers, and were found as overexpressed in a wide range of disease states [117-
119, 122]. 14-3-3 isoforms have been related to liver cancer [121], while little is known 
about ERp27, except its interaction with PDI [116]. In addition, PDI, GRP78 and ERp27 
are all localized at level of endoplasmic reticulum and share folding properties [114-
115]; 14-3-3 has been associated to various signalling pathways, especially related to 
cell cycle and apoptosis regulation [120]. GeLC-MS/MS analysis results show an 
excellent consistency with 2D-DIGE-MS identifications, confirming robustness and 
trustworthiness of both methods, in spite of the historical “inaccessibility” of FFPE 
samples. 
Undoubtedly, several remarkable limitations remain still unresolved. For instance, in 
high molecular weight gel regions, a moderately high background is present, combined 
with a lower spot intensity, if compared with the signal of smaller proteins; this may 
cause a few troubles in image analysis performances. It is very important to note that 
comparison must be done only between FFPE samples; it should be senseless, at 
present, to perform a “hybrid” differential proteomic investigation, with both FFPE and 
fresh samples. Instead, when comparing FFPE extracts, drawbacks, even if existing, are 
shared, and so can be somehow equally “subtracted”. Nonetheless, there is a certain 
need to further improve methodologies for the analysis of FFPE samples, here included 
extraction procedures and analytical methods. 
A secondary aim of this study was to infer from 2D-DIGE data information about 
chemical modifications of fixed proteins. Two crucial evidences were argued: a diffuse 
acidic-shift, and a possible correlation between lysine percentage and spot intensity 
reduction, always as compared to fresh-frozen proteins. The first phenomenon 
provoked by fixation seems to affect spots trains all along the 2D map, and presents a 
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clear visual impact, highlighted by DIGE technology. Rait et al. [67] took notice of an 
isoelectric point decrease in bovine RNAse A, when treated with formaldehyde; 
however, a widespread pI shifting were never demonstrated before. A possible 
explanation of this event might be found in the impact on protein charge of chemical 
modifications, caused by formaldehyde, on basic residues and N-termini: bond 
formation probably modifies basicity of nitrogens, bearing a pI variation.  
Also the involvement of lysine in fixation reactions has been previously described [60-
62]; several works count lysine as one of the most reactive residues in fixation 
procedures. Therefore, it seems reasonable to state that lysine-rich proteins form a 
wider number of crosslinks, and this may make them more difficult to be adequately 
extracted and/or impair their correct migration on gel. Some of the FFPE more 
abundant spots, listed in Appendix 6, are actually truncated forms of larger proteins. 
According to sequence coverage information obtained from LC-MS/MS data, it was 
possible to estimate what part of the protein corresponded to the selected spot (data 
not shown). Intriguingly, all these protein “by-products” own a lower lysine residues 
number than the original molecules; perhaps not by chance, they result more 
abundant in FFPE, even if perfectly detectable also in fresh-frozen pattern. 
As described in results section, FFPE protein preservation appears to depend on 
molecular weight and pI, with large size and basic proteins somehow “handicapped”. 
Moreover, also extraction buffer pH has been indicated as a factor that can influence 
selectivity in protein extraction [123]. The extraction procedure used in this work is 
based on a basic buffer; according to preceding papers, it might favour the release of 
acid proteins, in despite of basic ones. 
Another interesting point is represented by the fact that lysine is also the target of 
cyanines in minimal labelling procedure. It could be thought that FFPE modified 
lysines, reacting only partially with CyDyes, give a less intense staining; however, a 
rapid comparison with skeletal muscle silver-stained maps, previously published by our 
group, or with Coomassie-stained gels generated for spot picking and MS identification 
purposes (images not shown), clearly demonstrates how preservation/depletion trend 
of FFPE proteins is highly conserved, also in differently stained gels.  
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In conclusion, data reported here can be considered as the first stable step in 2D-DIGE 
characterisation of FFPE samples. A widespread application of this technology on rare 
disease samples, together with a refinement of FFPE protein extraction and analysis 
methods, might represent a precious weapon for biomarker discovery studies in the 
years to come.  
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I. Introduction  
 
Quantifying changes in protein abundance between samples is a key requirement for 
differential proteomic studies. In the last years, two principle methods for estimating 
protein quantitative variation were proposed: labelling approaches, which consist in 
isotope or mass tag labelling of peptides, and label-free approaches, which base 
themselves on MS/MS peak area or spectrum number measurement. Even if perhaps 
less sensitive, label-free methods count the advantage of low costs and lack of 
supplementary chemical reactions or data analyses, that are required by isotope-
labeling.  
GeLC-MS/MS represents an interesting “hybrid” between gel-based proteomics and 
shotgun proteomics; it allows to achieve a quite complex proteomic profiling, without 
the need of extremely sophisticated MS instrumentation and starting from a full-
length protein characterisation step. 
Thus, the aim of this work was to determine whether, following a typical GeLC-MS/MS 
workflow, an estimation of protein abundance could be successfully obtained, and to 
establish which MS parameter, among total peptide hits, unique peptides, and 





In order to investigate GeLC-MS/MS suitability to semi-quantitative studies, three 
protein standards were chosen (bovine serum albumin, yeast enolase, and equine 
myoglobin, ranging from about 15 to 70 kDa), and a total E. coli protein extract  was 
prepared, as a complex protein mixture. A bacterial extract was preferred, since 
belonging to a species not phylogenetically closed to those where standards come 
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from, to limit MS identification overlap. Then, a SDS-PAGE was carried out as follows: 
250, 100, or 40 nanograms of each protein marker were added to the E. coli extract, or 
loaded in the adjacent lane as “pure” proteins (Figure 7.1). Hence, the intention was to 
investigate the behaviour of each protein both alone and within a composite mixture, 
and its influence on MS identification, and then on protein abundance estimation. 
Following a standard GeLC-MS/MS procedure, after Coomassie-staining, 9 gel slices, 
comprising all marker visible bands, and the corresponding gel regions along the E. Coli 
1-D pattern, were excised; trypsin in-gel digestion was carried out, and tryptic peptides 
were extracted and analysed in LC-MS/MS.  
 
 
Figure 7.1. SDS-PAGE of standard protein dilutions. 250, 100, and 40 nanograms of each protein were 
loaded in lane 1, 2, and 3, respectively. In lanes marked with “a”, protein standards were mixed with 20 
micrograms of total E. coli protein extract. 
 
MS identifications data are presented in Table 7.1, indicating for each experiment total 
peptide hits, unique peptides, and percentage sequence coverage. At a first sight, a 
substantial correlation between these parameters and protein quantity comes out, 
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1a 33 20 40 
 
1a 11 7 21 
 
1a 46 6 51 
2a 10 9 16 
 
2a 0 0 0 
 
2a 9 3 22 
3a 8 8 12 
 
3a 0 0 0 
 
3a 0 0 0 
    
 
    
 
    
1b 94 30 52 
 
1b 34 12 30 
 
1b 60 6 51 
2b 40 23 34 
 
2b 21 11 30 
 
2b 11 5 40 
3b 17 12 19 
 
3b 12 9 25 
 
3b 4 2 14 
 
A more in-depth data analysis shows a few interesting features. First, as shown in 
Table 7.2 and Figure 7.2 (Panel A, B, and C), and summarised in Figure 7.3, values 
concerning “pure” proteins change significantly in comparison to the “mixture”. 
Paradoxically, in presence of a plenty of other proteins, MS data seem more consistent 
with actual protein quantity, at least for sequence coverage and unique proteins. 
However, total peptide hits parameter keeps in both conditions and for all three 
proteins an optimal correlation trend, never below 0,95 (R-squared value) and with a 
top of 1,000 for pure albumin. Instead, unique proteins and sequence coverage criteria 
demonstrate a wider variability, and only in one-fifth of the cases reach a higher 
coefficient of determination than total peptide hits method.  
Enolase peptides, when mixed with E. coli ones, coming from co-migrating bacterial 
proteins, could not be detected from 100 nanograms of protein loaded downwards: it 
is an important issue, which will be discussed in the next paragraph.  
 
Table 7.2. Summary of R-squared values obtained for each experiment. 
  Sample Total peptide hits Unique peptides Seq. coverage 
Mixture A 0,957 0,958 0,978 
 
E - - - 
 
M 0,991 0,942 0,973 
 
main 0,974 0,950 0,976 
     
Pure A 1,000 0,970 0,964 
 
E 0,981 0,824 0,519 
 
M 0,973 0,750 0,793 
 
main 0,985 0,848 0,759 
     
Overall main 0,979 0,899 0,867 
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Figure 7.2. Panel A: Correlation between total peptide hits number and protein abundance for three 
protein standards, in a mixture with E. coli extract (a), or as pure proteins (b). R-squared values are 
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Figure 7.2. Panel B: Correlation between unique peptides number and protein abundance for three 
protein standards, in a mixture with E. coli extract (a), or as pure proteins (b). R-squared values are 
reported for each plot. 
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Figure 7.2. Panel C: Correlation between sequence coverage and protein abundance for three protein 
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III. Discussion and concluding remarks 
 
In view of the results obtained, even if referring to a not exhaustive survey, a clear, 
significant correlation between MS total peptide hits and protein abundance was 
revealed. Therefore, this parameter can be used as a valid (semi-)quantitative index for 
comparing differential expression of the same protein between two groups of samples 
analysed with a GeLC-MS/MS approach. 
Enolase data demonstrate that analysis effectiveness largely depends on the context in 
which target protein is inserted. As can be noted in Figure 7.1, E. coli protein pattern 
shows a strongly intense band at the height of “pure” enolase band; probably, an 
ample difference in the order of magnitude between neighbouring bacterial highly 
expressed protein and enolase (present in a quantity not higher than 100 nanograms) 
hided enolase signal, preventing a correct identification, and quantification. As a 
consequence, it should not be reliable to compare with this method the abundance of 
different proteins. In fact, every gel area presents a proper protein profile, and so a 
dissimilar protein density, and this difference might impair a trustworthy comparison, 
even between two protein with an identical concentration. Nevertheless, an 
evaluation of total peptide hits of the same protein in two similar samples, being 
 72 
Alessandro Tanca, Novel methods for proteomics analysis of formalin-fixed, paraffin-embedded tissues (FFPE), and their 
applications for biomarker discovery, Tesi di dottorato in Scienze biomolecolari e biotecnologiche, Università degli studi di Sassari 
surrounded by the same co-migrating proteins, should be surely more informative and 
allow a confident semi-quantitative analysis.  
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8. IDENTIFICATION OF LUNG NEUROENDOCRINE TUMOURS CANDIDATE BIOMARKERS BY 
GEL-BASED PROTEOMICS ANALYSIS OF FORMALIN-FIXED, PARAFFIN-EMBEDDED SAMPLES 
 
 
I. Introduction  
 
Lung neuroendocrine tumours (lung NETs) represent a spectrum of neoplastic tissues 
arising from neuroendocrine cells of lung epithelium, and comprise about 20% of all 
pulmonary cancers. Although sharing structural and morphological features, they are 
separated into four subgroups: typical carcinoid tumour (TC), atypical carcinoid tumour 
(AC), large-cell neuroendocrine carcinoma (LCNEC), and small-cell lung carcinoma 
(SCLC), which exhibit a considerably dissimilar biology [124]. The frequent mistakes in 
differential diagnosis between TC and SCLC have been described as one of the most 
important “pitfalls” in the management of lung cancers [125]. In combination with the 
histological appearance, a variety of markers, including Ki-67, chromogranin A (CgA), 
neuron-specific enolase (NSE), serotonin, synaptophysin, and adrenocorticotrophic 
hormone (ACTH), have some utility in establishing the differential diagnosis. However, 
a molecule with a satisfactory degree of sensitivity and specificity has still to be found. 
For instance, an increase of plasma CgA level is a relatively sensitive marker of lung 
carcinoids, but also it shows positivity also in about 60% of SCLC cases [124]. 
In the past few years, some gene expression studies comprising lung NETs were carried 
out, but no conclusive information about diagnostic or prognostic biomarkers was 
inferred [126-132]. As concerns proteomics, an in-depth systematic characterisation of 
these tissues has never been published so far; only a limited comparative 2D-PAGE 
survey has been conducted in 2005 by Cho et al. [133]. In fact, a thorough differential 
proteomic investigation, particularly comparing TC and SCLC protein patterns for 
biomarker discovery purposes, which might have a really significant diagnostic 
usefulness, has never been performed to date. 
From the point of view of biomedical research, the largest hindrance in lung NETs is 
represented by their low frequency, especially as regards carcinoids [134]. Hence, the 
scarce availability of fresh biopsies makes extremely difficult to carry out a biomarker 
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discovery study, without the help of formalin-fixed, paraffin-embedded (FFPE) tissue 
banks, stored in hospitals worldwide. Our group recently optimised a novel FFPE 
protein extraction method, and described the application to these extracts of several 
proteomic techniques (as illustrated in previous chapters).  
In view of this, a GeLC-MS/MS differential proteomic analysis was conducted on FFPE 
TC and SCLC samples, in order to molecularly characterise these tissues, and to identify 
a panel of putative protein biomarkers, to subsequently validate by means of 
immunological high-throughput techniques. Moreover, a 2D-DIGE-MS experiment was 
also performed, with the intention of confirming, or disproving, differential expression 





1. GeLC-MS/MS analysis leads to detect over 400 proteins for each kind of 
pathological tissue and to assess biological variability 
In order to perform a differential analysis, six human FFPE bioptic samples, three 
diagnosed as typical carcinoids, and three as small cell lung carcinomas, were 
subjected to the protein extraction procedure previously developed in our laboratory. 
Two identical aliquots of each protein extract were separated by SDS-PAGE, and then 
the polyacrilamide gel were cut according one of the following methods: excision of 
the only 13 clearly visible bands (VB method), or fractionation of the whole lane into 
38 homogeneous slices, independently from band intensities (AL method). Thus, a 
total of 306 gel portions were in situ digested with trypsin; tryptic peptides were 
extracted and analysed by LC-MS/MS; finally, MS identification data were processed, in 
order to obtain a complete proteomic profile for each probed extract. The complete 
experimental workflow of this study is illustrated in the flowchart of Figure 8.1.  
 75 
Alessandro Tanca, Novel methods for proteomics analysis of formalin-fixed, paraffin-embedded tissues (FFPE), and their 
applications for biomarker discovery, Tesi di dottorato in Scienze biomolecolari e biotecnologiche, Università degli studi di Sassari 
 
Figure 8.1. Experimental workflow. 
 
Overall GeLC-MS/MS results were generated merging proteomic information of two 
replicates (obtained by VB and AL methods, respectively) for each sample, while total 
datum derives from combining profiles of single samples into classes. Complete lists of 
protein identifications, classified according to tumour subgroup, are presented in 
Appendices 8-9. As summarised in Table 8.1, a total of 420 and 442 unique proteins for 
TC and SCLC, respectively, and a mean of almost 240 proteins per sample, and 430 
proteins per class, were detected, whereas total peptide hits value per sample was 
around 5000. 
As concerns distribution of identified proteins among individual samples (see Table 
8.2), no less than a half of total identified proteins belong only to a single sample. It 
might appear the consequence of a dramatic biological variability; actually, if 
considering mean peptide number per protein, it can be noted that they are often 
single-peptide proteins, whose “random” finding is largely caused by the coincidence 
between their low concentration and the detection limit of the instrument, rather than 
by a “real” varied abundance among samples. As a confirm of this, protein and peptide 
percentages in function of the number of sample in which they were detected 
highlight an opposite trend: common proteins are generally the most abundant, whilst 
those detected only in a little fraction of samples exhibit a low abundance. Thus, 
except for particular cases (such as hyaluronan and proteoglycan link protein 1, highly 
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expressed in a SCLC sample and absolutely undetected in all the others), variability 
seems to be much more technical than biological. 
 
Table 8.1. Summary of GeLC-MS/MS data, according to sample classes 
Sample Unique proteins Total peptide hits 
TC1 224 5624 
TC2 218 5146 
TC3 261 4981 
mean TC 234 5250 
total TC 420 15751 
   SCLC1 262 5685 
SCLC2 155 4709 
SCLC3 295 3815 
mean SCLC 237 4736 
total SCLC 442 14209 
   mean NET 236 4993 
total NET 616 29960 
 










% Proteins % Peptides 
1 305 884 3 50 3 
2 97 578 3 16 2 
3 78 766 3 13 3 
4 49 1076 5 8 4 
5 36 2204 12 6 7 
6 51 24452 80 8 82 
 
On the other hand, 51 proteins are shared by all samples (listed in Appendix 10); 
together with a few “housekeeping proteins”, also forms belonging to distinctive 
tumoral pathways proteins can be identified, as will be illustrated in next paragraphs. 
Figure 8.2 shows sharing and intersection of protein identifications among samples 
belonging to the same tumour subgroup. 102 and 79 proteins can be considered 
peculiar of TC and SCLC, respectively, since were detected in all cases of their proper 
disease type. Combining these data, identities of proteins always detected in a class 
and never in the other were found: 11 proteins were detected in all TC cases and in 
none of SCLCs, and only 3 proteins were detected in all SCLC cases and in none of TCs. 
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These 14 proteins, which can be more consistently judged as differentially expressed, 
are listed in Table 8.3.  
 
 
Figure 8.2. Venn diagrams illustrating distribution of identified proteins among the three samples of the 
same tumour subtype.  
 
Table 8.3. List of differentially expressed protein identifications.  
Accession no. Protein TC TPH SCLC TPH 
P10645 Chromogranin-A  66 0 
Q8IWL2 Pulmonary surfactant-associated protein A1  15 0 
P00441 Superoxide dismutase [Cu-Zn]  9 0 
P08294 Extracellular superoxide dismutase [Cu-Zn]  8 0 
P02794 Ferritin heavy chain  7 0 
O60888 Protein CutA  7 0 
P30044 Peroxiredoxin-5, mitochondrial  6 0 
P02766 Transthyretin  6 0 
Q96IU4 Abhydrolase domain-containing protein 14B  5 0 
P07988 Pulmonary surfactant-associated protein B  5 0 
P18669 Phosphoglycerate mutase 1  4 0 
    P16401 Histone H1.5  0 39 
P09651 Heterogeneous nuclear ribonucleoprotein A1  0 27 
Q13242 Splicing factor, arginine/serine-rich 9  0 9 
 
2. “All lane” fractionation method assures a significant enlargement of proteomic 
data set, especially for low-abundant proteins 
In a previous work, a GeLC-MS/MS investigation of FFPE sheep muscle extract was 
conducted, by cutting only band visibile after colloidal Coomassie staining. However, in 
our experience protein identification is achievable also analysing gel regions which 
does not show a visible signal; this brought to hypothesise that subjecting to a GeLC-
MS/MS analysis gel slices excised from the whole lane might improve quantitatively 
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and qualitatively proteomic data. Thus, as secondary aim of this work, a comparison of 
visible band (VB) and all lane (AL) fractionation methods data was conducted.  
Results, summarised in Table 8.4 and in Figure 8.3, demonstrate that also 
“transparent” gel regions can provide precious information, particularly regarding to 
low-abundant proteins; actually, over fifty percent of identified proteins were detected 
only by means of this fractionation procedure. It is a remarkable outcome, not 
forgetting that a “strange” matrix, as a FFPE tissue, was examined. Nevertheless, VB 
replicates allow to exclusively find 62 proteins; on account of this, both fractionation 
replicates were considered in GeLC-MS/MS results.  
 
Table 8.4. Comparison of identification data between different fractionation methods.  
Method Data Unique proteins Total peptide hits 
Average peptides 
per protein 
VB Total 286 6164 22 
 Average per exp 108 1027 10 
AL Total 554 23796 43 




Figure 8.3. Panel A: Representative 1D-PAGE profile of a FFPE lung NET extract (lane 1). Illustration of 
fractionation methods by visible bands cutting (VB, lane 2), and all lane cutting (AL, lane 3). Panel B: 
Venn diagram showing distribution of proteins identified with both fractionation methods (light blue), 
only with VB (dark blue), or only with AL (white). Panel C: Venn diagram showing distribution of peptides 
corresponding to proteins identified with both fractionation methods (light blue), only with VB (dark 
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3. Main tissues proteins form a sort of “background noise” in a high percentage of 
gel regions 
As reported in our previous works, FFPE extracts seem to contain protein artificial 
complexes which co-migrate with restored “normal” proteins. These complexes appear 
to be composed by a combination of the most expressed proteins of the tissue. Also 
for human FFPE lung NETs extracts, GeLC-MS/MS analysis demonstrated this 
phenomenon: in fact, the overall protein abundance (according to total peptide hits, 
for all the bands examined) correlates quite well with the percentage of bands in 
which the protein was identified, as shown in Figure 8.4. For example, beta subunit of 
hemoglobin, which exhibits also the highest total peptide hits value, was found in 
nearly 95% of gel slices, also in the highest molecular weight ones (see Table 8.5). The 
most widely represented proteins are globins, histone isoforms and serum albumin. 





Figure 8.4. Plot indicating correlation between protein total peptide hits and number of bands in which 
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Table 8.5. List of the five most represented proteins along gel bands. Total peptide hits in all samples 
analysed are also indicated. 
Protein No. of bands % bands Total peptide hits 
Hemoglobin subunit beta  288 94,1 4693 
Histone H4 276 90,2 2582 
Hemoglobin subunit alpha  264 86,3 3434 
Actin, cytoplasmic 1  179 58,5 1875 
Serum albumin 167 54,6 1811 
 
4. Gene ontology analysis allows to characterise functional features of TC and SCLC 
proteomes 
Apart from a few gene expression studies, an evident lack of molecular information 
about lung neuroendocrine tumours has to be noticed. Small cell carcinoma has been 
seldom considered in the proteomic investigations described so far, whilst to our 
knowledge lung carcinoids were never subjected to a systematic proteomic survey. 
Thus, an in-depth classification of these tissues, following Gene Ontology parameters, 
has a reasonable degree of novelty. Pie charts in Figures 8.5 and 8.6 show percentage 
protein distribution for molecular function, biological process, and cellular localisation. 
Comparing functional data of tumour subgroups, as described in the following 
histogram (Figures 8.7), wider differences in protein distribution concern mRNA 
splicing factors, protein kinases (more abundant in SCLC), and oxidoreductases 
(present in a larger number in TC). Moreover, TCs show a larger amount of 
extracellular proteins, whereas SCLCs of intracellular proteins. Finally, almost 50% of 
proteins detected in both tissues are encoded by genes which are known to be 
expressed in brain tissue; this datum is consistent with neuroendocrine origin of this 
kind of cancers. 
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Figure 8.5. Pie charts representing distribution of TC proteins according to molecular function (top), 
biological process (middle), and cellular localisation (bottom). 
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Figure 8.6. Pie charts representing distribution of SCLC proteins according to molecular function (top), 
biological process (middle), and cellular localisation (bottom). 
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Figure 8.7. Histogram comparing number of TC and SCLC proteins belonging to the main molecular 
function classes. AB, actin-binding proteins; CB, calcium-binding proteins; CH, chaperones; MC, 
microtubular cytoskeleton proteins; RN, mRNA processing and splicing factors; OR, oxidoreductases; PK, 
protein kinases; TF, transcription factors; TC, transfer/carrier proteins. 
 
5. Several protein families seem to exhibit a differential expression abundance 
between TC and SCLC 
Total number of peptide hits was used in this work as a protein abundance index, 
according to spectral count label-free protein quantitation approach. A demonstration 
of linear correlation between protein quantity and peptide hits for GeLC-MS/MS 
analyses was described in chapter 7. 
Considering variation in total peptides number among protein functional classes 
between TC and SCLC, RNA-binding proteins and microtubular cytoskeleton proteins 
exhibit a significant overexpression in SCLC, while calcium-binding proteins and iron 
homeostasis proteins are more abundant in TC (Fig. 8.8). More deeply, comparing 
peptide hits distribution in some specifically expressed protein families, it can be 
pointed out that peroxiredoxins, annexins, S100 proteins and transgelins seem more 
“typical” of TC, whilst plenty of hnRNPs and splicing factors appears as a peculiar 
signature of SCLC, as indicated in Figure 8.9. Furthermore, tubulins, histones, hnRNPs 
and splicing factors are present with a wider variability and abundance of isoforms in 
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Figure 8.8. Histogram comparing total peptide hits of proteins belonging to some peculiar protein 
functional classes. OR, oxidoreductases; CB, calcium-binding proteins; IH, iron homeostasis proteins; RB, 
RNA-binding proteins; MC, mucrotubular cytoskeleton proteins; CH, chaperones. 
 
 
Figure 8.9. Histogram comparing total peptide hits of proteins belonging to main differentially 
distributed protein families. 
 
 
6. Statistical analysis provides a list of 35 proteins significantly differentially 
expressed, which may represent potential disease biomarkers 
The final purpose of this work was to identify a panel of putative biomarkers, which 
could help in lung NETs differential diagnosis. As semi-quantitative parameter, total 
number of peptide hits was used, as stated above. With the purpose of identifying a 
set of statistically-supported, robust, and authentically differentially expressed 
candidate biomarkers, a non-parametric Kruskal-Wallis test was performed. The task 
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of this statistical “filter” was to select proteins homogeneously abundant among the 
samples of a disease class, and absent (or significantly, evenly underexpressed) within 
the other subgroup. Proteins which fell into a 95% confidence interval are displayed in 
Table 8.6.  
 
Table 8.6. List of proteins identified as differentially expressed by means of statistical analysis. 







ABHEB_HUMAN Abhydrolase domain-containing protein 14B   5 0 TC 
ANXA5_HUMAN Annexin A5   49 17 TC 
CMGA_HUMAN Chromogranin-A   66 0 TC 
CUTA_HUMAN Protein CutA   7 0 TC 
EF1A1_HUMAN Elongation factor 1-alpha 1   4 40 SCLC 
FRIH_HUMAN Ferritin heavy chain   7 0 TC 
H12_HUMAN Histone H1.2   18 135 SCLC 
H15_HUMAN Histone H1.5   0 39 SCLC 
H2A1D_HUMAN Histone H2A type 1-D   138 859 SCLC 
H31T_HUMAN Histone H3.1t   104 404 SCLC 
H4_HUMAN Histone H4 725 1857 SCLC 
HBA_HUMAN Hemoglobin subunit alpha   2580 854 TC 
HBB_HUMAN Hemoglobin subunit beta   3459 1234 TC 
HBD_HUMAN Hemoglobin subunit delta   929 142 TC 
HNRPC_HUMAN Heterogeneous nuclear ribonucleoproteins C1/C2   13 29 SCLC 
HNRPK_HUMAN Heterogeneous nuclear ribonucleoprotein K   6 24 SCLC 
PGAM1_HUMAN Phosphoglycerate mutase 1   4 0 TC 
PRDX5_HUMAN Peroxiredoxin-5, mitochondrial   6 0 TC 
PRDX6_HUMAN Peroxiredoxin-6   19 3 TC 
PSPB_HUMAN Pulmonary surfactant-associated protein B   5 0 TC 
RL18_HUMAN 60S ribosomal protein L18 2 12 SCLC 
RL23A_HUMAN 60S ribosomal protein L23a 1 13 SCLC 
ROA1_HUMAN Heterogeneous nuclear ribonucleoprotein A1   0 27 SCLC 
RS26L_HUMAN Putative 40S ribosomal protein S26-like 1 1 9 SCLC 
RS4X_HUMAN 40S ribosomal protein S4, X isoform   1 7 SCLC 
S10A8_HUMAN Protein S100-A8   15 1 TC 
SFRS9_HUMAN Splicing factor, arginine/serine-rich 9   0 9 SCLC 
SFTA1_HUMAN Pulmonary surfactant-associated protein A1   15 0 TC 
SODC_HUMAN Superoxide dismutase [Cu-Zn]   9 0 TC 
SODE_HUMAN Extracellular superoxide dismutase [Cu-Zn]   8 0 TC 
STMN1_HUMAN Stathmin   1 34 SCLC 
TAGL2_HUMAN Transgelin-2   46 22 TC 
TBA1A_HUMAN Tubulin alpha-1A chain   37 223 SCLC 
TBB5_HUMAN Tubulin beta chain   14 155 SCLC 
TTHY_HUMAN Transthyretin   6 0 TC 
 
Besides not significative elements (globins, for instance), and well-known 
neuroendocrine markers (such as chromogranin A), an interesting list of proteins, 
which comprises superoxide dismutase, protein Cut A, peroxiredoxin-5, and protein 
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S100-A8, may represent a potential markers panel useful for specifically diagnosing TC. 
On the other hand, among SCLC candidate biomarkers, proteins like hnRNP A1, splicing 
factor arginine/serine-rich 9, and stathmin were discovered. Obviously, 
trustworthiness of differential expression has now to be validated with 
complementary approaches, such as immunohistochemistry, on a wider gamut of 
bioptic samples. 
 
7. 2D-DIGE-MS/MS analysis confirms several candidate biomarkers previously 
identified by GeLC-MS/MS 
As a final step, also a 2D-DIGE analysis was performed, with the aim of comparing TC 
and SCLC patterns. Two FFPE samples (different from those analsyed by GeLC-MS/MS), 
were subjected to protein extraction, protein precipitation (following a standard 
TCA/acetone method), CyDye labelling, and 2D-DIGE analysis, as described in 
Experimental activities section.  
 
 
Figure 8.10. 2D-DIGE of TC and SCLC FFPE samples (upper, single channel images; lower, overlay image). 
Picked and MS-analysed spots are marked with red circles and indicated by numbers.  
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Image analysis with DeCyder software highlighted four spots, as shown in Figure 8.10, 
which exhibited a more intense signal in typical carcinoid 2D-map. Such spots were 
picked, digested with trypsin, and their derivate peptide mixtures were analysed by LC-
MS/MS. MS identifications are in greater part consistent with those found by GeLC-
MS/MS approach (as summarised in Table 8.7). In fact, some members previously 
inserted in Table 8.6 were detected, as chromogranin A (in truncated forms), protein 
CutA, and annexin A5. Moreover, a lot of proteins formerly identified in TC extracts, 
and presenting a higher peptides number in comparison with SCLC, were identified, 
such as S100 protein A11 and A6 isoforms, Peroxiredoxin-2, and ProSAAS. 
 
Table 8.7. List of MS identifications from 2D-DIGE spots. Proteins stated as overexpressed in GeLC-
















1 Q9NP97 Dynein light chain 
roadblock-type 1 
10915 6,58 74 1 1 12 
 P14174 Macrophage migration 
inhibitory factor 
12639 7,74 61 1 1 9 
 P31949 Protein S100-A11 11847 6,56 61 1 1 8 
 P06703 Protein S100-A6 10230 5,33 49 4 2 16 
 P61604 10 kDa heat shock protein, 
mitochondrial 
10925 8,89 44 1 1 9 
 A6NHG4 D-dopachrome 
decarboxylase-like protein 
14414 5,89 44 1 1 5 
  P14854 Cytochrome c oxidase 
subunit 6B1 
10414 6,54 41 1 1 9 
2 P10645 Chromogranin-A* 50829 4,58 544 16 3 9 
 P08758 Annexin A5* 35971 4,94 103 1 1 5 
 O60888 Protein CutA 19218 5,42 85 1 1 7 
 Q15121 Astrocytic 
phosphoprotein PEA-15 
15088 4,93 68 1 1 7 
 P12277 Creatine kinase B-type * 42902 5,34 59 1 1 2 
 P52907 F-actin-capping protein 
subunit alpha-1* 
33073 5,45 57 1 1 3 
 P32119 Peroxiredoxin-2 22049 5,66 48 1 1 5 
  Q15370 Transcription elongation 
factor B polypeptide 2 
13239 4,73 46 2 2 18 
3 P10645 Chromogranin-A* 50829 4,58 190 4 3 15 
4 Q9UHG2 ProSAAS 19077 4,86 343 5 5 25 
 Q9Y2B0 Protein canopy homolog 2 20981 4,81 100 1 1 8 
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III. Discussion and concluding remarks 
 
After optimisation of FFPE extraction method, and its application on model sheep 
tissues (see Chapters 4-6), the following challenge was to perform a complete 
differential proteomics study on human bioptic fixed samples. Efficacy, suitability, and 
reproducibility of extraction procedure were widely confirmed by homogeneity, 
consistency, and overall quality of GeLC-MS/MS data. Taking into account the 
complexity of FFPE matrix, the amount of proteins and peptides detected, the 
sensitivity level of MS instrumentation used, and the high similarity between TC and 
SCLC, the achieved results are very satisfactory: a plethora of specific and comparative 
proteomic data were obtained, and a significative panel of candidate biomarkers to be 
validated were generated. 
Label-free GeLC-MS/MS application for biomarker discovery exhibits several pros and 
cons. SDS-PAGE prefractionation allows to decrease sample complexity, and, unlike 
two-dimensional separation, information about proteins with extreme pIs is widely 
preserved; moreover, performing a LC-MS/MS analysis starting from full-length 
electrophoresed proteins facilitates correct peptide matching, increasing identification 
significance. On the other hand, compared to classical “shotgun” proteomics 
experiments, initial gel separation may deplete extracts of the highest- and/or lowest 
molecular weight proteins; in addition, an uneliminable variability in band picking and 
peptide extraction has to be considered; finally, label-free quantitation (at least for the 
simplified form utilised here) must be regarded as a (good) abundance estimation 
method, rather than an actual quantitation (see Chapter 7). 
Proteomic profiling can undoubtedly aid the comprehension of lung neuroendocrine 
tumours molecular features; in particular, data about proteins (and protein families) 
differentially expressed between carcinoid and small cell carcinoma might open the 
way to a more in-depth characterisation of biological processes and molecular patways 
in which they are involved, such as cellular redox balance regulation, calcium 
homeostasis maintenance, mRNA splicing and processing, and so on.  
As concerns identified putative biomarkers, several of them has been already 
described as correlated to neoplastic diseases. Overexpression of various isoforms of 
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heterogeneous nuclear ribonucleoproteins, included A1, was demonstrated for 
different kinds of tumour [135-138]; it is still debated whether this mRNA-binding 
proteins increase represents a driving force for, or a consequence of, cell cycle 
deregulation [139]. Some variants of arginine/serine rich splicing factors were 
identified as receptors for lung colonisation of cancer cells [140]. A few surveys 
indicate a correlation between stathmin expression and cancer development, in 
neuroendocrine types as well [141-142]. Annexin A5, unlike other members of its 
super-family, has been used as a probe to mesaure apoptosis in vivo and in vitro, also 
in tumoral tissues, but has not been still directly related to cancer development [143]. 
Among oxidoreductases, peroxiredoxins are expressed by several normal and tumoral 
tissues; especially, type 6 is typical of lung (both healthy and diseased) [144-147]. 
Superoxide dismutase isoforms are present at heterogeneous ratios in cancer tissues, 
mostly in the lung, as a consequence of its constant exposition to oxygen [148-149].  
As regards calcium-binding proteins, S100 protein family members have been variously 
linked to tumours; S100 A8 were detected in colorectal, breast, and gastric cancer 
tissues [150-151]. Other proteins are more consistent with a neuroendocrine 
differentiation, such as transthyretin and protein CutA. Transthyretin plays a crucial 
role in senile systemic amyloidosis development [152]. Little is known about protein 
CutA, apart from its role in acetylcholinesterase secretion pathway [153]. Finally, 
transgelin was suggested as a tumour suppressor, but recently was demonstrated by 
proteomic investigations to be overexpressed in lung and gastric adenocarcinomas 
[154-156]. 
Even though being not an ample and robust investigation by itself, the 2D-DIGE 
experiment included in this work has the merit of supporting GeLC-MS/MS data, and 
demonstrates that also 2D-DIGE can be useful for biomarker discovery in FFPE tissues, 
at least as a complementary approach.  
In conclusion, this study provides a global molecular characterisation of 
neuroendocrine tumours at a proteomic level, and makes available a list of assorted 
candidate biomarkers, useful for lung NETs differential diagnosis. The further objective 
in this research field will be to validate the most promising putative biomarkers, by 
means of immunological approaches, such as immunohistochemistry, on a wider 
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number of samples (including also intermediate subgroups, namely, atypical carcinoid 
and large cell carcinoma). On the other hand, carrying out a complementary 
transcriptomic investigation (by cDNA microarrays, in situ hybridisation, or qPCR) 
might represent a significant widening of the study, and a decisive corroboration of the 
results obtained in proteomics. 
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9. GENERAL CONCLUSIONS AND FUTURE PERSPECTIVES 
 
 
I. General conclusions 
 
A wealth of statistically supported information on disease is encased within FFPE tissue 
repositories. Recently, scientists have been trying to access this “locked proteome” 
with the development and application of various protein extraction strategies; 
however, so far, the spectrum and the reproducibility of downstream applications 
have been limited by yield and quality issues affecting proteins extracted from the 
formalin-fixed tissue matrix. The full-length protein extraction method described here 
is versatile, reliable, amenable to different analytical platforms, such as 1-D and 2-D 
PAGE, GeLC-MS/MS, 2D-PAGE-MS, 2D-DIGE-MS, 1-D and 2-D western blotting, reverse 
phase protein arrays, and ELISA. 
Recent achievements in the field of proteomic characterization of FFPE tissues, mostly 
limited to gel-free shotgun approaches, the application of gel-based proteomics (i.e. 
GeLC-MS/MS, 2D-PAGE-MS, and 2D-DIGE-MS) to these fixed protein matrices had 
never been reported in a comparative fashion with matched fresh tissue samples. 
Rather, past efforts in this direction produced discouraging results. Nevertheless, the 
ability to apply the investigational power of gel-based proteomics to FFPE tissue 
repositories would enhance our knowledge on the proteomic repertoire of disease, 
and deserves further efforts. In this study, the applicability of 2D-PAGE-MS and 2D-
DIGE-MS to FFPE tissues was demonstrated by using matched animal tissue model 
samples. This approach led to obtain satisfactory amounts of fresh tissues for 
comparison, and also to eliminate variability factors such as differences in fixing times, 
individual differences in samples, anatomical or regional heterogeneity, and other 
possible sources of variability, in FFPE samples. 1-D and 2-D FFPE protein profiles show 
a high reproducibility and a satisfactory quality, and MS identifications are largely 
comparable with fresh-frozen extracts. Moreover, DIGE and MS characterisation of 
FFPE samples allowed the discovery, or the confirmation, of a few peculiar chemical 
features of fixed proteins, such as pI acidic shift, artificial complexes existence and 
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their electrophoretical behaviour, and influence of lysine percentage in crosslinks 
formation and/or restoration. 
Implications are noteworthy under several aspects. Surgical biopsies are extremely 
valuable for investigating disease processes, but require highly invasive procedures 
and cannot be collected for this purpose only. On the other hand, the production of 
high quality protein extracts from archival FFPE tissues allows not only to access a large 
number of diseased tissues, but also to recover samples collected along prolonged 
time intervals and for which the clinical course has been established. Furthermore, 
proteomic profiling of the immunohistochemistry diagnosis “leftovers” opens the way 
to statistically supported studies on low-incidence diseases, such as rare tumour 
forms. In addition, the extremely stable nature and biological safety of FFPE tissues 
greatly facilitates long distance exchange of samples for performing multicentric 
studies.  
Once a robust and reliable FFPE proteomic analysis workflow was developed and 
validated, it was exploited for carrying out a biomarker discovery investigation in the 
field of lung neuroendocrine cancer. Differential diagnosis of these diseases represents 
often an arduous task for pathologists, because of the lack of specific and sensitive 
markers which can facilitate, and make unfailing, discrimination between several 
tumour subgroups. In view of such a need, the differential proteomics survey 
illustrated in this work, and the successful identification of a panel of putative 
diagnostic and/or prognostic biomarkers, may have crucial repercussions in terms of 
clinical significance and analytical usefulness. Moreover, given the want of proteomics 
study which elucidate molecular and functional profile of lung NETs, specifically for 
lung carcinoids, proteomic information provided here is a noteworthy contribution for 
the understanding of these diseases, and may open the way to in-depth investigations 
of signal transduction pathways and biological processes involved in neuroendocrine 
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II. Short-term perspectives 
 
With regard to the “methodologic” issue of protein extraction and characterisation 
from FFPE tissues, a further challenge might be to evaluate correlation between 
fixation time, or bioptic section “age”, and proteomic profile quality by 2D-PAGE 
and/or 2D-DIGE. Similar surveys were recently performed with shotgun proteomics 
approaches [96]; however, actual effects of fixation-related factors on full-length 
protein electrophoretic profile may be quite different, and their description would be a 
very interesting topic.  
As extensively discussed in the previous sections of this writing, the following step of 
this biomarker discovery research will be candidate biomarkers validation. By means of  
immunohistochemistry, or other immunological high-throughput techniques, protein 
expression will be evaluated within a wide gamut of neuroendocrine tumour samples, 
in order to point out positive/negative correlation between antigen abundance (or 
cellular localisation) and cancer malignancy, therefore assigning to the marker a 
diagnostic or prognostic value. Also quantitative analysis of transcripts, with the help 
of in situ hybridisation, and/or real time RT-PCR, may contribute to strengthen 
proteomic evidences from a complementary point of view. 
 
 
III. Long-term perspectives and future research directions   
 
Another interesting issue to deal with, if owning a highly significative number of lung 
NETs cases, would be to carry out a transcriptomic biomarker discovery study by cDNA 
microarrays. It may provide a robust complementary data set, which would give an 
actual contribute to the research. 
Furthermore, proteins belonging to the molecular pathways which appear to be 
involved in neuroendocrine differentiation might be subjected to functional studies, 
with both proteomics and genomics methods. For instance, their post-translational 
modifications may be studied, or relative ratios of protein isoforms may be 
determined.   
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Finally, once concluded validation phase, the most reliable candidate biomarkers might 
be searched for in patients’ sera. This is the final purpose of every cancer biomarker 
discovery project; in fact, the possibility to make a lung tumour diagnosis simply taking 
a sample of blood would be an extraordinary and remarkable result. 
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ADDENDUM 
 
Other experimental approaches which were applied or taken into account during the 
doctorate: 
 genotyping by mass-spectrometry techniques (MALDI-MS detection of 
oligonucletotides and DNA restriction fragments) 
 genotyping by DNA microarrays (by Illumina bead-arrays system) 
 gene expression analysis by cDNA microarrays (by Illumina bead-arrays system) 
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List of fresh-frozen skeletal muscle proteins identified by 1D-GeLC-MS/MS, ordered 
according to the number of queries matched. For “number of queries matched” is 
intended the total number of peptide hits assigned to a protein, as a sum of data 
obtained from all 21 cut gel bands. Sequence coverage instead refers to the best 
percentage reached for a single gel band. Shaded lines indicate proteins identified also 
















Myosin heavy chain (several 
isoforms) 
281 36 5519 223764 5.57 Q9BE40 
Actin, alpha skeletal muscle 171 47 2947 42366 5.23 P68138 
Creatine kinase M-type 163 37 3353 43190 6.63 Q9XSC6 
Fructose-bisphosphate aldolase 
A 
78 42 1754 39774 8.31 P00883 
Myoglobin 77 43 2686 17044 6.87 P02190 
Myosin light chain 1, skeletal 
muscle isoform 
67 35 635 20994 4.97 P02602 
Pyruvate kinase muscle isozyme 52 25 997 58522 7.24 P11979 
Alpha-actinin-2 47 35 1998 104284 5.31 Q3ZC55 
Tropomyosin-1 alpha chain 44 54 1531 32718 4.69 P58771 
Tropomyosin beta chain 43 39 1041 32931 4.66 P58774 
Triosephosphate isomerase 41 53 1343 26901 6.45 Q5E956 
Troponin C, skeletal muscle 40 65 1116 18141 4.06 P02586 
Glycogen phosphorylase, muscle 
form 
40 26 725 97702 6.65 O18751 
Myosin regulatory light chain 2, 
skeletal muscle isoform 
39 60 1310 19057 4.82 P97457 
Troponin I, fast skeletal muscle 37 31 895 21496 8.87 P48788 
Glyceraldehyde-3-phosphate 
dehydrogenase 
34 31 1386 36073 8.50 P04406 
Serum albumin precursor 31 23 624 71139 5.80 P14639 
Four and a half LIM domains 
protein 1 
30 26 615 33821 8.76 Q9WUH4 
Alpha-actinin-3 26 23 975 103605 5.31 O88990 
ADP/ATP translocase 1 25 27 320 33174 9.84 P02722 
Phosphoglucomutase-1 25 16 654 61805 6.58 P00949 
Carbonic anhydrase 3 24 32 682 29637 7.17 Q3SZX4 
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Beta-enolase 23 19 667 47409 7.6 Q3ZC09 
ATP synthase sub. alpha, mit. 
prec. 
19 15 614 59828 9.16 P25705 
ATP synthase sub. beta, mit. 
prec. 
17 24 784 56249 5.15 P00829 
L-lactate dehydrogenase A chain 16 23 445 36947 8.16 P19858 
Heat shock cognate 71 kDa 16 22 577 71424 5.49 P19120 
Desmin 15 28 400 53556 5.21 O62654 
Heat shock 70 kDa protein 
1A/1B 
15 19 604 70495 5.54 Q27975 
Sarcoplasmic/endoplasmic 
reticulum calcium ATPase 1 
15 5 322 110532 2.17 Q0VCY0 
Creatine kinase, sarcomeric 
mitoch. prec. 
14 15 375 47899 8.64 Q6P8J7 
Glutathione S-transferase Mu 1 13 21 457 25789 6.90 Q9N0V4 
Aconitate hydratase, mitoch. 
prec 
13 12 186 86151 8.08 Q99KI0 
6-phosphofructokinase 13 10 353 86083 8.48 Q867C9 
Alpha crystallin B chain 12 28 202 20024 6.76 P02510 
Troponin T, fast skeletal muscle 11 14 100 31805 5.71 P45378 
Fructose-bisphosphate aldolase 
C 
11 9 933 39830 6.41 P09972 




9 21 123 38194 6.42 Q5EA88 
Phosphoglycerate mutase 2 9 12 194 28919 8.99 P15259 
Glucose-6-phosphate isomerase 9 8 239 63059 7.33 Q3ZBD7 
Troponin T, slow skeletal muscle 9 7 199 31265 5.71 Q8MKH6 
Troponin I, slow skeletal muscle 7 24 181 21856 9.61 Q9WUZ5 
Malate dehydrogenase, mitoch. 
prec. 
7 21 118 36102 8.82 Q32LG3 
Voltage-dependent anion-
selective channel protein 1 
7 17 292 30836 8.62 P45879 
Phosphatidylethanolamine-BP 1 6 21 174 21087 6.96 P13696 
PDZ and LIM domain protein 7 6 7 142 47486 8.69 Q3SX40 
Troponin C, slow skel. and card. 
muscles 
5 24 294 18519 4.05 P63315 
Glutathione S-transferase A1 5 21 70 25549 8.66 Q28035 
14-3-3 protein gamma 5 14 68 28456 4.80 P61981 
Phosphoglycerate kinase 1 5 8 146 44985 8.30 P00558 
Voltage-dependent anion-
selective channel protein 3 
5 7 197 31062 8.95 Q9MZ13 
Myotilin 5 4 125 55738 9.02 Q9JIF9 
Heat-shock protein beta-6 4 28 142 17515 5.95 Q148F8 
Histone H2A type 1-B 4 21 64 14127 11.05 P04908 
NADH dehydrogenase iron-
sulfur protein 3, mitoch. prec. 
4 12 201 30473 6.54 P17694 
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Elongation factor 1-alpha 2 4 7 93 50780 9.11 Q32PH8 
Very-long-chain specific acyl-
CoA dehydrogenase, mitoch. 
prec. 
4 5 78 70745 8.92 P48818 
AMP deaminase 1 4 4 134 87118 6.43 P23109 
AP-1 complex subunit mu-1 4 1 31 48727 6.82 Q2KJ81 
Calsequestrin-1 3 25 97 6610 4.61 P31236 
14-3-3 protein epsilon 3 7 70 29326 4.63 P62261 
Aldehyde dehydrogenase, 
mitochondrial precursor 
3 6 104 57129 7.55 P20000 
Malate dehydrogenase, 
cytoplasmic 
3 6 94 36700 6.16 Q3T145 
Aspartate aminotransferase, 
mitochondrial 
3 4 98 44938 9.04 P08907 
Myosin-binding protein C, slow-
type 
3 3 111 129240 5.78 Q00872 
Carbonic anhydrase 2 2 32 682 29637 7.71 P00921 
Protein DJ-1 2 12 94 20194 6.84 Q5E946 
Alpha-S1-casein precursor 2 10 55 24570 4.98 P02662 
Heat-shock protein beta-1 2 8 127 22436 5.98 Q3T149 
ATP synthase gamma chain, 
mitochondrial precursor 
2 7 76 33108 9.34 Q4LDE7 
Myozenin-1 2 6 75 31654 9.17 Q8SQ24 
Kappa-casein precursor 2 5 64 21370 6,30 P02668 
Dihydrolipoyl dehydrogenase, 
mitochondrial precursor 
2 4 90 54689 7.95 P49819 
PDZ and LIM domain protein 5 2 4 52 64544 8.61 Q8CI51 
Four and a half LIM domains 
protein 3 
2 3 62 33792 5.75 Q9R059 
Heat shock protein HSP 90-alpha 2 3 70 85077 4.93 Q76LV2 
LIM domain-binding protein 3 2 1 53 78226 8.47 O75112 
Cytochrome c1 heme protein, 
mitochondrial precursor 
1 4 45 35616 9.14 P00125 
Cytochrome c oxidase subunit 2 1 3 48 25836 4.74 P00405 
Transmembrane protein 38A 1 3 47 33694 8.56 Q9H6F2 
Succinate dehydrogenase iron-
sulfur protein,  mitoch. prec. 
1 3 32 32296 8.91 Q3T189 
Myosin-binding protein H 1 2 85 52531 6.30 Q13203 
Myc box-dependent-interact. 
prot. 1 
1 1 39 64887 4.97 O00499 
SET and MYND domain-
containing protein 1 
1 1 46 57549 6.66 Q8NB12 
Total: 85 proteins identified in fresh-frozen skeletal muscle tissue extracts 
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Appendix 2 
List of FFPE skeletal muscle proteins identified by 1D-GeLC-MS/MS, ordered according 
to the number of queries matched. For “number of queries matched” is intended the 
total number of peptide hits assigned to a protein, as a sum of data obtained from all 
21 cut gel bands. Sequence coverage instead refers to the best percentage reached for 
















Actin, alpha skeletal muscle  456 49 3075 42381 5.23 P68138 
Creatine kinase M-type  153 26 856 43190 6.63 Q9XSC6 
Myosin light chain 1, skeletal 
muscle isoform 
124 39 1547 20993 4.97 P02602 
Myoglobin 121 46 1642 17044 6.87 P02190 
Fructose-bisphosphate aldolase 
A 
92 39 1343 39774 8.31 P00883 
Triosephosphate isomerase 69 47 1676 26901 6.45 Q5E956 
Heat-shock protein beta-1 60 63 1181 22436 5.98 Q3T149 
Beta-enolase 54 35 1676 47409 7.6 Q3ZC09 
Carbonic anhydrase 3  50 16 155 29637 7.71 Q3SZX4 
Tropomyosin-1 alpha chain 48 21 441 32746 4.69 P09493 
Tropomyosin beta chain 41 30 389 32945 4.66 P07951 
Myosin regulatory light chain 2, 
skeletal muscle isoform  
40 56 1235 19057 4.82 P97457 
Serum albumin precursor 38 18 319 71139 5.80 P14639 
Glyceraldehyde-3-phosphate 
dehydrogenase 
29 11 379 36073 8.50 P04406 
Pyruvate kinase muscle isozyme 22 21 378 58522 7.24 P11979 
Myosin heavy chain (several 
isoforms) 
22 5 485 223946 5.59 Q9BE40 
Adenylate kinase isoenzyme 1 19 29 210 21764 8.40 P00570 
Alpha-actinin-2 19 16 953 104284 5.31 Q3ZC55 
ATP synthase sub. alpha, mit. 
prec. 
16 20 708 59797 9.21 P25705 
Fructose-bisphosphate aldolase 
C 
14 39 1343 39774 8.31 P09972 
Phosphoglycerate mutase 2 13 16 205 28919 8.99 P15259 
Hemoglobin subunit alpha-1/2 12 25 153 15212 8,72 P68240 
Alpha crystallin B chain 11 32 156 20024 6.76 P02510 
Glycogen phosphorylase, muscle 
form 
11 14 297 97702 6.65 O18751 
Alpha-actinin-3 11 11 449 103605 5.31 O88990 
Phosphatidylethanolamine-
binding protein 1 
10 25 147 21087 6.96 P13696 
 116 
Alessandro Tanca, Novel methods for proteomics analysis of formalin-fixed, paraffin-embedded tissues (FFPE), and their 
applications for biomarker discovery, Tesi di dottorato in Scienze biomolecolari e biotecnologiche, Università degli studi di Sassari 
ATP synthase sub. beta, mit. 
prec. 
10 14 571 56249 5.15 P00829 
Hemoglobin subunit beta-C 9 16 130 15680 11,57 P68056 
Glutathione S-transferase Mu 1 9 16 261 25789 6.90 Q9N0V4 
Creatine kinase, sarcomeric 
mitochondrial precursor  
9 5 160 47714 8.45 Q3ZBP1 
Troponin I, slow skeletal muscle  8 20 206 21850 9.61 Q9WUZ5 
Heat shock 70 kDa protein 1A/1B 8 12 311 70500 5.68 Q27975 
Troponin I, fast skeletal muscle 7 26 129 21496 8.87 P48788 
Phosphoglucomutase-1 6 9 127 71764 6.30 P00949 
Troponin C, skeletal muscle 5 35 206 18167 4.06 P02586 
Calsequestrin-1 5 25 176 6610 4.71 P31236 
Glutathione S-transferase A1 5 12 61 25549 8.66 Q28035 
Malate dehydrogenase, mitoch. 
prec. 
5 7 41 36102 8.82 Q32LG3 
Heat shock cognate 71 kDa 
protein 
5 5 245 71423 5.49 P19120 
L-lactate dehydrogenase A chain 5 3 151 36947 8.16 P19858 
14-3-3 protein gamma  4 14 67 28456 4.80 P61981 
Malate dehydrogenase, 
cytoplasmic  
4 7 116 36700 6.16 Q3T145 
PDZ and LIM domain protein 7 4 5 67 47486 8.69 Q3SX40 
Peroxiredoxin-6  3 13 115 25108 6.00 O77834 
Troponin T, fast skeletal muscle 3 10 81 31805 5.71 P45378 
Phosphoglycerate kinase 1  3 6 63 44908 8.48 P00558 
Decorin precursor  3 5 48 40196 8.72 P21793 
Troponin T, slow skeletal muscle 3 4 78 31265 5.71 Q8MKH6 
Heat-shock protein beta-6 2 14 65 17515 5.95 Q148F8 
Telethonin 2 13 93 19204 5.50 Q6T8D8 
Histone H2B type 1-A 2 12 32 14159 10.31 Q96A08 
Thioredoxin-dependent peroxide 
reductase, mitoch. prec. 
2 10 74 28406 7.15 P35705 
NADH dehydrogenase 
flavoprotein 2, mitoch. prec. 
2 9 91 27575 8.21 P25708 
NADH dehydrogenase iron-sulfur 
protein 3, mitoch. prec. 
2 9 115 30437 6.54 P17694 
Histone H2A type 1-A  2 6 42 14225 10.86 P04908 




2 2 45 38194 6.42 Q5EA88 
Sarcalumenin precursor  2 1 89 101069 4.34 Q86TD4 
Superoxide dismutase [Mn], 
mitochondrial  
1 4 52 22348 6.86 Q8HXP0 
Carbonic anhydrase 2 1 3 35 29193 6.41 P00921 
Cytochrome c oxidase subunit 2 1 3 53 25836 4.74 P00405 
Voltage-dependent anion-
selective channel protein 1 
1 3 70 30836 8.62 P45879 
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Collagen alpha-2(I) chain 
precursor  
1 2 40 53495 7.23 Q28668 
Prolargin precursor  1 2 43 44054 9.59 Q9GKN8 
Glucose-6-phosphate isomerase 1 1 36 63335 8.43 Q3ZBD7 
Myc box-dependent-interacting 
prot. 1 
1 1 51 64887 4.97 O00499 
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Appendix 3  
List of proteins comparatively identified in fresh-frozen and FFPE tissues by 2D-PAGE-MS. Queries matched value represents number of 

























Est. pI  on 
gel 
     
FRESH FFPE 
1 Myosin heavy chain, skeletal 
muscle, adult 1 
Q9BE40 223764 5.57 50 25 88612 5.44 11 27 83781 5.42 
2 Serum albumin precursor P14639 71139 5.80 19 38 71139 5.80 16 33 71139 5.80 
3 Phosphoglucomutase-1 P00949 61805 6.58 31 23 64523 6.75 11 10 63677 6.54 
4 Myosin heavy chain, skeletal 
muscle, adult 1 
Q9BE40 223764 5.57 18 10 62967 5.72 3 20 59770 5.79 
5 Pyruvate kinase isozyme M1 P11979 58522 7.24 13 30 58522 7.24 31 22 58522 7.24 
6 Desmin O62654 53556 5.21 27 65 56967 5.30 4 9 56411 5.41 
7 ATP synthase subunit beta, 
mitochondrial precursor 
P00829 56249 5.15 21 53 53835 5.02 3 6 53453 5.04 
8 Beta-enolase Q3ZC09 47409 7.60 13 41 49258 7.42 11 37 48823 7.25 
9 Beta-enolase Q3ZC09 47409 7.60 13 41 49125 7.15 11 37 48584 7.08 
10 Beta-enolase Q3ZC09 47409 7.60 13 41 48730 7.00 11 37 48465 6.90 
11 Beta-enolase Q3ZC09 47409 7.60 15 39 48730 6.83 11 37 48111 6.71 
12 Beta-enolase Q3ZC09 47409 7.60 11 33 48862 6.64 11 37 47525 6.51 
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13 Actin, alpha skeletal muscle P68138 42366 5.23 18 49 47054 5.56 6 16 45365 5.86 
14 Actin, alpha skeletal muscle P68138 42366 5.23 18 49 46801 5.70 6 16 45143 6.02 
15 Actin, alpha skeletal muscle P68138 42366 5.23 18 49 44828 5.20 15 48 45143 5.29 
16 Creatine kinase M-type Q9XSC6 43190 6.63 12 35 42136 6.94 10 30 44376 7.03 
17 Fructose-bisphosphate aldolase 
A 
P00883 39774 8.31 11 30 40034 8.65 6 24 40931 8.59 
18 Troponin T, slow skeletal muscle Q8MKH6 31265 5.71 2 9 39926 5.70 2 9 38784 5.71 
19 Tropomyosin-1 alpha chain P58771 32931 4.66 43 65 38243 4.89 43 58 38879 4.83 
 Tropomyosin beta chain P58774 32718 4.69 36 57 38243 4.89 14 47 38879 4.83 
 Tropomyosin alpha-3 chain P06753 32856 4.68 9 51 38243 4.89 10 51 38879 4.83 
20 Glyceraldehyde-3-phosphate 
dehydrogenase 
P10096 36073 8.50 14 49 35370 7.29 13 45 36930 7.34 




Q5EA88 38194 6.42 12 34 34338 6.76 4 8 35511 6.85 
22 Carbonic anhydrase 3 Q3SZX4 29637 7.71 5 16 29611 7.32 9 35 28868 7.39 
23 14-3-3 protein gamma P61981 28456 4.80 11 21 29215 4.78 6 26 31573 5.02 
 14-3-3 protein epsilon P62261 29326 4.63 5 9 29215 4.78 4 15 31573 5.02 
24 Phosphoglycerate mutase 2 O70250 28980 8.65 6 15 28908 8.65 4 14 28908 8.65 
25 Triosephosphate isomerise Q5E956 26901 6.45 6 31 26925 7.00 13 68 26094 6.99 
26 Triosephosphate isomerise Q5E956 26901 6.45 11 58 26698 6.54 7 36 26102 6.52 
27 Triosephosphate isomerise Q5E956 26901 6.45 6 31 26623 6.70 13 68 25593 6.61 
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28 Triosephosphate isomerise Q5E956 26901 6.45 6 31 26623 6.86 13 68 25792 6.83 
29 Heat-shock protein beta-1 Q3T149 22436 5.98 2 9 24526 5.41 8 47 23224 5.45 
30 Heat-shock protein beta-1 Q3T149 22436 5.98 6 47 24182 5.56 8 47 23405 5.65 
31 Heat-shock protein beta-1 Q3T149 22436 5.98 10 58 23507 5.86 8 47 22866 5.88 
32 Heat-shock protein beta-1 Q3T149 22436 5.98 2 13 22917 6.15 7 37 22513 6.19 
33 Myosin light chain 1, skeletal 
muscle isoform 
P02602 20993 4.97 28 58 20993 4.97 30 60 20993 4.97 
34 Adenylate kinase isoenzyme 1 P00570 21764 8.40 12 53 20433 8.56 2 11 20203 8.60 
35 Myosin light chain 1, skeletal 
muscle isoform 
P02602 20993 4.97 10 28 20382 4.91 13 36 19785 4.88 
36 Troponin C, skeletal muscle P02586 18141 4.06 9 60 19951 4.45 9 60 19635 4.31 
37 Alpha crystallin B chain P23927 20056 6.76 15 62 19926 7.05 10 60 19681 7.43 
38 Heat-shock protein beta-6 Q148F8 17515 5.95 6 44 19764 6.21 4 23 19510 6.54 
39 Myosin regulatory light chain 2, 
skeletal muscle isoform 
P02608 19128 4.82 16 78 19128 4.82 16 78 19128 4.82 
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Appendix 4  
Analysis of spot intensity reproducibility among DIGE maps. A well-preserved spot was chosen as standard, and volumes of ten selected 
spots per tissue were normalised, according to standard volume. Means, standard deviations (SD), and coefficients of variation (CV) are 
reported for each spot, and for the whole spot panel as average. 
 
A - Skeletal muscle 
 
  Frfr1 Frfr2 Frfr3 Frfr Frfr1 Frfr2 Frfr3 Frfr Frfr Frfr FFPE1 FFPE2 FFPE3 FFPE FFPE1 FFPE2 FFPE3 FFPE FFPE FFPE 
 
Master no. Volume Volume Volume mean Norm. vol Norm. vol Norm. vol Norm. mean SD CV Volume Volume Volume mean Norm. vol Norm. vol Norm. vol Norm. mean SD CV 
 
  
         
  
         
  
std 2447 438173 134938 2449354 1007488 1,0000 1,0000 1,0000 1,0000 0,0000 0,00 59220 55050 343578 152616 1,0000 1,0000 1,0000 1,0000 0,0000 0,00 
 
  
         
  
         
  
1 994 1085070 321916 6203006 2536664 2,4764 2,3857 2,5325 2,4648 0,0741 0,03 144951 125804 987848 419534 2,4477 2,2853 2,8752 2,5360 0,3047 0,12 
2 1323 2266008 800983 7110388 3392460 5,1715 5,9359 2,9030 4,6701 1,5774 0,34 215868 192874 536535 315092 3,6452 3,5036 1,5616 2,9035 1,1642 0,40 
3 1552 946710 314690 6066125 2442508 2,1606 2,3321 2,4766 2,3231 0,1582 0,07 38438 22281 345383 135367 0,6491 0,4047 1,0053 0,6864 0,3020 0,44 
4 2007 986925 303342 5689669 2326645 2,2524 2,2480 2,3229 2,2744 0,0421 0,02 266815 138370 1125603 510263 4,5055 2,5135 3,2761 3,4317 1,0051 0,29 
5 2108 370933 421836 6993028 2595266 0,8465 3,1261 2,8550 2,2759 1,2453 0,55 109641 75872 630445 271986 1,8514 1,3782 1,8349 1,6882 0,2686 0,16 
6 2197 1393018 665216 7397226 3151820 3,1792 4,9298 3,0201 3,7097 1,0596 0,29 183619 401247 1750714 778527 3,1006 7,2888 5,0955 5,1616 2,0949 0,41 
7 2204 826117 273674 4496053 1865281 1,8854 2,0281 1,8356 1,9164 0,0999 0,05 230114 201859 974661 468878 3,8857 3,6668 2,8368 3,4631 0,5534 0,16 
8 4291 14756668 5882788 21622416 1007488 33,6777 43,5962 8,8278 28,7006 17,9106 0,62 3417189 4164877 5305322 152616 57,7033 75,6563 15,4414 49,6003 30,9144 0,62 
9 3723 1093903 298664 3304156 1565574 2,4965 2,2133 1,3490 2,0196 0,5978 0,30 298350 235217 1202202 578590 5,0380 4,2728 3,4991 4,2699 0,7695 0,18 
10 3745 461548 130329 3120149 1237342 1,0533 0,9658 1,2739 1,0977 0,1587 0,14 209291 171141 2038987 806473 3,5341 3,1088 5,9346 4,1925 1,5236 0,36 
 
                                          
 
mean 
   
2212105 
   
5,1452 2,2924 0,24 
   
443733 
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B - Liver 
 
  Frfr1 Frfr2 Frfr3 Frfr Frfr1 Frfr2 Frfr3 Frfr Frfr Frfr FFPE1 FFPE2 FFPE3 FFPE FFPE1 FFPE2 FFPE3 FFPE FFPE FFPE 
 
Master no. Volume Volume Volume mean Norm. vol Norm. vol Norm. vol Norm. mean SD CV Volume Volume Volume mean Norm. vol Norm. vol Norm. vol Norm. mean SD CV 
 
  
         
  
         
  
std 3482 454360 483503 1629488 855784 1,0000 1,0000 1,0000 1,0000 0,0000 0,00 155925 356753 493121 335266 1,0000 1,0000 1,0000 1,0000 0,0000 0,00 
 
  
         
  
         
  
1 2130 860784 719337 2051218 1210446 1,8945 1,4878 1,2588 1,5470 0,3220 0,21 280041 908580 823355 670659 1,7960 2,5468 1,6697 2,0042 0,4742 0,24 
2 2258 1336657 1141394 3029084 1835712 2,9418 2,3607 1,8589 2,3871 0,5419 0,23 286039 1730284 824352 946892 1,8345 4,8501 1,6717 2,7854 1,7899 0,64 
3 2398 625572 620515 1077762 774616 1,3768 1,2834 0,6614 1,1072 0,3889 0,35 38674 196676 80244 105198 0,2480 0,5513 0,1627 0,3207 0,2042 0,64 
4 3014 1645170 1198431 4137239 2326947 3,6209 2,4786 2,5390 2,8795 0,6427 0,22 111562 448166 459739 339822 0,7155 1,2562 0,9323 0,9680 0,2721 0,28 
5 3269 971706 740817 2778897 1497140 2,1386 1,5322 1,7054 1,7921 0,3124 0,17 124982 252231 652779 343331 0,8016 0,7070 1,3238 0,9441 0,3322 0,35 
6 3435 913120 953507 2168567 1345065 2,0097 1,9721 1,3308 1,7709 0,3815 0,22 219560 1225616 1057543 834240 1,4081 3,4355 2,1446 2,3294 1,0262 0,44 
7 5428 10370122 5401476 22270230 855784 22,8236 11,1715 13,6670 15,8874 6,1351 0,39 1290008 2358838 3700118 335266 8,2733 6,6120 7,5035 7,4629 0,8314 0,11 
8 3498 2062528 1158786 4106799 2442704 4,5394 2,3966 2,5203 3,1521 1,2030 0,38 175199 311320 319744 268754 1,1236 0,8726 0,6484 0,8816 0,2377 0,27 
9 4285 1642346 813342 3372819 1942836 3,6146 1,6822 2,0699 2,4556 1,0223 0,42 572762 861700 1825338 1086600 3,6733 2,4154 3,7016 3,2634 0,7346 0,23 
10 4723 1151510 656323 2908894 1572242 2,5344 1,3574 1,7852 1,8923 0,5957 0,31 383355 863685 1703133 983391 2,4586 2,4210 3,4538 2,7778 0,5857 0,21 
 
                                          
 
mean 
   
1580349 
   
3,4871 1,1546 0,29 
   
591415 
   
2,3737 0,6488 0,34 
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Appendix 5 
List of proteins differentially represented in fresh-frozen skeletal muscle and liver 2D-
DIGE maps. Percentage of lysine, and arginine residues, and lysine-to-arginine ratio 
(K/R) for all proteins in list are indicated. 
 
Skeletal muscle 
Spot n. ID % Lys % Arg K/R 
1 Myosin-1 10,8% 5,3% 2,0 
2 Serum albumin 10,3% 3,8% 2,7 
3 ATP-synthase subunit beta, mitochondrial 4,6% 4,6% 1,0 
4 Tropomyosin alpha-1 chain 13,7% 4,9% 2,8 
5 Pyruvate kinase isozymes M1/M2 7,0% 5,8% 1,2 
6 Phosphoglycerate kinase 1 10,3% 2,6% 4,0 
7 Glyceraldehyde-3-phosphate dehydrogenase  7,8% 3,0% 2,6 
8 Fructose-bisphosphate aldolase A 7,2% 4,1% 1,8 
9 Beta-enolase 8,5% 4,2% 2,0 
10 Troponin T, fast skeletal muscle  14,1% 9,6% 1,5 
 
      mean 9,4% 4,8% 2,2
 
Liver 
Spot n. ID % Lys % Arg K/R 
1 78 kDa glucose regulated protein 9,4% 4,2% 2,2 
2 ATP-synthase subunit beta, mitochondrial 4,6% 4,6% 1,0 
3 Protein disulfide-isomerase (A1)  10,4% 2,0% 5,2 
4 Calreticulin 10,2% 2,0% 5,1 
5 60 kDa heat shock protein, mitochondrial 9,7% 3,1% 3,1 
6 Alpha-enolase 8,5% 4,2% 2,0 
7 Endoplasmin 10,0% 4,6% 2,2 
8 Serum albumin 10,3% 3,8% 2,7 
9 Heat shock cognate 71 kDa protein 8,3% 4,3% 1,9 
10 Aldose 1-epimerase  5,6% 3,8% 1,5 
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Appendix 6 
List of proteins differentially represented in FFPE skeletal muscle and liver 2D-DIGE 
maps. Percentage of lysine, and arginine residues, and lysine-to-arginine ratio (K/R) for 
all proteins in list are indicated. 
 
Skeletal muscle 
Spot n. ID % Lys % Arg K/R 
1 Actin, cytoplasmic 1 5,1% 4,8% 1,1 
2 Heat shock protein beta-1 3,5% 7,5% 0,5 
3 Myosin light chain 1, skeletal muscle isoform  9,9% 2,1% 4,7 
4 Triosephosphate isomerase 8,5% 3,2% 2,7 
5 Myosin regulatory light chain 2, skeletal muscle isoform type 2 9,5% 3,6% 2,6 
6 Cytochrome c oxidase subunit 5° 6,4% 6,4% 1,0 
7 Troponin C, skeletal muscle 5,7% 4,4% 1,3 
8 Myosin light chain 1, skeletal muscle isoform (truncated form 55-192) 7,2% 2,9% 2,5 
9 Actin, cytoplasmic 1 (truncated form 2-245) 4,5% 4,9% 0,9 
10 Troponin C, skeletal muscle (truncated form 2-143) 5,6% 4,2% 1,3 
     




Spot n. ID % Lys % Arg K/R 
1 3-hydroxyacyl-CoA dehydrogenase type-2 4,2% 5,0% 0,8 
2 Actin, cytoplasmic 1 5,1% 4,8% 1,1 
3 Ferritin light chain 5,7% 7,5% 0,8 
4 Superoxide dismutase [Cu-Zn] 7,3% 3,3% 2,2 
5 Catalase 5,3% 6,1% 0,9 
6 Sorbitol dehydrogenase 6,5% 3,7% 1,8 
7 Short-chain specific acyl-CoA dehydrogenase, mitochondrial  6,2% 4,6% 1,3 
8 Proteasome subunit beta type-6 2,0% 5,4% 0,4 
9 Enoyl-CoA hydratase, mitochondrial 8,0% 3,0% 2,7 
10 Heat shock protein beta-1 3,5% 7,5% 0,5 
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Appendix 7 
List of proteins identified by GeLC-MS/MS in sheep FFPE pathological liver extracts 
(samples A and B).  
 
Band AN Protein MW pI Score QM UP SC 
A1 Q0VCX2 78 kDa glucose-regulated protein 72470 5,07 376 11 10 19% 
A1 P14639 Serum albumin  71139 5,80 226 9 8 13% 
A1 Q13087 Protein disulfide-isomerase A2 58512 4,89 133 9 6 8% 
A1 P19483 ATP synthase subunit alpha, mitochondrial 59797 9,21 98 1 1 2% 
A1 P19120 Heat shock cognate 71 kDa protein 71424 5,37 94 2 2 3% 
A1 P62803 Histone H4 11360 11,36 92 2 2 17% 
A1 P30122 Bile salt-activated lipase (Fragment) 65463 5,32 63 1 1 2% 
A1 P05307 Protein disulfide-isomerase 57629 4,80 60 4 4 7% 
A1 Q5I597 Betaine--homocysteine S-
methyltransferase 1 
45306 6,40 57 1 1 2% 
A1 Q95M18 Endoplasmin 92654 4,76 41 1 1 1% 
A1 P61284 60S ribosomal protein L12 17979 9,48 40 1 1 5% 
A1 Q8NHW5 60S acidic ribosomal protein P0-like 34514 5,41 38 1 1 3% 
A1 Q8NF86 Serine protease 33 30395 10,03 35 1 1 2% 
A1 P68103 Elongation factor 1-alpha 1 50451 9,10 34 1 1 1% 
A2 P05307 Protein disulfide-isomerase 57629 4,80 487 19 14 27% 
A2 Q95140 60S acidic ribosomal protein P0 34520 5,71 225 7 6 30% 
A2 Q5EAD2 D-3-phosphoglycerate dehydrogenase 57327 6,47 215 8 5 10% 
A2 P19483 ATP synthase subunit alpha, mitochondrial 59797 9,21 212 5 4 8% 
A2 P38657 Protein disulfide-isomerase A3 57293 6,23 177 6 5 11% 
A2 P17248 Tryptophanyl-tRNA synthetase, 
cytoplasmic 
54177 5,49 172 5 5 10% 
A2 P00829 ATP synthase subunit beta, mitochondrial 56249 5,15 93 2 2 5% 
A2 Q2KJ32 Selenium-binding protein 1 53092 6,03 89 1 1 2% 
A2 P52193 Calreticulin 48180 4,31 88 5 5 10% 
A2 P62803 Histone H4 11360 11,36 85 3 3 27% 
A2 Q5I597 Betaine--homocysteine S-
methyltransferase 1 
45306 6,40 81 4 4 8% 
A2 Q2NL29 Inositol-3-phosphate synthase 1 61293 5,68 81 2 2 4% 
A2 Q3SYU2 Elongation factor 2 96276 6,41 74 2 2 2% 
A2 Q07536 Methylmalonate-semialdehyde 
dehydrogenase [acylating], mitochondrial 
58482 8,29 72 2 2 3% 
A2 Q5E995 40S ribosomal protein S6 28820 10,85 70 3 3 13% 
A2 A5PK51 Nicotinate phosphoribosyltransferase 58291 6,69 69 2 2 4% 
A2 P68103 Elongation factor 1-alpha 1 50451 9,10 68 3 3 5% 
A2 Q13087 Protein disulfide-isomerase A2 58512 4,89 64 2 2 4% 
A2 P63243 Guanine nucleotide-binding protein 
subunit beta-2-like 1 
35511 7,60 56 2 2 6% 
A2 P26452 40S ribosomal protein SA 32977 4,80 55 1 1 4% 
A2 Q32L47 Endoplasmic reticulum resident protein 
ERp27 
23072 4,81 50 1 1 5% 
A2 P00766 Chymotrypsinogen A 26220 8,52 49 1 1 3% 
A2 P02075 Hemoglobin subunit beta  16120 6,75 49 1 1 6% 
A2 P31081 60 kDa heat shock protein, mitochondrial 61240 5,60 48 1 1 1% 
A2 P04908 Histone H2A type 1-B/E 14127 11,05 43 2 2 21% 
A2 Q96A08 Histone H2B type 1-A 14159 10,31 41 3 2 12% 
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A2 Q64316 Actin, cytoplasmic 1 42052 5,29 38 1 1 4% 
A2 Q96L12 Calreticulin-3 45195 6,19 35 2 2 3% 
A2 Q3T169 40S ribosomal protein S3 26842 9,68 34 1 1 3% 
A2 P68250 14-3-3 protein beta/alpha 28178 4,80 31 1 1 3% 
A2 P30122 Bile salt-activated lipase (Fragment) 65463 5,32 31 1 1 1% 
A3 Q3T169 40S ribosomal protein S3 26842 9,68 272 8 7 30% 
A3 P26452 40S ribosomal protein SA 32977 4,80 148 3 3 12% 
A3 Q32L47 Endoplasmic reticulum resident protein 
ERp27 
23072 4,81 139 3 2 7% 
A3 Q64475 Histone H2B type 1-B 13944 10,31 132 8 5 40% 
A3 P63243 Guanine nucleotide-binding protein 
subunit beta-2-like 1 
35511 7,60 126 4 4 11% 
A3 P62261 14-3-3 protein epsilon 29326 4,63 112 3 3 12% 
A3 Q8NHW5 60S acidic ribosomal protein P0-like 34514 5,41 111 4 4 17% 
A3 Q5E983 Elongation factor 1-beta 24960 4,51 103 1 1 6% 
A3 Q5E973 60S ribosomal protein L1 21636 11,69 100 1 1 6% 
A3 O18789 40S ribosomal protein S2 31501 10,25 94 2 2 7% 
A3 Q2KJE4 Electron transfer flavoprotein subunit 
alpha, mitochondrial 
35282 8,77 93 2 2 8% 
A3 Q5E995 40S ribosomal protein S6 28820 10,85 93 2 2 8% 
A3 Q76N24 40S ribosomal protein S4, X isoform 29807 10,16 92 4 4 9% 
A3 P62803 Histone H4 11360 11,36 88 4 4 38% 
A3 P62265 40S ribosomal protein S14 16434 10,07 80 1 1 7% 
A3 P04908 Histone H2A type 1-B/E 14127 11,05 78 4 2 21% 
A3 Q3T165 Prohibitin 29843 5,57 66 1 1 4% 
A3 P68103 Elongation factor 1-alpha 1 50451 9,10 65 2 2 4% 
A3 Q9N1F5 Glutathione S-transferase omega-1 27743 6,84 63 1 1 5% 
A3 Q64316 Actin, cytoplasmic 1 42052 5,29 61 2 2 7% 
A3 Q3T0S6 60S ribosomal protein L8 28235 11,03 59 2 2 6% 
A3 Q56JX6 40S ribosomal protein S28 7893 10,70 59 1 1 17% 
A3 P02253 Histone H1.1 (Fragment) 10359 10,49 57 1 1 11% 
A3 P02075 Hemoglobin subunit beta  16120 6,75 54 1 1 6% 
A3 Q56K03 60S ribosomal protein L27a 16681 11,12 52 1 1 7% 
A3 P00766 Chymotrypsinogen A 26220 8,52 50 1 1 3% 
A3 P81623 Endoplasmic reticulum protein ERp29 28845 5,63 50 1 1 4% 
A3 Q56JX5 40S ribosomal protein S25 13791 10,12 50 1 1 8% 
A3 P68002 Voltage-dependent anion-selective channel 
protein 2 
32113 7,48 47 1 1 4% 
A3 Q28153 Chymotrypsin-like elastase family member 
1 
28956 8,89 44 2 2 7% 
A3 Q28960 Carbonyl reductase [NADPH] 1 32015 7,60 44 1 1 3% 
A3 Q3T0X6 40S ribosomal protein S16 16549 10,21 44 1 1 6% 
A3 Q6NXT2 Histone H3-like 15318 11,10 41 1 1 5% 
A3 Q9MZS8 Cathepsin D (Fragment) 40245 6,54 40 1 1 2% 
A3 Q9JKY1 Peroxiredoxin-1 22533 8,22 39 2 2 9% 
A3 Q32PD5 40S ribosomal protein S19 16051 10,31 38 1 1 6% 
A3 P05631 ATP synthase subunit gamma, 
mitochondrial 
33108 9,34 37 1 1 3% 
A3 P68250 14-3-3 protein beta/alpha 28178 4,80 36 2 2 6% 
A3 Q0VC36 14-3-3 protein sigma 27946 4,65 36 2 2 6% 
A3 Q2TBQ5 60S ribosomal protein L7a 30178 10,61 32 3 2 7% 
A3 Q3T0W9 60S ribosomal protein L19 23565 11,48 31 1 1 4% 
A4 O02691 3-hydroxyacyl-CoA dehydrogenase type-2 27294 8,45 410 8 7 39% 
A4 Q9BGI2 Peroxiredoxin-4 30950 6,01 396 10 7 33% 
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A4 Q28153 Chymotrypsin-like elastase family member 
1 
28956 8,89 177 6 5 28% 
A4 Q56JZ1 60S ribosomal protein L13 24391 11,59 169 5 5 25% 
A4 Q9N0V4 Glutathione S-transferase Mu 1 25789 6,90 168 6 6 28% 
A4 P02075 Hemoglobin subunit beta  16120 6,75 157 5 4 30% 
A4 P00766 Chymotrypsinogen A 26220 8,52 155 4 3 15% 
A4 Q5E956 Triosephosphate isomerase 26901 6,45 143 4 4 21% 
A4 Q5E958 40S ribosomal protein S8 24475 10,32 140 4 4 22% 
A4 P62803 Histone H4 11360 11,36 128 5 4 38% 
A4 Q3T114 Ribonuclease UK114 14321 6,18 128 3 3 32% 
A4 Q5E947 Peroxiredoxin-1 22423 8,59 124 4 3 15% 
A4 P33778 Histone H2B type 1-B 13942 10,31 109 3 3 24% 
A4 P05805 Proproteinase E 27890 5,11 108 5 4 16% 
A4 P68240 Hemoglobin subunit alpha-1/2  15212 8,72 103 2 2 16% 
A4 Q8NHW5 60S acidic ribosomal protein P0-like 34514 5,41 91 3 3 11% 
A4 Q32L47 Endoplasmic reticulum resident protein 
ERp27 
23072 4,81 89 1 1 5% 
A4 O46415 Ferritin light chain  20032 5,89 84 1 1 8% 
A4 Q3T149 Heat shock protein beta-1  22436 5,98 82 3 3 21% 
A4 Q3T0U2 60S ribosomal protein L14  23535 10,79 80 1 1 5% 
A4 Q3SZ18 Hypoxanthine-guanine 
phosphoribosyltransferase  
24711 7,66 79 2 2 11% 
A4 P26452 40S ribosomal protein SA 32977 4,80 73 3 3 14% 
A4 O15173 Membrane-associated progesterone 
receptor component 2 
23861 4,76 73 1 1 6% 
A4 Q99895 Chymotrypsin-C 30092 7,53 66 1 1 4% 
A4 O77834 Peroxiredoxin-6 25108 6,00 65 2 2 10% 
A4 Q91WS4 Betaine--homocysteine S-
methyltransferase 2 
40416 6,10 59 2 2 4% 
A4 P19803 Rho GDP-dissociation inhibitor 1 23464 5,12 58 1 1 7% 
A4 Q3T0W9 60S ribosomal protein L19 23565 11,48 55 1 1 4% 
A4 Q56K03 60S ribosomal protein L27a 16681 11,12 54 1 1 7% 
A4 Q3T0S6 60S ribosomal protein L8 28235 11,03 54 1 1 4% 
A4 P00767 Chymotrypsinogen B 26309 4,99 53 1 1 6% 
A4 Q64316 Actin, cytoplasmic 1 42052 5,29 51 1 1 2% 
A4 P62265 40S ribosomal protein S14 16434 10,07 51 1 1 7% 
A4 P15246 Protein-L-isoaspartate(D-aspartate) O-
methyltransferase  
24664 7,05 50 1 1 4% 
A4 Q5E988 40S ribosomal protein S5 23033 9,73 48 1 1 7% 
A4 Q5E9E6 60S ribosomal protein L10a  24987 9,94 46 1 1 3% 
A4 P04908 Histone H2A type 1-B/E 14127 11,05 38 3 3 26% 
A4 Q2TBV3 Electron transfer flavoprotein subunit beta  27910 8,24 36 2 2 8% 
A4 Q2YDE4 Proteasome subunit alpha type-6 27838 6,34 33 1 1 5% 
A4 Q3T0X6 40S ribosomal protein S16 16549 10,21 33 1 1 6% 
A4 Q2TBQ3 Guanidinoacetate N-methyltransferase  26821 5,70 29 2 2 8% 
B1 P00432 Catalase 60106 6,78 391 14 10 19% 
B1 P02769 Serum albumin  71244 5,82 322 18 17 31% 
B1 P00367 Glutamate dehydrogenase 1, mitochondrial  61701 7,66 203 11 9 17% 
B1 P68240 Hemoglobin subunit alpha-1/2  15212 8,72 156 5 3 23% 
B1 P00829 ATP synthase subunit beta, mitochondrial  56249 5,15 129 3 3 8% 
B1 Q9N0V4 Glutathione S-transferase Mu 1 25789 6,90 117 3 3 13% 
B1 P19483 ATP synthase subunit alpha, mitochondrial  59797 9,21 110 3 3 7% 
B1 O02691 3-hydroxyacyl-CoA dehydrogenase type-2 27294 8,45 105 6 6 37% 
B1 Q64316 Actin, cytoplasmic 1 42052 5,29 100 4 4 13% 
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B1 P02075 Hemoglobin subunit beta  16120 6,75 93 4 3 21% 
B1 Q27975 Heat shock 70 kDa protein 1A  70500 5,68 87 2 2 3% 
B1 P62803 Histone H4  11360 11,36 77 3 3 27% 
B1 P31327 Carbamoyl-phosphate synthase 
[ammonia], mitochondrial  
165975 6,30 69 2 2 1% 
B1 Q2KJH9 4-trimethylaminobutyraldehyde 
dehydrogenase  
54854 5,84 57 1 1 2% 
B1 P13745 Glutathione S-transferase A1  25706 9,04 54 2 2 6% 
B1 P30115 Glutathione S-transferase A3  25401 8,76 54 2 2 7% 
B1 P79381 Epoxide hydrolase 1 52646 7,25 51 1 1 1% 
B1 Q9UC56 Stress-70 protein, mitochondrial  73920 5,87 50 2 2 3% 
B1 P52210 Fructose-bisphosphate aldolase B 39948 8,58 45 1 1 3% 
B1 P15392 Cytochrome P450 2A4  56672 9,15 37 2 2 3% 
B1 Q9TTJ5 Regucalcin 33857 5,54 33 2 2 8% 
B2 P00432 Catalase 60106 6,78 872 26 15 35% 
B2 O02691 3-hydroxyacyl-CoA dehydrogenase type-2 27294 8,45 322 4 3 18% 
B2 P00367 Glutamate dehydrogenase 1, mitochondrial  61701 7,66 277 11 11 23% 
B2 Q07536 Methylmalonate-semialdehyde 
dehydrogenase [acylating], mitochondrial 
58482 8,29 269 8 6 11% 
B2 P19483 ATP synthase subunit alpha, mitochondrial  59797 9,21 268 5 5 11% 
B2 P31327 Carbamoyl-phosphate synthase 
[ammonia], mitochondrial  
165975 6,30 188 5 4 2% 
B2 P00829 ATP synthase subunit beta, mitochondrial  56249 5,15 122 2 2 5% 
B2 P51977 Retinal dehydrogenase 1  55417 6,37 96 3 3 5% 
B2 Q6UWU3 Dehydrogenase/reductase SDR family 
member 4  
27782 7,66 92 2 2 8% 
B2 P09488 Glutathione S-transferase Mu 1 25923 6,24 87 3 2 14% 
B2 Q58DM8 Enoyl-CoA hydratase, mitochondrial  31565 8,82 78 1 1 7% 
B2 P02075 Hemoglobin subunit beta  16120 6,75 76 3 3 21% 
B2 Q16788 Liver carboxylesterase 1 62766 6,15 72 2 2 4% 
B2 Q2KJH9 4-trimethylaminobutyraldehyde 
dehydrogenase  
54854 5,84 69 1 1 2% 
B2 P20000 Aldehyde dehydrogenase, mitochondrial  57073 7,55 68 2 2 3% 
B2 Q6Q2C2 Epoxide hydrolase 2 63354 6,06 62 1 1 1% 
B2 P68240 Hemoglobin subunit alpha-1/2  15212 8,72 61 3 2 16% 
B2 P31081 60 kDa heat shock protein, mitochondrial  61240 5,60 60 1 1 1% 
B2 Q05555 Cytochrome P450 2A10  57325 9,24 54 3 3 5% 
B2 A7YWE4 Delta-1-pyrroline-5-carboxylate 
dehydrogenase, mitochondrial  
62084 8,37 50 2 2 3% 
B2 Q2KJ32 Selenium-binding protein 1 53092 6,03 47 1 1 2% 
B2 Q64316 Actin, cytoplasmic 1 42052 5,29 44 2 2 7% 
B2 Q2TBR0 Propionyl-CoA carboxylase beta chain, 
mitochondrial  
58901 7,14 41 2 2 3% 
B2 P12378 UDP-glucose 6-dehydrogenase  55786 7,51 37 2 2 4% 
B2 Q5E956 Triosephosphate isomerase  26901 6,45 35 1 1 5% 
B2 P10096 Glyceraldehyde-3-phosphate 
dehydrogenase  
36073 8,50 33 1 1 4% 
B3 Q9TTJ5 Regucalcin 33857 5,54 204 3 3 14% 
B3 P00432 Catalase 60106 6,78 154 5 3 9% 
B3 Q2KJE4 Electron transfer flavoprotein subunit 
alpha, mitochondrial  
35282 8,77 125 4 4 14% 
B3 Q16698 2,4-dienoyl-CoA reductase, mitochondrial  36330 9,35 116 3 3 10% 
B3 O02691 3-hydroxyacyl-CoA dehydrogenase type-2 27294 8,45 105 1 1 7% 
B3 P31327 Carbamoyl-phosphate synthase 165975 6,30 98 2 2 1% 
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[ammonia], mitochondrial  
B3 Q3T0Z7 Dihydropteridine reductase  25716 6,90 97 3 3 14% 
B3 Q58DK5 Delta-aminolevulinic acid dehydratase  36514 6,51 96 1 1 4% 
B3 P00829 ATP synthase subunit beta, mitochondrial  56249 5,15 93 1 1 2% 
B3 O35459 Delta(3,5)-Delta(2,4)-dienoyl-CoA 
isomerase, mitochondrial  
36437 7,60 92 2 2 7% 
B3 P25325 3-mercaptopyruvate sulfurtransferase  33443 6,13 90 1 1 4% 
B3 P68240 Hemoglobin subunit alpha-1/2  15212 8,72 89 3 3 23% 
B3 Q9D7V9 N-acylethanolamine-hydrolyzing acid 
amidase 
40221 5,99 86 1 1 4% 
B3 P02080 Hemoglobin subunit beta-C(NA) 15680 11,57 85 4 3 14% 
B3 P05631 ATP synthase subunit gamma, 
mitochondrial  
33108 9,34 83 2 2 7% 
B3 P00366 Glutamate dehydrogenase 1, mitochondrial  61815 7,25 80 2 2 3% 
B3 P45879 Voltage-dependent anion-selective channel 
protein 1 
30836 8,62 71 2 2 7% 
B3 Q3T001 Hydroxysteroid 17-beta dehydrogenase 6 36517 8,65 64 2 2 6% 
B3 Q2KJ64 Arginase-1 35272 6,09 63 1 1 3% 
B3 Q9N1F5 Glutathione S-transferase omega-1  27743 6,84 52 1 1 5% 
B3 Q32LG3 Malate dehydrogenase, mitochondrial  36102 8,82 51 2 2 6% 
B3 Q96CN7 Isochorismatase domain-containing protein 
1 
32501 6,96 51 1 1 4% 
B3 P61603 10 kDa heat shock protein, mitochondrial  10925 8,89 44 1 1 9% 
B3 Q28035 Glutathione S-transferase A1  25549 8,66 41 2 2 6% 
B3 P30115 Glutathione S-transferase A3  25401 8,76 41 2 2 7% 
B3 Q64316 Actin, cytoplasmic 1 42052 5,29 38 1 1 2% 
B3 Q96QV6 Histone H2A type 1-A 14225 10,86 38 1 1 6% 
B3 O97764 Zeta-crystallin  35532 8,29 38 1 1 3% 
B3 P04908 Histone H2A type 1-B/E 14127 11,05 37 2 2 21% 
B3 Q3T165 Prohibitin 29843 5,57 34 1 1 4% 
B3 P09670 Superoxide dismutase [Cu-Zn]  15856 6,14 33 1 1 5% 
B3 Q96A08 Histone H2B type 1-A 14159 10,31 30 2 2 12% 
B4 O02691 3-hydroxyacyl-CoA dehydrogenase type-2 27294 8,45 605 13 8 43% 
B4 Q58DM8 Enoyl-CoA hydratase, mitochondrial  31565 8,82 318 7 6 28% 
B4 Q5E956 Triosephosphate isomerase  26901 6,45 282 6 6 30% 
B4 Q9TSM5 Glutathione S-transferase Mu 1 25732 6,09 214 6 5 16% 
B4 P28161 Glutathione S-transferase Mu 2 25899 6,00 207 6 5 16% 
B4 P68240 Hemoglobin subunit alpha-1/2  15212 8,72 175 5 4 30% 
B4 P02075 Hemoglobin subunit beta  16120 6,75 166 7 4 22% 
B4 P04040 Catalase 59947 6,90 123 3 3 6% 
B4 Q3T094 Protein ETHE1, mitochondrial  28395 6,25 119 3 3 14% 
B4 P08760 GTP:AMP phosphotransferase 
mitochondrial  
25656 9,02 109 4 4 17% 
B4 Q2TBV3 Electron transfer flavoprotein subunit beta  27910 8,24 96 5 4 14% 
B4 O77834 Peroxiredoxin-6 25108 6,00 67 1 1 5% 
B4 Q28035 Glutathione S-transferase A1  25549 8,66 61 5 4 17% 
B4 P00366 Glutamate dehydrogenase 1, mitochondrial  61815 7,25 56 3 3 5% 
B4 P51781 Glutathione S-transferase alpha M14  25378 8,86 53 4 4 15% 
B4 P60713 Actin, cytoplasmic 1 42052 5,29 53 1 1 2% 
B4 P42126 3,2-trans-enoyl-CoA isomerase, 
mitochondrial  
33080 8,80 52 1 1 2% 
B4 Q9N1F5 Glutathione S-transferase omega-1  27743 6,84 52 1 1 5% 
B4 P62803 Histone H4  11360 11,36 44 2 2 17% 
B4 P30115 Glutathione S-transferase A3  25401 8,76 38 2 2 7% 
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B4 Q3T0S5 Fructose-bisphosphate aldolase B 39917 8,69 31 1 1 3% 
B4 bis O02691 3-hydroxyacyl-CoA dehydrogenase type-2 27294 8,45 2360 38 10 44% 
B4 bis Q5E956 Triosephosphate isomerase  26901 6,45 290 6 6 30% 
B4 bis P68240 Hemoglobin subunit alpha-1/2  15212 8,72 171 6 4 23% 
B4 bis O97492 Catalase 60102 6,88 166 6 5 10% 
B4 bis Q9N0V4 Glutathione S-transferase Mu 1 25789 6,90 166 5 5 21% 
B4 bis P02080 Hemoglobin subunit beta-C(NA) 15680 11,57 131 5 4 16% 
B4 bis Q28035 Glutathione S-transferase A1  25549 8,66 128 11 7 26% 
B4 bis Q3T149 Heat shock protein beta-1  22436 5,98 117 5 4 25% 
B4 bis P51781 Glutathione S-transferase alpha M14  25378 8,86 108 8 4 15% 
B4 bis Q3T094 Protein ETHE1, mitochondrial  28395 6,25 85 1 1 5% 
B4 bis O18879 Glutathione S-transferase A2  25814 8,66 81 6 3 11% 
B4 bis P30115 Glutathione S-transferase A3  25401 8,76 69 6 2 7% 
B4 bis P19803 Rho GDP-dissociation inhibitor 1 23464 5,12 56 1 1 7% 
B4 bis P35705 Thioredoxin-dependent peroxide 
reductase, mitochondrial  
28406 7,15 53 3 3 12% 
B4 bis P62803 Histone H4  11360 11,36 51 1 1 7% 
B4 bis Q9N1F5 Glutathione S-transferase omega-1  27743 6,84 43 1 1 5% 
 
AN, Swiss-Prot Accession number; QM, Queries Matched; UP, Unique Peptides; SC, Sequence Coverage. 
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Appendix 8 









A2RUB1 Uncharacterized protein FLJ35848 1 1 
A6NHG4 D-dopachrome decarboxylase-like protein   1 1 
A8MT79 Putative zinc-alpha-2-glycoprotein-like 1 5 1 
O00299 Chloride intracellular channel protein 1   1 1 
O00483 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex 
subunit 4   
3 3 
O14558 Heat shock protein beta-6   2 1 
O14773 Tripeptidyl-peptidase 1   4 1 
O15049 NEDD4-binding protein 3   1 1 
O15145 Actin-related protein 2/3 complex subunit 3   3 2 
O15511 Actin-related protein 2/3 complex subunit 5   1 1 
O43488 Aflatoxin B1 aldehyde reductase member 2   6 5 
O43598 Deoxyribonucleoside 5'-monophosphate N-glycosidase   1 1 
O43678 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex 
subunit 2   
1 1 
O60888 Protein CutA   7 1 
O75340 Programmed cell death protein 6   1 1 
O75367 Core histone macro-H2A.1   3 2 
O75368 SH3 domain-binding glutamic acid-rich-like protein 1 1 
O75964 ATP synthase subunit g, mitochondrial   1 1 
O94772 Lymphocyte antigen 6H   1 1 
O95399 Urotensin-2   1 1 
O95716 Ras-related protein Rab-3D 1 1 
O95994 Anterior gradient protein 2 homolog   5 2 
O96009 Napsin-A   4 2 
P00167 Cytochrome b5 2 2 
P00338 L-lactate dehydrogenase A chain   8 2 
P00352 Retinal dehydrogenase 1   6 3 
P00387 NADH-cytochrome b5 reductase 3   3 3 
P00403 Cytochrome c oxidase subunit 2   11 2 
P00441 Superoxide dismutase [Cu-Zn]   9 2 
P00558 Phosphoglycerate kinase 1   1 1 
P00568 Adenylate kinase isoenzyme 1   6 4 
P00738 Haptoglobin 13 4 
P00739 Haptoglobin-related protein 1 1 
P00915 Carbonic anhydrase 1   54 6 
P00918 Carbonic anhydrase 2   3 3 
P01009 Alpha-1-antitrypsin   18 4 
P01011 Alpha-1-antichymotrypsin   9 4 
P01591 Immunoglobulin J chain 2 1 
P01605 Ig kappa chain V-I region Lay 2 1 
P01614 Ig kappa chain V-II region Cum 2 1 
P01620 Ig kappa chain V-III region SIE 3 2 
P01621 Ig kappa chain V-III region NG9   1 1 
P01700 Ig lambda chain V-I region HA 1 1 
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P01763 Ig heavy chain V-III region WEA 1 1 
P01834 Ig kappa chain C region 87 5 
P01842 Ig lambda chain C regions 42 2 
P01857 Ig gamma-1 chain C region 11 4 
P01859 Ig gamma-2 chain C region 25 4 
P01860 Ig gamma-3 chain C region   1 1 
P01861 Ig gamma-4 chain C region 1 1 
P01876 Ig alpha-1 chain C region 60 6 
P02008 Hemoglobin subunit zeta   3 2 
P02042 Hemoglobin subunit delta   929 9 
P02100 Hemoglobin subunit epsilon   7 2 
P02452 Collagen alpha-1  3 1 
P02647 Apolipoprotein A-I   16 7 
P02649 Apolipoprotein E   1 1 
P02743 Serum amyloid P-component   9 4 
P02753 Retinol-binding protein 4   3 3 
P02763 Alpha-1-acid glycoprotein 1   2 1 
P02766 Transthyretin   6 2 
P02768 Serum albumin 1287 27 
P02787 Serotransferrin   16 4 
P02790 Hemopexin   11 3 
P02792 Ferritin light chain   55 6 
P02794 Ferritin heavy chain   7 2 
P04004 Vitronectin   1 1 
P04040 Catalase   4 2 
P04075 Fructose-bisphosphate aldolase A   25 8 
P04083 Annexin A1   1 1 
P04179 Superoxide dismutase [Mn], mitochondrial   5 3 
P04406 Glyceraldehyde-3-phosphate dehydrogenase   59 8 
P04632 Calpain small subunit 1   1 1 
P04732 Metallothionein-1E   8 1 
P04792 Heat shock protein beta-1   54 6 
P04908 Histone H2A type 1-B/E   737 6 
P05060 Secretogranin-1   51 5 
P05109 Protein S100-A8   15 5 
P05164 Myeloperoxidase   1 1 
P05387 60S acidic ribosomal protein P2   2 1 
P05408 Neuroendocrine protein 7B2   1 1 
P06576 ATP synthase subunit beta, mitochondrial   33 5 
P06702 Protein S100-A9   11 5 
P06703 Protein S100-A6   39 3 
P06733 Alpha-enolase   20 6 
P06748 Nucleophosmin   1 1 
P07203 Glutathione peroxidase 1   1 1 
P07305 Histone H1.0   4 2 
P07339 Cathepsin D   23 6 
P07355 Annexin A2   16 8 
P07437 Tubulin beta chain   14 5 
P07602 Proactivator polypeptide 6 3 
P07737 Profilin-1   2 1 
P07741 Adenine phosphoribosyltransferase   8 3 
P07910 Heterogeneous nuclear ribonucleoproteins C1/C2   13 2 
P07988 Pulmonary surfactant-associated protein B   5 2 
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P08107 Heat shock 70 kDa protein 1   9 5 
P08123 Collagen alpha-2  13 3 
P08238 Heat shock protein HSP 90-beta   3 3 
P08294 Extracellular superoxide dismutase [Cu-Zn]   8 2 
P08311 Cathepsin G   3 1 
P08670 Vimentin 52 14 
P08758 Annexin A5   49 6 
P08865 40S ribosomal protein SA   15 4 
P09104 Gamma-enolase   2 2 
P09211 Glutathione S-transferase P   4 2 
P09382 Galectin-1   1 1 
P09417 Dihydropteridine reductase   4 1 
P09471 Guanine nucleotide-binding protein G(o) subunit alpha 2 2 
P09525 Annexin A4   1 1 
P09972 Fructose-bisphosphate aldolase C   1 1 
P0C7P4 Cytochrome b-c1 complex subunit Rieske-like protein 1 2 2 
P10253 Lysosomal alpha-glucosidase   2 2 
P10412 Histone H1.4   2 2 
P10599 Thioredoxin   1 1 
P10645 Chromogranin-A   66 5 
P10909 Clusterin   3 2 
P11021 78 kDa glucose-regulated protein   5 5 
P11142 Heat shock cognate 71 kDa protein   13 4 
P11226 Mannose-binding protein C   1 1 
P11684 Uteroglobin   1 1 
P12277 Creatine kinase B-type   16 3 
P12724 Eosinophil cationic protein   2 1 
P13521 Secretogranin-2   3 1 
P13929 Beta-enolase   2 2 
P13987 CD59 glycoprotein   2 1 
P14174 Macrophage migration inhibitory factor   11 2 
P14314 Glucosidase 2 subunit beta   2 1 
P14649 Myosin light chain 6B   2 1 
P14678 Small nuclear ribonucleoprotein-associated proteins B and 
B'   
1 1 
P14854 Cytochrome c oxidase subunit 6B1   3 1 
P15151 Poliovirus receptor   1 1 
P15157 Tryptase alpha-1   2 2 
P15309 Prostatic acid phosphatase   3 1 
P15531 Nucleoside diphosphate kinase A   5 3 
P15924 Desmoplakin   1 1 
P16070 CD44 antigen   2 1 
P16104 Histone H2A.x   13 3 
P16403 Histone H1.2   18 3 
P16870 Carboxypeptidase E   3 1 
P16949 Stathmin   1 1 
P17066 Heat shock 70 kDa protein 6   6 3 
P17661 Desmin 1 1 
P17900 Ganglioside GM2 activator   2 1 
P18085 ADP-ribosylation factor 4 2 1 
P18124 60S ribosomal protein L7 1 1 
P18621 60S ribosomal protein L17   3 2 
P18669 Phosphoglycerate mutase 1   4 2 
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P19105 Myosin regulatory light chain 12A   15 4 
P19484 Transcription factor EB 2 2 
P20336 Ras-related protein Rab-3A 1 1 
P20337 Ras-related protein Rab-3B 1 1 
P20592 Interferon-induced GTP-binding protein Mx2   2 1 
P20671 Histone H2A type 1-D   138 6 
P20711 Aromatic-L-amino-acid decarboxylase   2 1 
P20774 Mimecan   5 2 
P20962 Parathymosin 12 3 
P21291 Cysteine and glycine-rich protein 1   2 1 
P21810 Biglycan   1 1 
P22061 Protein-L-isoaspartate  1 1 
P22090 40S ribosomal protein S4, Y isoform 1 1 1 
P22392 Nucleoside diphosphate kinase B   3 3 
P22492 Histone H1t   15 1 
P22626 Heterogeneous nuclear ribonucleoproteins A2/B1   62 7 
P23284 Peptidyl-prolyl cis-trans isomerase B   29 7 
P23396 40S ribosomal protein S3 2 2 
P23528 Cofilin-1   13 3 
P23763 Vesicle-associated membrane protein 1   1 1 
P24666 Low molecular weight phosphotyrosine protein 
phosphatase   
1 1 
P24844 Myosin regulatory light polypeptide 9   7 4 
P25705 ATP synthase subunit alpha, mitochondrial 22 6 
P25786 Proteasome subunit alpha type-1   1 1 
P26447 Protein S100-A4   2 2 
P26599 Polypyrimidine tract-binding protein 1   1 1 
P27348 14-3-3 protein theta   15 5 
P27635 60S ribosomal protein L10   1 1 
P27695 DNA-(apurinic or apyrimidinic site) lyase 1 1 
P28065 Proteasome subunit beta type-9   3 1 
P28070 Proteasome subunit beta type-4   1 1 
P28072 Proteasome subunit beta type-6   6 2 
P28074 Proteasome subunit beta type-5   2 1 
P29401 Transketolase   2 2 
P30041 Peroxiredoxin-6   19 3 
P30043 Flavin reductase   8 3 
P30044 Peroxiredoxin-5, mitochondrial   6 1 
P30048 Thioredoxin-dependent peroxide reductase, mitochondrial   10 3 
P30049 ATP synthase subunit delta, mitochondrial   3 2 
P30050 60S ribosomal protein L12 24 3 
P30086 Phosphatidylethanolamine-binding protein 1   57 5 
P30101 Protein disulfide-isomerase A3   7 1 
P30626 Sorcin   1 1 
P31151 Protein S100-A7   2 2 
P31942 Heterogeneous nuclear ribonucleoprotein H3   1 1 
P31946 14-3-3 protein beta/alpha   35 5 
P31947 14-3-3 protein sigma   30 3 
P31949 Protein S100-A11   10 2 
P32119 Peroxiredoxin-2   191 11 
P32969 60S ribosomal protein L9 3 2 
P33778 Histone H2B type 1-B   334 6 
P35232 Prohibitin 1 1 
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P35237 Serpin B6   1 1 
P35268 60S ribosomal protein L22   2 1 
P37802 Transgelin-2   46 8 
P37837 Transaldolase   16 3 
P38159 Heterogeneous nuclear ribonucleoprotein G   1 1 
P39019 40S ribosomal protein S19 24 5 
P40121 Macrophage-capping protein   2 1 
P40925 Malate dehydrogenase, cytoplasmic   5 2 
P40926 Malate dehydrogenase, mitochondrial   9 3 
P42126 3,2-trans-enoyl-CoA isomerase, mitochondrial   2 1 
P42345 Serine/threonine-protein kinase mTOR   1 1 
P46776 60S ribosomal protein L27a 4 1 
P46781 40S ribosomal protein S9 4 4 
P46782 40S ribosomal protein S5  18 3 
P47929 Galectin-7   2 2 
P48047 ATP synthase subunit O, mitochondrial   3 2 
P48556 26S proteasome non-ATPase regulatory subunit 8   1 1 
P49189 4-trimethylaminobutyraldehyde dehydrogenase   6 3 
P49458 Signal recognition particle 9 kDa protein   1 1 
P49721 Proteasome subunit beta type-2   2 1 
P49755 Transmembrane emp24 domain-containing protein 10   1 1 
P50395 Rab GDP dissociation inhibitor beta   2 2 
P51148 Ras-related protein Rab-5C   2 1 
P51153 Ras-related protein Rab-13   2 2 
P51157 Ras-related protein Rab-28   1 1 
P51571 Translocon-associated protein subunit delta   1 1 
P51857 3-oxo-5-beta-steroid 4-dehydrogenase   1 1 
P51884 Lumican   12 3 
P51888 Prolargin   18 4 
P51911 Calponin-1   1 1 
P54578 Ubiquitin carboxyl-terminal hydrolase 14   1 1 
P56385 ATP synthase subunit e, mitochondrial 1 1 
P57721 Poly(rC)-binding protein 3  2 2 
P59665 Neutrophil defensin 1   18 1 
P59998 Actin-related protein 2/3 complex subunit 4   8 4 
P60174 Triosephosphate isomerase   36 6 
P60660 Myosin light polypeptide 6   53 5 
P60709 Actin, cytoplasmic 1   896 15 
P60866 40S ribosomal protein S20 11 4 
P60903 Protein S100-A10   1 1 
P61019 Ras-related protein Rab-2A 5 2 
P61088 Ubiquitin-conjugating enzyme E2 N   10 3 
P61160 Actin-related protein 2   2 2 
P61163 Alpha-centractin   2 1 
P61457 Pterin-4-alpha-carbinolamine dehydratase   3 2 
P61586 Transforming protein RhoA   2 1 
P61604 10 kDa heat shock protein, mitochondrial   7 2 
P61626 Lysozyme C   8 2 
P61769 Beta-2-microglobulin 2 2 
P61978 Heterogeneous nuclear ribonucleoprotein K   6 3 
P61981 14-3-3 protein gamma   12 4 
P62081 40S ribosomal protein S7 2 2 
P62158 Calmodulin   23 4 
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P62244 40S ribosomal protein S15a 1 1 
P62249 40S ribosomal protein S16 12 4 
P62258 14-3-3 protein epsilon   24 6 
P62263 40S ribosomal protein S14 13 2 
P62269 40S ribosomal protein S18   17 4 
P62277 40S ribosomal protein S13 4 2 
P62280 40S ribosomal protein S11 5 3 
P62304 Small nuclear ribonucleoprotein E   4 2 
P62306 Small nuclear ribonucleoprotein F   1 1 
P62310 U6 snRNA-associated Sm-like protein LSm3 4 1 
P62318 Small nuclear ribonucleoprotein Sm D3   2 1 
P62491 Ras-related protein Rab-11A   5 4 
P62701 40S ribosomal protein S4, X isoform   1 1 
P62736 Actin, aortic smooth muscle   284 13 
P62750 60S ribosomal protein L23a 1 1 
P62805 Histone H4 725 8 
P62807 Histone H2B type 1-C/E/F/G/I   348 7 
P62826 GTP-binding nuclear protein Ran   2 1 
P62829 60S ribosomal protein L23   4 1 
P62834 Ras-related protein Rap-1A   1 1 
P62851 40S ribosomal protein S25 8 3 
P62857 40S ribosomal protein S28 7 2 
P62873 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit 
beta-1 
6 3 
P62899 60S ribosomal protein L31 17 3 
P62913 60S ribosomal protein L11   14 2 
P62917 60S ribosomal protein L8 6 2 
P62937 Peptidyl-prolyl cis-trans isomerase A   45 7 
P62988 Ubiquitin 95 5 
P63104 14-3-3 protein zeta/delta   49 8 
P63208 S-phase kinase-associated protein 1   1 1 
P63220 40S ribosomal protein S21 3 2 
P63241 Eukaryotic translation initiation factor 5A-1   2 2 
P68104 Elongation factor 1-alpha 1   4 3 
P68363 Tubulin alpha-1B chain   2 2 
P68371 Tubulin beta-2C chain   10 5 
P68871 Hemoglobin subunit beta   3459 13 
P69891 Hemoglobin subunit gamma-1   15 2 
P69905 Hemoglobin subunit alpha   2580 10 
P80294 Metallothionein-1H   1 1 
P81605 Dermcidin   1 1 
P84074 Neuron-specific calcium-binding protein hippocalcin   1 1 
P84077 ADP-ribosylation factor 1 14 3 
P84090 Enhancer of rudimentary homolog 2 1 
P84103 Splicing factor, arginine/serine-rich 3   4 2 
Q01105 Protein SET   2 1 
Q01469 Fatty acid-binding protein, epidermal   6 2 
Q01995 Transgelin   41 10 
Q02543 60S ribosomal protein L18a 2 2 
Q03113 Guanine nucleotide-binding protein subunit alpha-12   2 1 
Q04837 Single-stranded DNA-binding protein, mitochondrial   7 1 
Q04917 14-3-3 protein eta   8 4 
Q06323 Proteasome activator complex subunit 1   2 1 
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Q06830 Peroxiredoxin-1   82 7 
Q07020 60S ribosomal protein L18 2 1 
Q07507 Dermatopontin   10 2 
Q07617 Sperm-associated antigen 1   1 1 
Q07955 Splicing factor, arginine/serine-rich 1   1 1 
Q08380 Galectin-3-binding protein   2 1 
Q12765 Secernin-1 1 1 
Q12905 Interleukin enhancer-binding factor 2   2 1 
Q12929 Epidermal growth factor receptor kinase substrate 8 2 1 
Q13011 Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial 3 1 
Q13017 Rho GTPase-activating protein 5   1 1 
Q13228 Selenium-binding protein 1   1 1 
Q13404 Ubiquitin-conjugating enzyme E2 variant 1   4 2 
Q13510 Acid ceramidase   14 3 
Q13885 Tubulin beta-2A chain 20 4 
Q13938 Calcyphosin   5 5 
Q14011 Cold-inducible RNA-binding protein   9 4 
Q14789 Golgin subfamily B member 1   3 3 
Q14894 Mu-crystallin homolog   9 4 
Q15084 Protein disulfide-isomerase A6   1 1 
Q15181 Inorganic pyrophosphatase   5 2 
Q15185 Prostaglandin E synthase 3   1 1 
Q15286 Ras-related protein Rab-35   1 1 
Q15365 Poly(rC)-binding protein 1 2 1 
Q15661 Tryptase beta-1   10 3 
Q15717 ELAV-like protein 1   1 1 
Q15772 Striated muscle preferentially expressed protein kinase   1 1 
Q15878 Voltage-dependent R-type calcium channel subunit alpha-
1E   
2 2 
Q16568 Cocaine- and amphetamine-regulated transcript protein 2 1 
Q16695 Histone H3.1t   104 6 
Q2LD37 Uncharacterized protein KIAA1109   1 1 
Q32P51 Heterogeneous nuclear ribonucleoprotein A1-like protein 2   3 2 
Q59H18 Serine/threonine-protein kinase TNNI3K   1 1 
Q5D862 Filaggrin-2   1 1 
Q5JNZ5 Putative 40S ribosomal protein S26-like 1 1 1 
Q5JSL3 Dedicator of cytokinesis protein 11   3 1 
Q5T7P6 Transmembrane protein 78 9 1 
Q5VV41 Rho guanine nucleotide exchange factor 16 1 1 
Q6AWC2 Protein WWC2   1 1 
Q6NXG1 Epithelial splicing regulatory protein 1   1 1 
Q6NXT2 Histone H3-like 50 2 
Q6PRD1 Probable G-protein coupled receptor 179   1 1 
Q6ZMR3 L-lactate dehydrogenase A-like 6A   2 2 
Q71U36 Tubulin alpha-1A chain   37 6 
Q71UI9 Histone H2A.V   14 3 
Q71UM5 40S ribosomal protein S27-like protein 2 1 
Q7L0Q8 Rho-related GTP-binding protein RhoU   1 1 
Q86V86 Serine/threonine-protein kinase Pim-3   1 1 
Q86XF0 Dihydrofolate reductase-like protein 1 2 2 
Q8IUE6 Histone H2A type 2-B 73 2 
Q8IWL2 Pulmonary surfactant-associated protein A1   15 3 
Q8IZX4 Transcription initiation factor TFIID 210 kDa subunit   1 1 
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Q8N257 Histone H2B type 3-B   3 3 
Q8N729 Neuropeptide W   1 1 
Q8N957 Ankyrin repeat and fibronectin type-III domain-containing 
protein 1 
2 1 
Q8NAT1 Uncharacterized glycosyltransferase AGO61   2 1 
Q8NEZ4 Histone-lysine N-methyltransferase MLL3   3 2 
Q8NFU3 Putative thiosulfate sulfurtransferase KAT   1 1 
Q8NHW5 60S acidic ribosomal protein P0-like 4 2 
Q8TDP1 Ribonuclease H2 subunit C   1 1 
Q8TEL6 Trpc4-associated protein   1 1 
Q8WU39 Proapoptotic caspase adapter protein   2 1 
Q8WY91 THAP domain-containing protein 4 1 1 
Q8WZ42 Titin   6 6 
Q8WZ73 E3 ubiquitin-protein ligase rififylin   1 1 
Q92522 Histone H1x 1 1 
Q92558 Wiskott-Aldrich syndrome protein family member 1   2 1 
Q92614 Myosin-XVIIIa   1 1 
Q92878 DNA repair protein RAD50   1 1 
Q92930 Ras-related protein Rab-8B 2 2 
Q969M7 NEDD8-conjugating enzyme UBE2F   1 1 
Q96A08 Histone H2B type 1-A   357 5 
Q96CX2 BTB/POZ domain-containing protein KCTD12   5 3 
Q96FQ6 Protein S100-A16   1 1 
Q96HE7 ERO1-like protein alpha   1 1 
Q96IU4 Abhydrolase domain-containing protein 14B   5 1 
Q96MF2 SH3 and cysteine-rich domain-containing protein 3 1 1 
Q96PC2 Inositol hexakisphosphate kinase 3   1 1 
Q96PS8 Aquaporin-10   1 1 
Q96PX9 Pleckstrin homology domain-containing family G member 
4B 
2 1 
Q96QV6 Histone H2A type 1-A   101 2 
Q96T51 RUN and FYVE domain-containing protein 1   1 1 
Q99497 Protein DJ-1   4 2 
Q99714 3-hydroxyacyl-CoA dehydrogenase type-2   2 1 
Q99758 ATP-binding cassette sub-family A member 3   1 1 
Q99943 1-acyl-sn-glycerol-3-phosphate acyltransferase alpha   11 1 
Q9BPX5 Actin-related protein 2/3 complex subunit 5-like protein   2 1 
Q9BTD8 RNA-binding protein 42   2 1 
Q9BVC6 Transmembrane protein 109   6 1 
Q9BXL6 Caspase recruitment domain-containing protein 14   1 1 
Q9BZJ3 Tryptase delta   4 2 
Q9H299 SH3 domain-binding glutamic acid-rich-like protein 3   5 1 
Q9H2A2 Aldehyde dehydrogenase family 8 member A1   1 1 
Q9H3E2 Sorting nexin-25 3 2 
Q9H853 Putative tubulin-like protein alpha-4B   2 1 
Q9NP55 Protein Plunc   2 2 
Q9NP80 Calcium-independent phospholipase A2-gamma   1 1 
Q9NP97 Dynein light chain roadblock-type 1   1 1 
Q9NRJ7 Protocadherin beta-16   3 1 
Q9NUJ1 Abhydrolase domain-containing protein 10, mitochondrial   1 1 
Q9NV79 Protein-L-isoaspartate O-methyltransferase domain-
containing protein 2 
1 1 
Q9NX65 Zinc finger protein 434   1 1 
Q9NY65 Tubulin alpha-8 chain   10 4 
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Q9P0M6 Core histone macro-H2A.2   2 1 
Q9P0M9 39S ribosomal protein L27, mitochondrial   1 1 
Q9UBR2 Cathepsin Z   2 1 
Q9UGV6 High mobility group protein 1-like 10   5 3 
Q9UHG2 ProSAAS   4 4 
Q9UHL4 Dipeptidyl-peptidase 2   3 2 
Q9UI15 Transgelin-3   8 3 
Q9UIF9 Bromodomain adjacent to zinc finger domain protein 2A   1 1 
Q9Y281 Cofilin-2   1 1 
Q9Y2V2 Calcium-regulated heat stable protein 1   2 1 
Q9Y5S9 RNA-binding protein 8A   1 1 
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Appendix 9 










A1L020 RNA-binding protein MEX3A   1 1 
A6NHQ2 rRNA/tRNA 2'-O-methyltransferase fibrillarin-like protein 1   1 1 
B0I1T2 Myosin-Ig 3 1 
O00148 ATP-dependent RNA helicase DDX39   1 1 
O00422 Histone deacetylase complex subunit SAP18   2 1 
O14569 Cytochrome b561 domain-containing protein 2   2 1 
O14672 
Disintegrin and metalloproteinase domain-containing 
protein 10   1 1 
O14737 Programmed cell death protein 5   1 1 
O15020 Spectrin beta chain, brain 2   1 1 
O15131 Importin subunit alpha-6   1 1 
O15145 Actin-related protein 2/3 complex subunit 3   3 1 
O15511 Actin-related protein 2/3 complex subunit 5   2 1 
O43390 Heterogeneous nuclear ribonucleoprotein R   2 2 
O43617 Trafficking protein particle complex subunit 3   1 1 
O43768 Alpha-endosulfine   1 1 
O43808 Peroxisomal membrane protein PMP34   2 1 
O75071 EF-hand domain-containing protein KIAA0494 2 1 
O75340 Programmed cell death protein 6   3 3 
O75347 Tubulin-specific chaperone A   1 1 
O75390 Citrate synthase, mitochondrial   1 1 
O75964 ATP synthase subunit g, mitochondrial   2 2 
O95399 Urotensin-2   1 1 
O95873 Uncharacterized protein C6orf47   1 1 
O95881 Thioredoxin domain-containing protein 12   1 1 
O95968 Secretoglobin family 1D member 1   1 1 
P00167 Cytochrome b5 3 2 
P00338 L-lactate dehydrogenase A chain   15 4 
P00403 Cytochrome c oxidase subunit 2   14 2 
P00558 Phosphoglycerate kinase 1   1 1 
P00738 Haptoglobin 12 2 
P00739 Haptoglobin-related protein 6 2 
P00915 Carbonic anhydrase 1   15 4 
P01009 Alpha-1-antitrypsin   10 4 
P01011 Alpha-1-antichymotrypsin   39 4 
P01024 Complement C3   1 1 
P01591 Immunoglobulin J chain 1 1 
P01598 Ig kappa chain V-I region EU 3 1 
P01605 Ig kappa chain V-I region Lay 4 1 
P01610 Ig kappa chain V-I region WEA 1 1 
P01614 Ig kappa chain V-II region Cum 1 1 
P01620 Ig kappa chain V-III region SIE 5 2 
P01621 Ig kappa chain V-III region NG9   4 1 
P01699 Ig lambda chain V-I region VOR 1 1 
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P01700 Ig lambda chain V-I region HA 4 2 
P01715 Ig lambda chain V-IV region Bau 1 1 
P01763 Ig heavy chain V-III region WEA 4 2 
P01834 Ig kappa chain C region 54 4 
P01842 Ig lambda chain C regions 32 3 
P01857 Ig gamma-1 chain C region 70 7 
P01859 Ig gamma-2 chain C region 28 5 
P01860 Ig gamma-3 chain C region   26 5 
P01876 Ig alpha-1 chain C region 19 4 
P01889 HLA class I histocompatibility antigen, B-7 alpha chain   1 1 
P02042 Hemoglobin subunit delta   142 7 
P02100 Hemoglobin subunit epsilon   10 2 
P02452 Collagen alpha-1(I) chain 1 1 
P02671 Fibrinogen alpha chain 25 7 
P02675 Fibrinogen beta chain 25 7 
P02743 Serum amyloid P-component   3 2 
P02751 Fibronectin   3 2 
P02768 Serum albumin 524 19 
P02787 Serotransferrin   4 3 
P02790 Hemopexin   2 1 
P02792 Ferritin light chain   10 3 
P04004 Vitronectin   2 1 
P04075 Fructose-bisphosphate aldolase A   34 8 
P04406 Glyceraldehyde-3-phosphate dehydrogenase   56 4 
P04792 Heat shock protein beta-1   56 8 
P04908 Histone H2A type 1-B/E   612 5 
P05109 Protein S100-A8   1 1 
P05114 Non-histone chromosomal protein HMG-14   1 1 
P05141 ADP/ATP translocase 2   3 3 
P05204 Non-histone chromosomal protein HMG-17   5 1 
P05387 60S acidic ribosomal protein P2   5 1 
P06576 ATP synthase subunit beta, mitochondrial   24 5 
P06702 Protein S100-A9   3 2 
P06703 Protein S100-A6   16 2 
P06731 Carcinoembryonic antigen-related cell adhesion molecule 5   4 3 
P06733 Alpha-enolase   34 9 
P06748 Nucleophosmin   1 1 
P07195 L-lactate dehydrogenase B chain   2 2 
P07311 Acylphosphatase-1   1 1 
P07339 Cathepsin D   3 2 
P07355 Annexin A2   10 3 
P07437 Tubulin beta chain   155 10 
P07737 Profilin-1   5 4 
P07741 Adenine phosphoribosyltransferase   2 2 
P07900 Heat shock protein HSP 90-alpha   10 3 
P07910 Heterogeneous nuclear ribonucleoproteins C1/C2   29 6 
P07996 Thrombospondin-1 1 1 
P08107 Heat shock 70 kDa protein 1   3 3 
P08123 Collagen alpha-2(I) chain 7 3 
P08238 Heat shock protein HSP 90-beta   11 4 
P08514 Integrin alpha-IIb   1 1 
P08670 Vimentin 48 18 
P08708 40S ribosomal protein S17 2 2 
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P08758 Annexin A5   17 4 
P08865 40S ribosomal protein SA   18 4 
P09104 Gamma-enolase   11 3 
P09211 Glutathione S-transferase P   21 4 
P09382 Galectin-1   1 1 
P09455 Retinol-binding protein 1   1 1 
P09496 Clathrin light chain A   2 1 
P09651 Heterogeneous nuclear ribonucleoprotein A1   27 6 
P09936 Ubiquitin carboxyl-terminal hydrolase isozyme L1   21 6 
P09972 Fructose-bisphosphate aldolase C   3 2 
P0C0L4 Complement C4-A   2 2 
P0C7M2 
Putative heterogeneous nuclear ribonucleoprotein A1-like 
protein 3   2 2 
P0C7P4 Cytochrome b-c1 complex subunit Rieske-like protein 1 6 2 
P10412 Histone H1.4   2 2 
P10809 60 kDa heat shock protein, mitochondrial   2 1 
P10909 Clusterin   2 2 
P10915 Hyaluronan and proteoglycan link protein 1   87 11 
P11021 78 kDa glucose-regulated protein   8 4 
P11142 Heat shock cognate 71 kDa protein   20 4 
P11226 Mannose-binding protein C   1 1 
P12004 Proliferating cell nuclear antigen   4 3 
P12109 Collagen alpha-1(VI) chain 4 2 
P12111 Collagen alpha-3  6 2 
P12235 ADP/ATP translocase 1   1 1 
P12277 Creatine kinase B-type   15 5 
P12724 Eosinophil cationic protein   1 1 
P13224 Platelet glycoprotein Ib beta chain   4 2 
P13688 Carcinoembryonic antigen-related cell adhesion molecule 1   7 1 
P13929 Beta-enolase   2 2 
P14136 Glial fibrillary acidic protein   10 3 
P14174 Macrophage migration inhibitory factor   7 2 
P14314 Glucosidase 2 subunit beta   5 2 
P14618 Pyruvate kinase isozymes M1/M2   4 2 
P14625 Endoplasmin   1 1 
P14649 Myosin light chain 6B   4 1 
P14678 
Small nuclear ribonucleoprotein-associated proteins B and 
B'   4 2 
P14770 Platelet glycoprotein IX   1 1 
P14854 Cytochrome c oxidase subunit 6B1   2 1 
P14866 Heterogeneous nuclear ribonucleoprotein L   1 1 
P15153 Ras-related C3 botulinum toxin substrate 2   2 2 
P15311 Ezrin   3 2 
P15531 Nucleoside diphosphate kinase A   5 3 
P15880 40S ribosomal protein S2   4 2 
P16401 Histone H1.5   39 2 
P16402 Histone H1.3   3 3 
P16403 Histone H1.2   135 5 
P16442 Histo-blood group ABO system transferase   1 1 
P16949 Stathmin   34 7 
P17066 Heat shock 70 kDa protein 6   5 2 
P18124 60S ribosomal protein L7 6 1 
P18621 60S ribosomal protein L17   5 2 
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P19105 Myosin regulatory light chain 12A   10 3 
P20039 HLA class II histocompatibility antigen, DRB1-11 beta chain   1 1 
P20592 Interferon-induced GTP-binding protein Mx2   3 1 
P20671 Histone H2A type 1-D   859 5 
P20930 Filaggrin 1 1 
P20962 Parathymosin 10 3 
P21291 Cysteine and glycine-rich protein 1   1 1 
P21796 Voltage-dependent anion-selective channel protein 1   1 1 
P21810 Biglycan   2 1 
P22061 Protein-L-isoaspartate  1 1 
P22087 rRNA 2'-O-methyltransferase fibrillarin   1 1 
P22532 Small proline-rich protein 2D   1 1 
P22626 Heterogeneous nuclear ribonucleoproteins A2/B1   76 8 
P23246 Splicing factor, proline- and glutamine-rich   1 1 
P23284 Peptidyl-prolyl cis-trans isomerase B   17 6 
P23396 40S ribosomal protein S3 10 4 
P23528 Cofilin-1   19 5 
P24844 Myosin regulatory light polypeptide 9   4 2 
P25705 ATP synthase subunit alpha, mitochondrial 22 5 
P26373 60S ribosomal protein L13   1 1 
P26447 Protein S100-A4   4 2 
P26599 Polypyrimidine tract-binding protein 1   2 2 
P27348 14-3-3 protein theta   23 6 
P27695 DNA-(apurinic or apyrimidinic site) lyase 2 1 
P28065 Proteasome subunit beta type-9   1 1 
P28072 Proteasome subunit beta type-6   3 1 
P29692 Elongation factor 1-delta   1 1 
P30041 Peroxiredoxin-6   3 3 
P30043 Flavin reductase   5 2 
P30048 Thioredoxin-dependent peroxide reductase, mitochondrial   5 2 
P30049 ATP synthase subunit delta, mitochondrial   2 2 
P30050 60S ribosomal protein L12 27 4 
P30086 Phosphatidylethanolamine-binding protein 1   21 5 
P30101 Protein disulfide-isomerase A3   3 1 
P30405 Peptidyl-prolyl cis-trans isomerase, mitochondrial   2 2 
P30626 Sorcin   8 3 
P31150 Rab GDP dissociation inhibitor alpha   5 4 
P31942 Heterogeneous nuclear ribonucleoprotein H3   21 6 
P31943 Heterogeneous nuclear ribonucleoprotein H   4 3 
P31946 14-3-3 protein beta/alpha   13 2 
P31947 14-3-3 protein sigma   25 3 
P31949 Protein S100-A11   5 3 
P32119 Peroxiredoxin-2   76 9 
P32969 60S ribosomal protein L9 1 1 
P33778 Histone H2B type 1-B   472 6 
P35232 Prohibitin 5 3 
P35241 Radixin 2 2 
P35268 60S ribosomal protein L22   1 1 
P35321 Cornifin-A   1 1 
P37802 Transgelin-2   22 4 
P37837 Transaldolase   5 2 
P38159 Heterogeneous nuclear ribonucleoprotein G   8 3 
P38405 Guanine nucleotide-binding protein G  2 1 
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P38919 Eukaryotic initiation factor 4A-III   2 2 
P39019 40S ribosomal protein S19 9 5 
P40121 Macrophage-capping protein   1 1 
P40925 Malate dehydrogenase, cytoplasmic   3 3 
P40926 Malate dehydrogenase, mitochondrial   11 4 
P41219 Peripherin 2 1 
P42766 60S ribosomal protein L35 4 2 
P46776 60S ribosomal protein L27a 8 1 
P46777 60S ribosomal protein L5 4 3 
P46778 60S ribosomal protein L21 4 3 
P46779 60S ribosomal protein L28 6 4 
P46781 40S ribosomal protein S9 29 8 
P46782 40S ribosomal protein S5  6 4 
P47914 60S ribosomal protein L29   2 1 
P48047 ATP synthase subunit O, mitochondrial   6 3 
P49006 MARCKS-related protein   7 2 
P49207 60S ribosomal protein L34 1 1 
P49720 Proteasome subunit beta type-3   2 1 
P50552 Vasodilator-stimulated phosphoprotein   1 1 
P51148 Ras-related protein Rab-5C   2 2 
P51149 Ras-related protein Rab-7a 12 3 
P51157 Ras-related protein Rab-28   5 1 
P51571 Translocon-associated protein subunit delta   2 1 
P51857 3-oxo-5-beta-steroid 4-dehydrogenase   2 1 
P51884 Lumican   1 1 
P52566 Rho GDP-dissociation inhibitor 2   1 1 
P52597 Heterogeneous nuclear ribonucleoprotein F   1 1 
P52907 F-actin-capping protein subunit alpha-1   1 1 
P53814 Smoothelin 4 2 
P53999 Activated RNA polymerase II transcriptional coactivator p15   1 1 
P56385 ATP synthase subunit e, mitochondrial 4 2 
P59665 Neutrophil defensin 1   5 1 
P59998 Actin-related protein 2/3 complex subunit 4   16 4 
P60059 Protein transport protein Sec61 subunit gamma 1 1 
P60174 Triosephosphate isomerase   42 8 
P60660 Myosin light polypeptide 6   19 3 
P60709 Actin, cytoplasmic 1   979 15 
P60842 Eukaryotic initiation factor 4A-I   2 1 
P60866 40S ribosomal protein S20 3 2 
P60903 Protein S100-A10   1 1 
P60981 Destrin   4 3 
P61019 Ras-related protein Rab-2A 4 2 
P61088 Ubiquitin-conjugating enzyme E2 N   4 1 
P61160 Actin-related protein 2   2 1 
P61163 Alpha-centractin   2 1 
P61313 60S ribosomal protein L15 10 3 
P61604 10 kDa heat shock protein, mitochondrial   12 4 
P61626 Lysozyme C   1 1 
P61769 Beta-2-microglobulin 2 1 
P61978 Heterogeneous nuclear ribonucleoprotein K   24 6 
P61981 14-3-3 protein gamma   6 4 
P62081 40S ribosomal protein S7 2 2 
P62158 Calmodulin   11 2 
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P62241 40S ribosomal protein S8 5 3 
P62244 40S ribosomal protein S15a 6 3 
P62249 40S ribosomal protein S16 12 3 
P62258 14-3-3 protein epsilon   7 3 
P62263 40S ribosomal protein S14 10 2 
P62266 40S ribosomal protein S23 2 2 
P62269 40S ribosomal protein S18   19 7 
P62277 40S ribosomal protein S13 7 5 
P62280 40S ribosomal protein S11 19 5 
P62304 Small nuclear ribonucleoprotein E   5 2 
P62306 Small nuclear ribonucleoprotein F   5 2 
P62310 U6 snRNA-associated Sm-like protein LSm3 1 1 
P62318 Small nuclear ribonucleoprotein Sm D3   3 1 
P62424 60S ribosomal protein L7a   1 1 
P62491 Ras-related protein Rab-11A   7 3 
P62701 40S ribosomal protein S4, X isoform   7 3 
P62736 Actin, aortic smooth muscle   126 9 
P62750 60S ribosomal protein L23a 13 3 
P62753 40S ribosomal protein S6   1 1 
P62805 Histone H4 1857 11 
P62807 Histone H2B type 1-C/E/F/G/I   1208 7 
P62820 Ras-related protein Rab-1A   8 2 
P62826 GTP-binding nuclear protein Ran   13 3 
P62829 60S ribosomal protein L23   2 1 
P62834 Ras-related protein Rap-1A   3 1 
P62847 40S ribosomal protein S24 1 1 
P62851 40S ribosomal protein S25 4 3 
P62857 40S ribosomal protein S28 6 2 
P62873 
Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit 
beta-1 8 3 
P62899 60S ribosomal protein L31 9 1 
P62913 60S ribosomal protein L11   28 7 
P62917 60S ribosomal protein L8 14 3 
P62937 Peptidyl-prolyl cis-trans isomerase A   19 6 
P62988 Ubiquitin 178 5 
P62995 Transformer-2 protein homolog beta   4 4 
P63000 Ras-related C3 botulinum toxin substrate 1   2 2 
P63104 14-3-3 protein zeta/delta   50 7 
P63173 60S ribosomal protein L38 1 1 
P63220 40S ribosomal protein S21 6 2 
P63241 Eukaryotic translation initiation factor 5A-1   1 1 
P63244 Guanine nucleotide-binding protein subunit beta-2-like 1   5 3 
P68104 Elongation factor 1-alpha 1   40 5 
P68363 Tubulin alpha-1B chain   32 8 
P68371 Tubulin beta-2C chain   56 10 
P68871 Hemoglobin subunit beta   1234 11 
P69891 Hemoglobin subunit gamma-1   3 2 
P69905 Hemoglobin subunit alpha   854 8 
P80723 Brain acid soluble protein 1   1 1 
P81605 Dermcidin   1 1 
P83731 60S ribosomal protein L24   5 4 
P84077 ADP-ribosylation factor 1 11 2 
P84085 ADP-ribosylation factor 5 1 1 
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P84098 60S ribosomal protein L19 3 1 
P84103 Splicing factor, arginine/serine-rich 3   26 3 
Q01105 Protein SET   4 1 
Q01130 Splicing factor, arginine/serine-rich 2   3 3 
Q01469 Fatty acid-binding protein, epidermal   1 1 
Q01995 Transgelin   13 4 
Q02543 60S ribosomal protein L18a 9 5 
Q03113 Guanine nucleotide-binding protein subunit alpha-12   2 1 
Q04837 Single-stranded DNA-binding protein, mitochondrial   6 3 
Q06830 Peroxiredoxin-1   56 11 
Q07020 60S ribosomal protein L18 12 3 
Q07507 Dermatopontin   4 2 
Q07812 Apoptosis regulator BAX   1 1 
Q07955 Splicing factor, arginine/serine-rich 1   19 5 
Q12905 Interleukin enhancer-binding factor 2   15 4 
Q12931 Heat shock protein 75 kDa, mitochondrial   1 1 
Q13011 Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial 2 2 
Q13162 Peroxiredoxin-4   1 1 
Q13242 Splicing factor, arginine/serine-rich 9   9 3 
Q13283 Ras GTPase-activating protein-binding protein 1   1 1 
Q13404 Ubiquitin-conjugating enzyme E2 variant 1   1 1 
Q13509 Tubulin beta-3 chain   50 6 
Q13765 Nascent polypeptide-associated complex subunit alpha   2 1 
Q13885 Tubulin beta-2A chain 28 7 
Q14011 Cold-inducible RNA-binding protein   3 1 
Q14019 Coactosin-like protein 4 2 
Q14697 Neutral alpha-glucosidase AB   1 1 
Q15084 Protein disulfide-isomerase A6   2 2 
Q15102 Platelet-activating factor acetylhydrolase IB subunit gamma   2 1 
Q15185 Prostaglandin E synthase 3   1 1 
Q15233 Non-POU domain-containing octamer-binding protein   1 1 
Q15286 Ras-related protein Rab-35   4 1 
Q15365 Poly(rC)-binding protein 1 10 3 
Q15366 Poly(rC)-binding protein 2 2 2 
Q15661 Tryptase beta-1   1 1 
Q15717 ELAV-like protein 1   3 2 
Q16629 Splicing factor, arginine/serine-rich 7   3 2 
Q16654 
Pyruvate dehydrogenase [lipoamide] kinase isozyme 4, 
mitochondrial   1 1 
Q16658 Fascin   3 3 
Q16695 Histone H3.1t   404 7 
Q16719 Kynureninase   1 1 
Q460N5 Poly [ADP-ribose] polymerase 14   1 1 
Q4G163 F-box only protein 43   1 1 
Q59H18 Serine/threonine-protein kinase TNNI3K   4 1 
Q5FWF4 Zinc finger Ran-binding domain-containing protein 3   2 1 
Q5HYI8 Rab-like protein 3 3 1 
Q5JNZ5 Putative 40S ribosomal protein S26-like 1 9 1 
Q5SVQ8 Zinc finger and BTB domain-containing protein 41 1 1 
Q5T2N8 ATPase family AAA domain-containing protein 3C 2 2 
Q5T7P6 Transmembrane protein 78 5 1 
Q5T8P6 RNA-binding protein 26   1 1 
Q5TID7 Uncharacterized protein C1orf114 2 1 
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Q5VTU8 ATP synthase subunit epsilon-like protein, mitochondrial 3 3 
Q5VV41 Rho guanine nucleotide exchange factor 16 2 1 
Q5XG87 DNA polymerase sigma   1 1 
Q63HR2 Tensin-like C1 domain-containing phosphatase   1 1 
Q6IAA8 UPF0404 protein C11orf59 1 1 
Q6IEE8 Schlafen family member 12-like 2 2 
Q6NVV1 Putative 60S ribosomal protein L13a-like MGC87657 4 3 
Q6NXG1 Epithelial splicing regulatory protein 1   2 1 
Q6NXT2 Histone H3-like 80 3 
Q6PRD1 Probable G-protein coupled receptor 179   2 1 
Q6R327 Rapamycin-insensitive companion of mTOR   1 1 
Q71U36 Tubulin alpha-1A chain   223 11 
Q71UI9 Histone H2A.V   36 3 
Q71UM5 40S ribosomal protein S27-like protein 3 2 
Q7L2R6 Zinc finger protein 765 3 1 
Q86SG6 Serine/threonine-protein kinase Nek8   1 1 
Q86U44 N6-adenosine-methyltransferase 70 kDa subunit   1 1 
Q86YZ3 Hornerin 1 1 
Q8IUE6 Histone H2A type 2-B 91 3 
Q8IY63 Angiomotin-like protein 1 1 1 
Q8IYB3 Serine/arginine repetitive matrix protein 1   2 2 
Q8N257 Histone H2B type 3-B   5 3 
Q8N5V2 Ephexin-1   1 1 
Q8N680 Zinc finger and BTB domain-containing protein 2 1 1 
Q8NEZ4 Histone-lysine N-methyltransferase MLL3   2 1 
Q8NHW5 60S acidic ribosomal protein P0-like 10 3 
Q8TD57 Dynein heavy chain 3, axonemal   1 1 
Q8WU39 Proapoptotic caspase adapter protein   11 4 
Q8WWR8 Sialidase-4   1 1 
Q92522 Histone H1x 7 2 
Q92576 PHD finger protein 3 1 1 
Q93045 Stathmin-2   6 2 
Q93077 Histone H2A type 1-C   43 7 
Q96A08 Histone H2B type 1-A   654 5 
Q96DB2 Histone deacetylase 11   1 1 
Q96KK5 Histone H2A type 1-H   48 8 
Q96L21 60S ribosomal protein L10-like 3 2 
Q96M91 Coiled-coil domain-containing protein 11 3 1 
Q96PX9 Pleckstrin homology domain-containing family G member 4B 1 1 
Q96Q83 Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3   1 1 
Q96QV6 Histone H2A type 1-A   92 2 
Q96ST8 Coiled-coil domain-containing protein 123, mitochondrial 3 2 
Q99623 Prohibitin-2   6 4 
Q99714 3-hydroxyacyl-CoA dehydrogenase type-2   1 1 
Q99758 ATP-binding cassette sub-family A member 3   1 1 
Q99880 Histone H2B type 1-L   7 3 
Q9BPX5 Actin-related protein 2/3 complex subunit 5-like protein   1 1 
Q9BRL6 Splicing factor, arginine/serine-rich 2B   11 2 
Q9BRX8 Uncharacterized protein C10orf58 1 1 
Q9BTC0 Death-inducer obliterator 1   1 1 
Q9BUP3 Oxidoreductase HTATIP2   1 1 
Q9BVA1 Tubulin beta-2B chain 15 6 
Q9BVC6 Transmembrane protein 109   4 1 
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Q9BWT7 Caspase recruitment domain-containing protein 10   2 1 
Q9BYT8 Neurolysin, mitochondrial   1 1 
Q9H299 SH3 domain-binding glutamic acid-rich-like protein 3   2 1 
Q9H3P7 Golgi resident protein GCP60   2 1 
Q9H3Z7 Uncharacterized protein C20orf135 1 1 
Q9H4B7 Tubulin beta-1 chain 8 4 
Q9H853 Putative tubulin-like protein alpha-4B   5 1 
Q9NPC6 Myozenin-2   1 1 
Q9NQ38 Serine protease inhibitor Kazal-type 5   2 1 
Q9NUJ7 PI-PLC X domain-containing protein 1 1 1 
Q9NUQ9 Protein FAM49B   1 1 
Q9NVH2 Integrator complex subunit 7   1 1 
Q9NX63 
Coiled-coil-helix-coiled-coil-helix domain-containing protein 
3, mitochondrial 1 1 
Q9NY64 
Solute carrier family 2, facilitated glucose transporter 
member 8   1 1 
Q9NY65 Tubulin alpha-8 chain   70 5 
Q9P2M7 Cingulin 1 1 
Q9P2X0 Dolichol-phosphate mannosyltransferase subunit 3   1 1 
Q9UBR2 Cathepsin Z   1 1 
Q9UBZ4 DNA-(apurinic or apyrimidinic site) lyase 2 2 1 
Q9UGV6 High mobility group protein 1-like 10   1 1 
Q9UHB6 LIM domain and actin-binding protein 1   1 1 
Q9UKL3 CASP8-associated protein 2   3 2 
Q9UNX3 60S ribosomal protein L26-like 1 8 3 
Q9UP52 Transferrin receptor protein 2   1 1 
Q9Y277 Voltage-dependent anion-selective channel protein 3   1 1 
Q9Y2H2 Phosphatidylinositide phosphatase SAC2   2 1 
Q9Y2Q3 Glutathione S-transferase kappa 1   1 1 
Q9Y2V2 Calcium-regulated heat stable protein 1   1 1 
Q9Y3U8 60S ribosomal protein L36 1 1 
Q9Y5G4 Protocadherin gamma-A9   1 1 
Q9Y6H5 Synphilin-1   2 1 
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Appendix 10 
List of proteins shared by all TC and SCLC samples.  
 
Accession no. Protein TC QM SCLC QM 
P31946 14-3-3 protein beta/alpha  35 13 
P62736 Actin, aortic smooth muscle  284 126 
P60709 Actin, cytoplasmic 1  896 979 
P02768 Serum albumin 1287 524 
P08758 Annexin A5  49 17 
P25705 ATP synthase subunit alpha, mitochondrial 22 22 
P06576 ATP synthase subunit beta, mitochondrial  33 24 
P61604 10 kDa heat shock protein, mitochondrial  7 12 
P23528 Cofilin-1  13 19 
P00403 Cytochrome c oxidase subunit 2  11 14 
P06733 Alpha-enolase  20 34 
P04406 Glyceraldehyde-3-phosphate dehydrogenase  59 56 
P62873 Guanine nucleotide-binding protein G 6 8 
P16403 Histone H1.2  18 135 
Q96QV6 Histone H2A type 1-A  101 92 
P04908 Histone H2A type 1-B/E  737 612 
P20671 Histone H2A type 1-D  138 859 
Q8IUE6 Histone H2A type 2-B 73 91 
Q96A08 Histone H2B type 1-A  357 654 
P33778 Histone H2B type 1-B  334 472 
P62807 Histone H2B type 1-C/E/F/G/I  348 1208 
Q16695 Histone H3.1t  104 404 
Q6NXT2 Histone H3-like 50 80 
P62805 Histone H4 725 1857 
P69905 Hemoglobin subunit alpha  2580 854 
P68871 Hemoglobin subunit beta  3459 1234 
P07910 Heterogeneous nuclear ribonucleoproteins C1/C2  13 29 
P04792 Heat shock protein beta-1  54 56 
P01876 Ig alpha-1 chain C region 60 19 
P01859 Ig gamma-2 chain C region 25 28 
P01834 Ig kappa chain C region 87 54 
P01842 Ig lambda chain C regions 42 32 
P14174 Macrophage migration inhibitory factor  11 7 
P19105 Myosin regulatory light chain 12A  15 10 
P60660 Myosin light polypeptide 6  53 19 
P62937 Peptidyl-prolyl cis-trans isomerase A  45 19 
P23284 Peptidyl-prolyl cis-trans isomerase B  29 17 
Q06830 Peroxiredoxin-1  82 56 
P32119 Peroxiredoxin-2  191 76 
P62913 60S ribosomal protein L11  14 28 
P30050 60S ribosomal protein L12 24 27 
P62899 60S ribosomal protein L31 17 9 
P22626 Heterogeneous nuclear ribonucleoproteins A2/B1  62 76 
P62263 40S ribosomal protein S14 13 10 
P62269 40S ribosomal protein S18  17 19 
Q04837 Single-stranded DNA-binding protein, mitochondrial  7 6 
P37802 Transgelin-2  46 22 
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Q71U36 Tubulin alpha-1A chain  37 223 
P07437 Tubulin beta chain  14 155 
P60174 Triosephosphate isomerase  36 42 




Alessandro Tanca, Novel methods for proteomics analysis of formalin-fixed, paraffin-embedded tissues (FFPE), and their 
applications for biomarker discovery, Tesi di dottorato in Scienze biomolecolari e biotecnologiche, Università degli studi di Sassari 
Appendix 11 
Distribution of protein isoforms within principal protein families.  
 





hnRNPs O43390 Heterogeneous nuclear ribonucleoprotein R   0 2 
 P07910 Heterogeneous nuclear ribonucleoproteins C1/C2   13 29 
 P09651 Heterogeneous nuclear ribonucleoprotein A1   0 27 
 P0C7M2 Putative heterog. nuclear ribonucleoprot. A1-like protein 3   0 2 
 P14678 Small nuclear ribonucleoprotein-associated proteins B and B'   1 4 
 P14866 Heterogeneous nuclear ribonucleoprotein L   0 1 
 P22626 Heterogeneous nuclear ribonucleoproteins A2/B1   62 76 
 P31942 Heterogeneous nuclear ribonucleoprotein H3   1 21 
 P31943 Heterogeneous nuclear ribonucleoprotein H   0 4 
 P38159 Heterogeneous nuclear ribonucleoprotein G   1 8 
 P52597 Heterogeneous nuclear ribonucleoprotein F   0 1 
 P61978 Heterogeneous nuclear ribonucleoprotein K   6 24 
 P62304 Small nuclear ribonucleoprotein E   4 5 
 P62306 Small nuclear ribonucleoprotein F   1 5 
 P62318 Small nuclear ribonucleoprotein Sm D3   2 3 
 Q32P51 Heterogeneous nuclear ribonucleoprotein A1-like protein 2   3 0 
     
Splicing factors P23246 Splicing factor, proline- and glutamine-rich 0 1 
 P84103 Splicing factor, arginine/serine-rich 3   4 26 
 Q01130 Splicing factor, arginine/serine-rich 2   0 3 
 Q07955 Splicing factor, arginine/serine-rich 1   1 19 
 Q13242 Splicing factor, arginine/serine-rich 9   0 9 
 Q16629 Splicing factor, arginine/serine-rich 7   0 3 
 Q9BRL6 Splicing factor, arginine/serine-rich 2B   0 11 
     
Tubulins P07437 Tubulin beta chain   14 155 
 P68363 Tubulin alpha-1B chain   2 32 
 P68371 Tubulin beta-2C chain   10 56 
 Q13509 Tubulin beta-3 chain   0 50 
 Q13885 Tubulin beta-2A chain 20 28 
 Q71U36 Tubulin alpha-1A chain   37 223 
 Q9BVA1 Tubulin beta-2B chain 0 15 
 Q9H4B7 Tubulin beta-1 chain 0 8 
 Q9H853 Putative tubulin-like protein alpha-4B   2 5 
 Q9NY65 Tubulin alpha-8 chain   10 70 
     
Histones O75367 Core histone macro-H2A.1   3 0 
 P04908 Histone H2A type 1-B/E   737 612 
 P07305 Histone H1.0   4 0 
 P10412 Histone H1.4   2 2 
 P16104 Histone H2A.x   13 0 
 P16401 Histone H1.5   0 39 
 P16402 Histone H1.3   0 3 
 P16403 Histone H1.2   18 135 
 P20671 Histone H2A type 1-D   138 859 
 P22492 Histone H1t   15 0 
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 P33778 Histone H2B type 1-B   334 472 
 P62805 Histone H4 725 1857 
 P62807 Histone H2B type 1-C/E/F/G/I   348 1208 
 Q16695 Histone H3.1t   104 404 
 Q6NXT2 Histone H3-like 50 80 
 Q71UI9 Histone H2A.V   14 36 
 Q8IUE6 Histone H2A type 2-B 73 91 
 Q8N257 Histone H2B type 3-B   3 5 
 Q92522 Histone H1x 1 7 
 Q93077 Histone H2A type 1-C   0 43 
 Q96A08 Histone H2B type 1-A   357 654 
 Q96KK5 Histone H2A type 1-H   0 48 
 Q96QV6 Histone H2A type 1-A   101 92 
 Q99880 Histone H2B type 1-L   0 7 
  Q9P0M6 Core histone macro-H2A.2   2 0 
 
 
